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Abstract 
Introduction and aim of the study Ileal conduit(IC) is the most frequent urinary 
diversion following radical cystectomy. Reports highlighted high rates of long term 
complications but the best schedule of surveillance remains undecided. The main 
aim of this study to investigate IC patients’ experience after surgery and to explore 
current practice of surveillance and investigate stakeholders’ views about alternative 
models. 
Materials and Methods This study was formed of two parts. Part A: 2000 IC 
patients were invited to complete a postal questionnaire. The questionnaire explored 
patients’ experience of complications and their views of follow up. Statistical analysis 
was conducted using Stata®14 software to identify association between reporting 
complications, patients’ satisfaction or views and patient characteristics. Part B: A 
multicentre qualitative study, using semi-structured interviews among health 
professionals involved in IC care was conducted. Interviews explored participants’ 
views of current practice and best surveillance model. Following thematic analysis, 
the framework of the NPT was used to analyse the data. 
Results Part A: 1092 completed questionnaires were analysed (response rate= 
60%). 88% of respondents reported ≥1 complication, and 45% ≥1 frequent 
complication. UTIs, hernia and appliances problems are the most reported ones. 
Multivariable logistic regression showed female gender, age < 60 years, benign 
indication for surgery and difficult access to stoma nurse were associated with 
reporting complications. Of the 44% who felt GP follow up is inappropriate; lack of 
experience was the main cause. Part B: 17 interviews were conducted with different 
types of health professionals at three centres. Participants described good 
understanding of surveillance scope and value. They highlighted the need for 
change due to lack of guidelines and service workload. The stoma nurse role was 
seen as pivotal in making surveillance workable. There was a lack of agreement over 
surveillance length. Participants raised concern regarding GPs willingness to 
participate and about lack of resources. 
Conclusion The high and cumulative incidence of IC related complications suggest 
the development of a standardised, evidence based long term surveillance protocol. 
A shared care community based nurse led scheme could be a suitable model. 
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Chapter 1: Introduction 
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1.1. Ileal conduit: History and trends in use  
 
The ileal conduit (IC) is a non-continent urinary diversion (UD) that is performed 
surgically following radical cystectomy (RC) for bladder cancer. It has also been 
used with or without RC as a last resort surgical option for benign intractable bladder 
conditions such as neurogenic bladder, interstitial cystitis and small bladder capacity 
(Osborn et al., 2014). This surgical technique was initially described in 1909 by 
Verhoogen and De Graeuve and has been used widely since then (Verhoogen and 
De Graeuwe, 1909). Further refinements of the technique have been described, 
these refinements focused mainly on different techniques of uretero-ileal 
anastomosis (Bricker, 1950; Wallace, 1970).  
Despite the development of different continent urinary diversion surgical techniques 
in an attempt to improve body image (Studer et al., 1989; Wenderoth et al., 1990; 
Philip et al., 2009), incontinent urinary diversion remained the predominant 
technique. It was seen as a simple, quick technique with lower risk of complications 
compared to continent diversion such as neobladder formation (Colombo and 
Naspro, 2010). Ileal conduit was the most commonly used UD (80.6%) following 
radical cystectomy in the UK over the period  between 2004-2012 (Cresswell et al., 
2015). The frequency of use of IC has  shown a further increase on reporting on the 
open radical cystectomies performed in the UK in 2014 & 2015 reaching up to 86.4 
% (Jefferies et al., 2018). In a comparison of the trends of UD after RC in the US and 
Germany from 2006 to 2014, ileal conduit was the most common UD in both 
countries. The trend in IC use was stable in the US  at 87-88%, and increased in 
Germany from 52.2% to 55.4% (Groeben et al., 2018). The data obtained from the 
Swedish registry for bladder cancer has shown conduit diversion as the UD 
technique for 81% of patients after RC in 2008 (Hautmann et al., 2011). The data 
obtained from several centres at  3 different continents ( North America, Europe and 
Africa) for 16,867 patients who had RC over different periods between 1968 and 
2010 , report a frequency of choosing incontinent conduit diversion at 42.2% of 
cases compared to 38.0% having neobladders (Hautmann et al., 2011). The rest of 
the cases in the series had continent cutaneous diversion. 
Knowing the trends of UD with RC and the number of yearly RC performed, the 
number of IC performed each year can be estimated. Between 2004 and 2012, 
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12,539 RC were performed in England according to data obtained from the HES 
website; this has increased from 1406 cases in 2004/2005 to 1798 cases in 
2011/2012  (Cresswell et al., 2015).  According to the British Association of 
Urological Surgeons (BAUS) national audit there were 5,857 radical cystectomies 
undertaken in England during the time period 2014-2016 (2,028 in 2014, 1,952 in 
2015 and 1,877 in 2016) (BAUS, 2018b). In another European country, Germany, a 
total of 60,447 RC procedures were performed between 2006 -2014 with an annual 
increase in the number from 5627 in 2006, to 7390 in 2014 (Groeben et al., 2018). 
Over the same period, 17,711 RC procedures were performed in the US with an 
annual caseload range of 1666–2009. 
1.2. Ileal conduit: The surgical technique 
The IC operation comprises three main steps:1) isolation of a loop of ileum, 2) 
uretero-ileal anastomosis and 3) formation of the stoma (Smith et al., 2016). A loop 
of ileum with a length of 15-20 cm, 10-12 cm away from the ileocoecal junction is 
selected to form the conduit. This is done to provide enough length for the conduit to 
reach up to the stoma site and to avoid the terminal ileum where vitamin B12 and bile 
salts are absorbed (Bricker, 1950). Once a suitable segment is marked, the segment 
is isolated with its mesenteric blood supply by dividing both ends from the ileum. The 
continuity of the ileum is restored by suturing or stapling the divided ends back 
together and the mesenteric defect is closed to avoid internal hernia formation 
(Figure 1.1) (Colombo and Naspro, 2010). 
The proximal end (non-stoma side) is then anastomosed to the distal end of the 
ureters. Two famous techniques have been described for this step: Bricker and 
Wallace (Bricker, 1950; Wallace, 1970). At the Bricker technique, an enterotomy is 
made on the IC proximal end and the spatulated end of the ureter is anastomosed to 
it using absorbable suture. The same is done for the other side and the anastomosis 
is supported by temporary stent that will be brought through the conduit out of the 
stoma. Instead of doing 2 enterotomies , one ureter could be anastomosed to the 
proximal open end of the IC, otherwise it is closed by sutures (Figure 1.2) (Lobo et 
al., 2016a).  In the Wallace technique, both ureters are spatulated and the inner 
walls are sutured together. The outer walls are then sutured to the circumference of 
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the opened proximal end of the IC using absorbable sutures. Again, this is supported 
by two stents (Figure 1.3) (Lobo et al., 2016a). 
The stoma is then created by excising a circle of skin at the pre-marked stoma site. 
The subcutaneous tissue is dissected down to the rectus muscle sheath. A cruciate 
incision is made in the sheath and the muscle is dissected to create a route to the 
abdominal cavity. The proximal end of the stoma is delivered through the abdominal 
wall created defect to the stoma site and secured by sutures to the rectus sheath.  
The mucosa is the then everted using absorbable suture that run between the 
sheath or the skin and the mucosal edge. 
In essence, this operation involves modification and surgical changes to three 
different body systems; the urinary tract, the small bowel and the anterior abdominal 
wall. 
 
 
Figure 1.1. A segment of ileum isolated and the continuity of the ileum is regained 
using suturing, reproduced with permission from corresponding author (Colombo and 
Naspro, 2010). 
5 
 
 
Figure 1.2. Bricker technique of uretero-ileal anastomosis, reproduced with 
permission from corresponding author (Lobo et al., 2016a). 
 
Figure1.3. Wallace technique of uretero-ileal anastomosis, reproduced with 
permission from corresponding author (Lobo et al., 2016a).  
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1.3. Pathophysiological and pressure changes following ileal conduit 
Following the formation of the IC, several changes can occur secondary to the new 
variations such as exposure of urine to bowel mucosa and absence of the ureteric 
anti-reflux mechanism. These alterations lead to metabolic and upper tract changes 
that can lead to the development of complications later on. 
1.3.1. Metabolic changes  
While the bladder urothelium is highly impermeable to urinary solutes, the bowel 
mucosa is highly permeable to water. On exposure of bowel segment to highly 
concentrated urine with an osmolality 500-850mOsmo per litre, the water is shifted 
into the IC lumen leading to loss of body fluid. This causes nocturia and leads to fluid 
depletion for IC patients (Cruz and Huot, 1997; Mills and Studer, 1999; Mundy, 1999; 
Newman and Price, 1999; Chang and Koch, 2000; Roth and Koch, 2018) 
Due to the nature of the antiports present on the surface membrane of the ileal 
mucosa, chloride is absorbed from urine and bicarbonate is excreted into the lumen 
of the IC leading to metabolic acidosis. In an attempt for compensation, the kidneys 
excrete hydrogen ions (H+) which is buffered by phosphate (PO43-) leading to 
depletion and bone demineralisation. In order to avoid further loss of phosphate, the 
kidneys create another buffer which is ammonium (NH4+). Subsequently, this gets 
reabsorbed leading to further acidosis in the form of hypercholermioc metabolic 
acidosis (Turnberg et al., 1970; Koch et al., 1990; McDougal et al., 1995; Stampfer 
and McDougal, 1997; Roth and Koch, 2018). 
In addition, the vitamin B12 receptors are more concentrated at the terminal ileum 
mainly at the last 120 cm. The loss of a significant length of the terminal ileum could 
affect the process of absorption leading to slow depletion of body stores over few 
years and eventually resulting in macrocytic anaemia and peripheral neuropathy 
(Jahnson and Pedersen, 1993; Mills and Studer, 1999; Roth and Koch, 2018). 
Normally, fatty acids are absorbed after binding to bile salts at the terminal ileum. 
The interruption of this process due to less absorbing surface of terminal ileum could 
lead to malabsorption of fat and steatorrhea.  The passage of bile salts into the colon 
could damage the mucosa and cause secretory diarrhoea (Durrans et al., 1989; Roth 
and Koch, 2018). 
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1.3.2. Effect on upper urinary tract 
One of the  driving forces for urological surgeons to develop the IC technique was 
the finding of significant reflux when colon was used as a conduit (Coffey, 1911). The 
effect of urine reflux on the morphology of the renal papillae has been demonstrated 
in animal modules (Hodson et al., 1975; Ransley and Risdon, 1975). Another animal 
model  compared the incidence of pyelonephritis between two samples, where an 
anti-reflux implantation technique was used for anastomosis in one group (Richie et 
al., 1974).The results indicated incidence of pyelonephritis  of 83 % in the reflux 
group compared to 7% in the anti-reflux one. The thin muscle layer of the ileum 
compared to colon, and the ileal peristaltic movement compared to the mass 
contraction of the colon, were both considered likely to make IC a low pressure 
conduit (Sagalowsky, 1995). Compared to colon, ileum is a lower pressurised 
conduit but unfortunately there is still an element of reflux. Several studies confirmed 
radiologically the reflux of urine from the ileal conduit back into the ureter and renal 
pelvis using loopogorams (Neal, 1985). In addition,  scarring of the kidney was 
detected by means of renal scintigraphy using (99m)Tc-dimercaptosuccinic acid 
(Kristjansson et al., 1995a). This occurs as a result of using the non-anti-reflux 
surgical technique of uretero-ileal anastomosis and also because of the increase of 
pressure inside the conduit. Not only stomal stenosis, but also the normal peristaltic 
waves that occur in the ileal conduit wall, can cause that rise in pressure. This was 
shown in a study that compared the pressure within the IC in 27 patients with normal 
upper tract to 17 patients who had upper tract dilatation, where a vigorous type of 
peristaltic waves with high frequency and amplitude occurred more frequently in the 
hydronephrotic group (Neal et al., 1985; Neal, 1989). 
This led to further attempts to refine the surgical technique to develop non-refluxing 
IC to overcome the back pressure resulting from the ileal peristaltic waves. Several 
such techniques were described in literature including Afferent nipple valve, afferent 
ileal loop, Le Duc technique, Split-cuff ureteric nipple, the serous-lined extramural 
tunnel (The Abol–Enein technique)(Warwick and Ashken, 1967; Studer et al., 1988; 
Shaaban et al., 1992; Abol-Enein and Ghoneim, 1994; Stein et al., 1996; 
Sagalowsky, 1998; Schwaibold et al., 1998). Despite being successful in minimising 
reflux, further reports showed a higher incidence of ureteric stricture with these 
techniques (Shaaban et al., 1992; Stein et al., 1996). 
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1.4. Long-term complications associated with ileal conduit 
There is emerging evidence of the development of IC related complications over 
time, and that complications can continue to develop up to 20 yrs. after surgery 
(Shimko et al., 2011). However, there are paucity of reports in the literature on rates 
of complication in long-term IC patients. Most of the available studies report on a 
mixture of short and long term complications, with a very small proportion of the 
patients who are 10 years or more after surgery (Hautmann et al., 2011). Studies 
reporting complications rates continue to be added to literature, however due the 
lack of standardisation in reporting, comparisons between studies and drawing 
conclusions from the results is challenging. For example, reports of incidence of 
renal function deterioration following IC may differ due to the use of different 
methods of assessment of renal function. While some series rely on serum 
creatinine measures, others use MDRD formula or radiographic changes to estimate 
the kidney function deterioration (Kristjansson et al., 1995b; Madersbacher et al., 
2003; Rouanne et al., 2015). Similarly, the diagnosis of parastomal hernia is based 
on radiological evidence in some studies and only on clinical examination in others 
(Narang et al., 2017). With the reported incidence of postoperative complications 
following IC reaching up to 66% of patients (Madersbacher et al., 2003), there is a 
need to standardise the method of reporting in order to enable clinicians as well as 
patients to take informed decisions regarding the choice of the method of UD. 
The following sections report the rates of different types of complications associated 
with IC as described in three of the largest available series with long median follow 
up. Two of the three large series that reported on long term IC complications were 
published by Madersbacher et al and by Shimko et al in 2003 and 2011 respectively 
(Madersbacher et al., 2003; Shimko et al., 2011). Madersbacher et al retrospectively 
analysed the records of 412 patients who had IC between 1971 and 1995 in Bern, 
and reported on 131 patients who survived for 5 years or more following their 
surgery. Of those, only 43 patients were survivors for 10 years or more. Shimko et al 
reported on their experience from the Mayo clinic in the US. The cohort was of 1507 
patients who had RC and conduit urinary diversion between 1980 and 1998. 409 
patients were a decade or more survivors and 215 survived 15 years or more post-
surgery. In the third study, Gilbert et al reported on the rate of complications for 544 
bladder cancer survivors who had IC using the registry of the 5% Medicare sample 
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from 1998 to 2005,. The study reported the complications rate at different periods 
following their surgery, up to 4-5 years (Gilbert et al., 2013). In addition to these 
three series, results from other studies that have focused only on a particular 
complication are described below under the relevant section describing this 
complication.  
A list of the studies that have reported complication frequency is shown in table 1.1. 
Under each section, the complication will be explained with its possible causes and 
presentation, followed by the frequency reported in literature and then methods of 
treatment or prevention described. 
First author Year Country No. of 
patients 
Complication 
reported 
Type of 
study 
Madersbacher 2003 Sweden 412 All CS 
Shimko 2011 US 1507 All CS 
Gilbert 2013 US 544 All CS 
Donahue 2014 US 433 PH CS 
Narang 2017 UK 3170 PH SR 
Kouba 2007 US 137 PH CS 
Liu 2014 US 516 PH CS 
Pisters 2014 US 496 PH CS 
Movassaghi 2016 US 670 PH CS 
Klein 1989 US 319 Stoma stenosis CS 
Magnusson 1996 Sweden 12 Stoma stenosis CS 
Wood 2004 UK 93 Stoma retraction CS 
Taneja 2009 US 45 Stoma retraction CS 
Brooke 1993 UK 37 Stoma prolapse CS 
Pernet 1985 Netherlands 132 UTI CS 
Kristjansson 1995 Sweden 18 Renal impairment RCT 
Samuel 2006 UK 340 Renal impairment CS 
Rouanne 2015 France 226 Renal impairment CS 
Tal 2007 Israel 221 Ureteric stricture CS 
Lobo 2016 UK 478 Ureteric stricture LR 
Schmidt 1973 USA 178 Urolithiasis CS 
Hall 1989 USA 898 Urolithiasis CS 
Turk 1999 USA 94 Urolithiasis CS 
Gupta 2014 USA 4,878 Bone 
demineralisation 
CS 
CS, case series; LR, literature review; RCT, randomised controlled trial; SR, systematic review 
Table 1.1. Summary of studies reporting on different IC related complications. 
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1.4.1. Parastomal hernia: 
As described above the formation of the stoma involves the creation of a channel at 
the abdominal wall to bring the distal end of the IC externally. The channel is created 
by removing an ellipse of skin, incising of the rectus sheath and dissection of the 
rectus muscle (Smith et al., 2012). This breach of the abdominal wall creates 
weakness at the integrity of the wall predisposing patients to the risk of parastomal 
hernia (PH). Parastomal hernia was defined by Pearl as ‘an incisional hernia that 
develops in the vicinity of a colostomy or ileostomy’ (Pearl, 1989). The European 
Hernia society (EHS) had defined incisional hernia as ‘an abdominal wall gap with or 
without a bulge in the area of a postoperative scar perceptible by clinical examination 
or imaging’ (Korenkov et al., 2001). On a further attempt to define PH, the EHS 
defined PH as ‘an abnormal protrusion of the contents of the abdominal cavity 
through the abdominal wall defect created during placement of a colostomy, 
ileostomy or ileal conduit stoma’ (Smietanski et al., 2014). On the same document 
the PH was classified into 4 categories according to size (small is ≤5 cm) and the 
presence of a concomitant incisional hernia. Patients with PH could present with 
symptoms such as pain or abdominal mass, but could also remain asymptomatic. A 
study of 433 patients with PH following IC showed that 40% of patients had 
symptomatic PH in the form of discomfort, pain or poor fit of appliance (Donahue et 
al., 2014). 
As a result of the variation of definition, the method of diagnosis, and the length of 
follow up, the incidence of reporting PH following IC is variable in literature (Narang 
et al., 2017). A systematic review reported on 12 studies that matched the review 
inclusion criteria and of a pooled total of 3170 patients who underwent IC surgery; it 
reported an incidence of PH of 17% (4-35%) (Narang et al., 2017). The diagnostic 
criteria were not reported in most of the studies. The Bern and the Mayo studies - 
with the longest median follow up in the review - reported an incidence of PH of 13.7 
% and 14.5% respectively. In one of the 12 studies, Donahue et al described the 
incidence of PH diagnosis when clinical examination is compared to radiology to 
establish the diagnosis. The results showed PH diagnosed clinically in 24% of the 
series in comparison to 35% when imaging was used (Donahue et al., 2014).  The 
same review reported on the results of an analysis of data obtained from 5 cohorts 
that studied the possible risk factors for PH; this showed that female gender, high 
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BMI, low preoperative albumin and previous history of laparotomy were significantly 
associated with the development of PH (Kouba et al., 2007b; Donahue et al., 2014; 
Liu et al., 2014; Pisters et al., 2014; Movassaghi et al., 2016).   
The results of the systematic review by Narang and colleagues indicated that 
between 8% and 75% with a PH were offered a repair at different series. It is worth 
noting that the incidence of recurrence of PH following repair was 27%-50% (Narang 
et al., 2017). In an attempt to minimise the rate of PH, some surgeons started to 
adopt prophylactic mesh at the area of the stoma during the surgery and RCTs 
showed a significant reduction of PH (Janes et al., 2004; Hammond et al., 2008; 
Lambrecht et al., 2015). 
1.4.2. Stomal stenosis, retraction and prolapse 
One of the possible causes of stomal stenosis  is the surgical technique when a 
small opening is created at the fascia prior to maturing the stoma (Syan-Bhanvadia 
and Daneshmand, 2017). Another cause is skin hyperkeratsosis which can occur 
due to stoma retraction leading to urine regular contact with skin causing skin 
irritation and keratsosis. Failure of emptying because of the stenosis could result into 
urinary stasis leading to infection, formation of stones and impaired renal function. 
Stomal stenosis was reported to occur to 2%-8% of patients after IC (Klein et al., 
1989; Magnusson et al., 1996; Colwell et al., 2001; Madersbacher et al., 2003) . 
Shimko et al reported an incidence of stomal stenosis in 2% of their series at a 
median of 9.2 years postoperatively (Shimko et al., 2011).  
Usually stenosis can be treated by gentle dilatation and patients might need to 
perform self-catheterisation to keep the stoma open (Lee et al., 2018). Sometimes 
surgical excision of skin or even distal end of the conduit and mobilisation of the 
stoma could be required. In a series of 300 patients, stomal stenosis developed in 8 
% of patients and only 5% of the whole series needed surgical repair (Klein et al., 
1989). 
Stoma retraction or prolapse are two other stoma-related complications described in 
literature. Both have been reported collectively as stoma-related complications 
together with PH and stoma stenosis in some series (Madersbacher et al., 2003; 
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Gilbert et al., 2013).These two complications could possibly occur secondary to poor 
surgical technique or the change of the patient’s body habitus. 
 Retraction occurrence has been reported as low as 0.5% (Klein et al., 1989), but 
another series reported the incidence to be as high as 31% in females who have the 
surgery for intractable urinary symptoms (Wood et al., 2004).  
 Stoma prolapse was reported in 0.5%-5.4% of patients (Klein et al., 1989; Brooke, 
1993; Kouba et al., 2007b). Kouba et al showed a significantly higher rate of stoma 
complications (27%) in obese (BMI more than 30 kg/m2) compared to patients with a 
normal BMI (less than 25 kg/m2)(4%). 
Taneja and Godoy described a new technique to minimise the risk of stoma 
retraction where maturing the stoma is performed prior  to transposing it to the skin 
by defatting of the distal mesentery, placement of everting sutures immediately 
adjacent to the bowel mesentery in a diamond configuration, and  full-thickness 
locking sutures to fix the eversion (Taneja and Godoy, 2009). In their series the 
retraction was observed in 2% of patients. 
1.4.3. Infection 
Urinary tract infection (UTI) is one of the most common reported complications 
following IC. The ascending contamination of the IC with bacteria combined with the 
urinary reflux into the kidney, and the use of a loop of bowel that is normally 
colonised with bacteria could all be predisposing factors for the development of 
infection at this group of patients. A series of 106 patients diagnosed with muscle 
invasive bladder cancer (MIBC) and treated with RC and different forms of urinary 
diversion demonstrated the presence of urinary bacterial colonisation at 97% of the 
IC group (Prcic and Begic, 2017). Neal et al reported the presence of reflux on 
loopogram in 72% of the normal renal units and 93% of the hydronephrotic ones in a 
series of 111 IC patients with a minimum 5 years of follow up (Neal, 1985).  In 
urinary conduit patients the urine is usually contaminated by ascending gram positive 
mixed skin flora (i.e., streptococcal species and Staphylococcus epidermidis), 
however patients are mostly asymptomatic (Wullt et al., 2004). 
In a series of 132 patients who had IC and a mean follow up of 4.5 years 
pyelonephritis was  found to have developed in 22 (16.6%) patients (Pernet and 
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Jonas, 1985).Gilbert et al reported on the rate of infection in a series of 1278 patients 
who underwent IC (Gilbert et al., 2013). By the end of the second year post 
operatively, 27% had developed UTIs. During the period between 4-5 years 13.7% 
had UTIs. The Mayo clinic and Bern series reported an occurrence of infection 
in16% and 23% of patients respectively (Madersbacher et al., 2003; Shimko et al., 
2011).The Mayo series results showed an occurrence of recurrent UTIs to 7% of 
patients at a median of 2.1 years (Shimko et al., 2011).   
Prompt treatment for active infection and investigating possible cause of recurrent 
infections seem to be the adequate management of UTIs in those patient rather than 
using long term prophylactic antibiotics , as any effort to eradicate bacteria will be in 
vain due to the continuous contamination from skin flora (Wullt et al., 2004). 
1.4.4. Renal Impairment  
By far, renal impairment is the most serious long term sequela of IC urinary 
diversion. Renal failure following IC could occur secondary to a list of causes such 
as stoma or ureteric stenosis, reflux and recurrent urosepsis.  The pressure effect of 
the IC on the upper tract has been discussed earlier in this chapter (Section 1.3.2.) , 
and  the reflux of urine into the kidney and the effect of that reflux had been 
demonstrated in animal models (Hodson et al., 1975; Ransley and Risdon, 1975). 
The radiological changes and the reflux evidence on loopograms confirmed these 
findings at patients’ series (Neal, 1985).  
Different methods were used to measure renal deterioration in patients including 
blood creatinine level,  estimated glomerular filtration rate (eGFR), upper tract 
imaging, renogram and isotopic GFR (Kristjansson et al., 1995a; Madersbacher et 
al., 2003; Samuel et al., 2006; Hautmann et al., 2011; Shimko et al., 2011; Jin et al., 
2012; Eisenberg et al., 2014; Rouanne et al., 2015). This led to a wide range of 
reported rates of renal impairment following IC postoperatively. The use of isotopic 
GFR measurement is considered to be the most accurate way of assessment of the 
renal function in those patients. Chromium -51 is ideal for this assessment as it is 
freely filtered by the glomeruli and its reabsorption by the intestinal mucosa is 
minimal (Hautmann et al., 2011).  
In 1995 Kristjansson used 51Cr-EDTA to measure the renal function pre-operatively 
and after a mean follow-up of 123 months (range 36-198) (Kristjansson et al., 
14 
 
1995b). The results showed a drop of GFR by >25% in 28% of the IC group. Samuel 
et al used serial isotopic (99m) technetium-diethylenetriaminepentaacetic acid GFR 
and F+20 (99m) technetium-mercaptoacetyltriglycine renography to monitor the renal 
function in 178 patients who had more than four years of follow up (Samuel et al., 
2006). 29% of the cohort demonstrated worsening renal function, and hypertension, 
recurrent urinary sepsis and an initial post-diversion GFR < 50 ml / minute / 1.73 m 
were found to be risk factors. No surgical cause was found in 18% of the cases who 
had deteriorating renal function. A retrospective study of 226 patients who underwent 
RC and IC and had a median follow-up period of 91 months (range, 61-235 months), 
showed median eGFR decreased from 66 to 59 mL/min/1.73 m2 (Rouanne et al., 
2015). The results showed a rapid decline during the first 2 postoperative years (-9 
mL/min/1.73 m2 and -4 mL/min/1.73 m2 in the first and second year, respectively). 
Urinary obstruction was only diagnosed in 51 patients (23%). There seems to be no 
confirmed association between the type of UD and the rate of development of renal 
failure when IC is compared with bladder substitution (Jin et al., 2012; Eisenberg et 
al., 2014; Nishikawa et al., 2014). 
Surgical management to correctable cause is warranted in those patients to halt the 
loss of renal function and ureteric re-implantation was shown to preserve the renal 
function (Neal, 1985; Samuel et al., 2006; Rouanne et al., 2015)(Table 1.1). 
1.4.5. Uretero-ileal stenosis 
Uretero-ileal stricture is one of the IC complications that demonstrates the necessity 
of follow-up for those patients. This is because, while some patients who have 
stricture develop symptoms like flank pain or infection, most are asymptomatic. In a 
case series of 221 patients of which 12.7% developed uretero-ileal stricture, 75% of 
those patients were asymptomatic (Tal et al., 2007). Untreated stricture could lead to 
impaired renal function and recurrent UTIs. The stricture usually develop on the left 
side (Anderson et al., 2013; Richards et al., 2015a), which could be explained by the 
increase of tension on the anastomosis due to the formation of the stoma usually on 
the right side and the need to mobilise the left ureter to pass in between the aorta 
and the inferior mesenteric artery . For asymptomatic patients, the presence of 
hydronephrosis on upper tract imaging and the level of obstruction demonstrated on 
CT urogram or loopogram can confirm the diagnosis.  It is not clear what is the exact 
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cause for development of uretero-ileal stricture, but urine leak, tension and 
ischaemia are all believed to play a role (Large et al., 2013; Richards et al., 2015b). 
On average 10% of patients develop uretero-ileal stricture usually within the first year 
although it can develop later (Tal et al., 2007; Shimko et al., 2011; Lobo et al., 
2016b; Lee et al., 2018). Stricture was not particularly associated with certain 
technique on comparing Wallace and Bricker anastomotic techniques (Kouba et al., 
2007a; Davis et al., 2015) (Table 1.1). 
Immediate management should involve insertion of a nephrostomy or a stent if 
possible to preserve the kidney followed by treatment of the stricture. Endoscopic 
management have evolved significantly where balloon dilatation or endoureterotomy 
have shown good success rate (Wolf et al., 1997; Lin et al., 1999; Laven et al., 
2003). Nevertheless, open repair is required in recurrent or difficult cases but with 
usually high sustainable success rates reaching up to 80% compared to 30-50% 
success rate for endourological approach (Laven et al., 2003). 
1.4.6. Urolithiasis 
Patients with IC are prone to development of urinary calculi due to the existence of 
several risk factors for stone formation. As discussed earlier (section 1.3.1), the high 
permeability of ileum and the concentrated nature of urine lead to shift of fluid from 
the body to IC leading to a state of dehydration (Newman and Price, 1999; Roth and 
Koch, 2018). Lack of fatty acids absorption due to loss of long segments of ileum 
could cause binding to calcium leaving oxalate free causing hyperoxaluria forming 
calcium oxalate stones (Steiner and Morton, 1991). Chronic acidosis result into 
failure of the kidney to produce citrate; a stone crystallisation inhibitor; increasing the 
risk further (Rudman et al., 1980; Pak, 1991). In addition, the colonisation of IC with 
urea-splitting organisms can predispose those patients to struvite stones (Chang and 
Koch, 2000). 
Similar to other complications, the reported incidence of urinary calculi in IC is 
variable. It has been reported to be as  low as 1.1% and as high as 38 % (Schmidt et 
al., 1973; Hall et al., 1989; Gilbert et al., 2013).The incidence of stone formation 
following IC was reported either within comparative studies of different urinary 
diversion techniques or a retrospective cohort reporting on IC complications. One 
study comparing the incidence of upper tract calculus amongst two groups, one 
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which received a non-continent conduit diversion and another which had a continent 
diversion reported an incidence of 11% in the conduit group (Turk et al., 1999). 
Another study comparing stone formation in refluxing and non-refluxing IC found the 
incidence to be 38% and 11% respectively (Hall et al., 1989). Madersbacher et al 
have reported in their series of 412 patients an incidence of urolithiasis of 9% during 
a median follow up of 98 months. In the Mayo clinic series, 15.3% developed stones 
at a median of 2.5 years post-surgery.  
The treatment of stone disease in this group of patients was found to be challenging 
due to the anatomical changes and the higher incidence of co-morbidities (Okhunov 
et al., 2011; Hertzig et al., 2013). Patients could be treated with all 3 modalities of 
stone surgery; ESWL, PCNL and ureteroscopy; but with higher complication and 
recurrence rate. Preventative measure have been suggested by Okhuno et al such 
as empting the conduit with catheterisation, correction of hypovolemia  or 
hypocitraturia, prophylactic antibiotics and the use of acetohydroxamic acid as a 
urease inhibitor (Okhunov et al., 2011). 
1.4.7. Metabolic acidosis 
As described earlier (section 1.3.1), chloride absorption from urine, excretion of 
bicarbonate and the reabsorption of ammonium could all lead to hyperchloremic 
metabolic acidosis (Turnberg et al., 1970; Koch et al., 1990; McDougal et al., 1995; 
Stampfer and McDougal, 1997; Roth and Koch, 2018). This complication is expected 
to occur with lower incidence in IC compared to colonic conduit and continent 
diversion due to short contact time between urine and bowel mucosa. The 
development of such a complication should raise concern regarding the conduit 
emptying and initiate investigation such as loopogram to rule out stoma stenosis 
(Amini and Djaladat, 2015).Patient with metabolic acidosis could present with 
symptoms of weakness, lethargy, and weight loss.  
Gilbert et al reported an incidence of metabolic changes/ acidosis in 19.4% 
(242/1,248) patients at 0-2 years and 8.6% (47/544) at 4-5 years (Gilbert et al., 
2013). The Mayo series defined metabolic acidosis as bicarbonate level < 20 mg/dl 
or requiring treatment and was found in 108 patients (10.2%) at a median of 1 year 
(Shimko et al., 2011).  
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Alkalinising agents such as potassium citrate and sodium bicarbonate are used to 
correct the acidosis in those patients(Amini and Djaladat, 2015). 
1.4.8. Vitamin B12 deficiency  
Because of the lengthy presence of vitamin B12 receptors at the terminal ileum and 
the large human stores, this complication usually takes up to 3 years to develop 
(Thompson and Wrathell, 1977; Mills and Studer, 1999).  
At the Mayo series, low vitamin B12 levels were detected in 32 patients (3%) of the 
series at a median of 9.1 years (Shimko et al., 2011).  
Vitamin B12 could easily be monitored by an annual blood check of serum levels and 
equally easy to treat by replacement oral supplements (Roth and Koch, 2018). 
1.4.9. Bone demineralisation 
Due to the development of acidosis, the kidney compensate by excreting hydrogen 
ions buffered by phosphate which is essential for bone mineralisation (Newman and 
Price, 1999). Experiments in animal models have confirmed that negative effect over 
bones (Lemann et al., 1967).  
In a cohort of 50,520 of non-metastatic bladder cancer patients of whom 4,878 of 
had cystectomy and urinary diversion, cystectomy was associated with a 21% 
greater risk of fracture compared to the rest of the cohort who received endoscopic 
treatment (Gupta et al., 2014). The incidence of fracture in the cystectomy group was 
6.55 fractures per 100 person-years. 
For this complication, it is better to treat the underlying acidosis rather than only 
using calcium and Vitamin D supplements for treatment (Roth and Koch, 2018). 
1.4.10. Bowel complications 
Following RC and IC, different bowel complications can occur. These could be in the 
form of diarrhoea secondary to the metabolic effects described earlier, constipation 
or obstruction due to adhesions, and enteric fistula secondary to bowel injury and 
poor healing. 
Most of the reports have understandably focused on serious bowel related 
complication such as bowel obstruction and development of enteric fistula. Other 
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less concerning complications such as constipation or diarrhoea are less reported in 
literature. Bowel related complications were reported in 20% and 24% patients  at a 
median follow up of 18 and 36 months in the Mayo clinic and Bern series 
respectively (Madersbacher et al., 2003; Shimko et al., 2011). Obstruction was the 
most common bowel related complication in both series. The bowel obstruction is 
believed to occur secondary to intestinal stenosis, adhesion bands, internal hernia, 
or volvulus (Amini and Djaladat, 2015). Gilbert et al reported an incidence of enteric 
fistula of 1.8% during the first 2 years following surgery; this dropped to only 0.4% 4-
5 years postoperatively (Gilbert et al., 2013). 
In the Mayo clinic series 7% of the bowel obstruction required surgical intervention, 
while the percentage rose to 50% at the Bern group of patients.  
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1.5. Patient reported outcomes and quality of life after ileal conduit 
Over the past decade, the use of patient-reported outcomes (PROMs) have become 
more popular and these measures has been used by researchers to investigate how 
the outcomes of treatment and surgery can be improved (Sanda et al., 2008; Coyne 
and Kelleher, 2010; Glaser et al., 2013; Borofsky et al., 2017). PROMs allow 
researchers to explore a different perspective from that of the clinician team, one that 
is only experienced by the patients and also, in some instances, their families.  A 
PROM is defined as any report coming directly from the patient, without 
interpretation by physicians or anyone else (Health et al., 2006; Patrick et al., 2007). 
This could include how they function or feel in relation to a disease or treatment, 
health-related quality of life (HRQoL) and treatment satisfaction.  
To date, PROMS have been relatively little used among IC patients, although IC 
surgery can potentially have a significant impact on patient quality of life (QoL), 
functioning, wellbeing and daily life. In one study, having a stoma, wearing bags, 
urine leak and the odour were found to negatively affect patients’ functional, 
emotional, social  and mental wellbeing (Bjerre et al., 1994). This study compared 
survey responses of 26 patients who had a continent urinary diversion to 50 who had 
IC found a significant increase at leakage related distress (80%) at the IC group 
(Bjerre et al., 1994). The same study showed a significant decrease at the physical 
contact between patient and partner reaching to 43% of the respondents. In a 
literature review of 21 studies which compared IC to orthotopic neobladder with a 
total of 2285 patients, sixteen studies reported no difference in QoL and four studies 
reported a better QoL with orthotopic neobladder (Ali et al., 2015). One study 
reported a better QoL in ileal conduit patients. 
The adverse effect of IC could go beyond health and wellbeing, to impact patients’ 
careers and financial status. A study of 47 patients who were working before surgery 
found that 34% had made permanent changes in their working conditions after 
surgery (Nordström et al., 1990). While some of them changed from full-time to part-
time working, others stopped work all together. On further follow up to the same 
cohort, a further  32% of patients who initially resumed work after their operation 
subsequently made permanent changes in their working conditions (Nordström et al., 
1990). 
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The literature lacks studies in which IC patients report on physical complications. 
Most of the available series (such as those in Table 1.1) relied on hospital 
attendance and investigations, rather than patient reports, to identify complications. 
While this is of great value, it does not necessarily capture the patients’ perspectives, 
personal community experience and expectations.  Due to the nature of the effect of 
IC on the patient’s life, not only physical  but also psychological and social, data on 
patient reported complications could add valuable information for those who provide 
care to this patients. 
1.6. Follow up 
As a result of the risk of complications and the potential adverse effect on patients’ 
quality of life following IC, a follow up/surveillance scheme seems essential to allow 
for early detection of medical complications and provide the patient with the 
emotional and psychological support they require. Traditionally, cancer patients have 
received follow-up care at the hospital at which they were treated. This approach 
was believed to be safer as it provides specialist care for patients thus enabling best 
support and early detection of recurrence. However, this model was scrutinised over 
the last years and alternative models have started to be examined (Howell et al., 
2012; Emery et al., 2014). 
1.6.1. Current guidelines 
Review of the current Urological national and international guidelines indicates there 
is no guidelines dedicated specifically to the follow up of ileal conduit (American 
Urological Association, 2018; BAUS, 2018a; European Association of Urology, 2018; 
The National Institute for Health and Care Excellence (NICE), 2018). Generally, the 
follow up of IC constitutes - if present at all - a short part of the follow up section in 
guidelines on the management of bladder cancer.(The National Institute for Health 
and Care Excellence 2015; Alfred Witjes et al., 2017; Chang et al., 2017). 
The American Urological Association (AUA) guidelines recommends imaging for the 
abdomen including upper tract every 6-12 months for up to 3 years, then suggests 
that this may continue annually(Chang et al., 2017). The guidelines states that one of 
the aims for this imaging is to detect hydronephrosis in addition to cancer 
recurrence. An annual blood test is recommended for renal function. The guidelines 
highlighted the need to monitor for metabolic changes such as hyperchloremic 
21 
 
metabolic acidosis and vitamin B12 levels without specifying the frequency of 
monitoring. 
At the end of the European guidelines on muscle invasive bladder cancer and its 
follow up, it is stated that bladder cancer patients who had urinary diversion ‘deserve 
functional follow-up’ (Alfred Witjes et al., 2017). It is suggested that follow up could 
stop after 15 years. These guidelines also name the potential complications 
associated with ileal conduit, but there are no recommendations regarding tests 
required and the frequency of investigations to detect the named complications. 
The National Institute for Health and Care Excellence (NICE) guidelines recommend 
at least an annual upper tract imaging and glomerular filtration rate estimate to 
monitor for hydronephrosis, stone formation and renal function(The National Institute 
for Health and Care Excellence 2015). NICE further recommended monitoring for 
metabolic acidosis, vitamin B12 deficiency and folic acid level at least once a year. In 
the research recommendation section, these guidelines raise the question of 
whether scheduled follow up or symptom-driven review is better for the overall 
survival, patients’ quality of life and cost. 
1.6.2. Bladder cancer survival and models of follow up 
Supported by several randomised trial results, the use of neo-adjuvant 
chemotherapy over the last decade has led to significantly improved survival of 
bladder cancer patients (Sherif et al., 2004; Advanced Bladder Cancer Meta-
analysis, 2005; International Collaboration of et al., 2011). The combined results of 2 
NORDIC studies showed an absolute mortality risk reduction of 8% in 5 years (Sherif 
et al., 2004). A phase III trial of 976 patients showed a significant reduction in death 
rate equivalent to an increase of 10 years cancer survival from 30% to 36% 
(International Collaboration of et al., 2011). With the increasing number of cancer 
survivors -for both bladder and other cancers - it is increasingly recognised that the 
limited resources in secondary care may not provide the most appropriate follow-up 
care and support required for cancer patients (Richards et al., 2011). For example, 
the limited time available for outpatient follow up appointments might not suffice to 
allow for the provision of the support many survivors need. In addition, it may be that 
traditional hospital-based follow-up may not be optimal from the perspective of the 
patient. A national quantitative study of cancer survivors in the UK found that 
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patients feel abandoned after finishing their treatment (Cardy et al., 2006).This has 
stimulated interest in exploring whether other methods of non-hospital follow up 
could be implemented.  Clearly, any model of surveillance for post-RC bladder 
cancer patients should not only address cancer recurrence detection, but also IC 
follow up as it is the most commonly used urinary diversion surgical approach 
following cystectomy (Cresswell et al., 2015; Groeben et al., 2018; Jefferies et al., 
2018). 
The conventional  hospital based follow up was challenged by several studies in 
which  the usual physician led follow up was compared to nurse-led or primary care 
follow up (Howell et al., 2012; Emery et al., 2014). A systematic review of ten 
practice guidelines and 9 RCT showed no significant difference in the recurrence 
detection rate when comparing conventional follow up with nurse led or primary care 
led follow up (Howell et al., 2012). These studies covered a variety of cancers such 
as colorectal, breast and prostate. Another review demonstrated similar findings 
when comparing physician led and nurse led follow up (Lewis et al., 2009a). This 
review found not only no significant difference in recurrence detection and survival 
but also reported on one study that found that nurse-led follow-up was associated 
with better HRQoL outcomes. The results of a non-randomised cohort of 169 
patients with prostate cancer who were allocated to telephone nurse-led follow up or 
the standard  medical follow up showed no significant difference at patient 
satisfaction after 6 months (Leahy et al., 2013). There was a suggestion of a greater 
patient satisfaction for the nurse-led model in this study, but this was not statistically 
significant.  
In terms of primary-care based follow-up, it is recognised that it could be less costly 
but would require the development of clear guidelines, well established channels of 
communication between primary, secondary and tertiary care and ready accessibility 
to specialist service when required (Emery et al., 2014). One qualitative study which 
explored cancer patients’ views found that while patients appreciate having their care 
locally, they emphasised the need for further training to GPs to fulfil this role (Hall et 
al., 2011). Another review of qualitative studies exploring patients’ and health 
professionals’ views about cancer follow up showed that patients find hospital-based 
regular specialist follow up reassuring (Lewis et al., 2009b). On the other hand, 
participants noted that secondary care appointments could lack the dedicated time 
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required to discuss issues and obtain/provide psychological support, due to the 
pressures on the service. 
One of the models that could address the burden in secondary health care and, at 
the same time, patients’ concerns regarding lack of cancer care experience in the 
community is shared community based care model. This was examined and found to 
be successful for prostate cancer follow-up (Emery et al., 2017). A prospective 
randomised trial of 88 men who completed their treatment for low / intermediate risk 
prostate cancer were randomised to usual care or shared care, there was no 
statistically significant differences between groups with regard to prostate cancer-
specific quality of life ,satisfaction with care and compliance with PSA monitoring. 
Along the same lines, there is growing evidence that patients’ active involvement in 
their own care could minimise pressure on both primary and secondary care. A 
review of literature has found that there is a  growing trend towards cancer patients’ 
empowerment that allows them to self-manage their condition and even self-refer to 
specialist care (Davies and Batehup, 2011). The review concluded that an active role 
for specialist nurses, and more use of technology as a mean of communication, 
could facilitate this approach of patient self-management. The results relied on 20 
studies covering breast, colorectal and lung cancer; and one study involved patients 
with a variety of urological conditions  (Fletcher et al., 2006). 
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1.7. Normalisation process theory and the study of implementation 
1.7.1. Rationale for a new (alternative) surveillance schedule for IC patients 
The high rate of IC related complications, the improvement in survival of bladder 
cancer patients and the annual thousands of patients who had ileal conduit as a 
method of urinary diversion are all reasons for the development of a standardised 
long term surveillance schedule or protocol for IC patients. The developers of such a 
protocol should take into consideration not only the clinical effectiveness of the 
protocol in terms of early detection of complications and the effectiveness at 
addressing QoL issues, but also the process of implementation of the new protocol. 
A new follow-up protocol could be considered a complex intervention as it will involve 
several stakeholders and will be implemented within the complexity of the health 
system.  
1.7.2. Frameworks and theories for developing and evaluating interventions 
The Medical Research Council developed a widely-used framework for the 
development and testing of complex interventions(Campbell et al., 2007; Craig et al., 
2008). It was suggested that the development of intervention should rely on a 
theoretical foundation and that qualitative methods could represent a helpful tool in 
understanding the process involved in developing the intervention and its evaluation 
(Hardeman et al., 2005; Oakley et al., 2006; Lewin et al., 2009) 
The Normalisation process theory (NPT) is a middle range social theory that 
proposes ‘a working model of implementation, embedding and integration in 
conditions marked by complexity and emergence’ (May and Finch, 2009). This 
theory provides a framework that aids the understanding and evaluation of how an 
intervention, such as a surveillance schedule for example, is embedded and 
sustained into practice. The NPT aids the understanding of the promoters and 
inhibitors in the process of implementation and evaluation of an intervention (i.e. new 
follow up protocol, a new technology, etc.) into a complex organisation, such as the 
NHS. It extends beyond the early stages of implementation to an advanced stage of 
normalisation where the new intervention is embedded into routine practice. The 
theory suggests that the understanding of the process of implementation should rely 
on the work that people do or their acts rather than what they say or believe.  
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At its early iteration, the NPT focused largely on explaining the operationalisation of 
interventions in health care (May, 2006; May et al., 2007). This was based on 
secondary analysis of several qualitative studies. Later on, the theory broadened in 
scope to explain how individuals are enrolled into the intervention, and how 
intervention are appraised. The value of NPT as a theory of implementation is that it 
provides a holistic approach for the understanding of how a practice is embedded 
into day practice in comparison to other frameworks where individual actors’ 
behaviours and popularity of the intervention into organisation are the main focus of 
study for innovations introduction (Greenhalgh et al., 2004; King and He, 2006; 
Elwyn et al., 2008). A systematic review of studies that have adopted the NPT 
framework showed that many authors found that NPT provides a generalised 
framework that is beneficial for the analysis of the implementation process at 
variable settings and allowed for the gradual development of knowledge over time 
(McEvoy et al., 2014). Because NPT is an action theory, and therefore more 
concerned with explaining what people do rather than their attitudes or beliefs, it 
comprises four main constructs that represent different kinds of work that people do 
around implementing a new practice -Coherence, Cognitive Participation, Collective 
Action, and Reflexive Monitoring - which are described by its founders as follows 
(May et al., 2018): 
Coherence 
This represents the sense-making work that people do when they are implementing 
a new practice or intervention. It describes the participants’ understanding of the 
intervention, why it was introduced, how is different from other practice, and its 
benefits. This involves: 
 Differentiation – the understanding how the new practice is different from 
others including existing ones. 
 Communal specification – people working together to build a shared 
understanding of the objectives, and expected benefits of a set of practices. 
 Individual specification – the individuals’ work that will help them to 
understand their own role. 
 Internalisation – the work of understanding the value of the intervention. 
Cognitive Participation  
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‘It is the relational work that people do to build and maintain a community of 
practice around a new intervention.’ This reflects the participants’ commitment to and 
engagements with the new practice, their willingness to invest time and effort to 
implement it. This includes: 
 Initiation – the work done by key persons to drive the new practice forward.  
 Enrolment – participants’ work to organise themselves to enact the new 
practice effectively, for example getting members of the team to buy in the 
new protocol or intervention. 
 Legitimation – the work of ensuring that other participants believe it is right 
for them to play an active role. 
 Activation – after starting the new practice, this is the work of defining the 
actions that is required to sustain the new practice. 
Collective Action  
This is the operational work that people do to implement an intervention and embed 
it into their daily practice. It describes what actually happen on the ground, how 
actors deal with artefacts and how skills and resources are allocated to implement 
the intervention. It is formed of: 
 Interactional Workability – this describes the interaction work that people do 
with each other, and with the new intervention itself to make it work. 
 Relational Integration – the knowledge work that people do to build 
confidence in the effectiveness of the new practice. 
 Skill set Workability – the tasks allocation work according to the available 
skills within the team members. 
 Contextual Integration – the work of allocation and management of available 
resources to operationalise a new practice. 
 
Reflexive Monitoring  
It is the appraisal work that people do to assess and build a feedback on how the 
new practices affect them. It also describes how participants make changes following 
the appraisal work. This includes: 
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 Systematization – the work of collecting information. 
 Communal appraisal – working together to evaluate the practices. 
 Individual appraisal – individual’s work to appraise the impact of the new 
intervention on them. 
 Reconfiguration – the work of modifying practice as a result of appraisal 
work. 
One of the recognised challenges of using NPT was the perceived overlap between 
different constructs which can make the allocation of codes challenging in some 
instances. Another observation was the inability to map some themes under the 
theory constructs, however the authors of the theory do recognise this and as a 
middle-range theory it is not expected to explain everything (McEvoy et al., 2014). 
The NPT has been used extensively as a theoretical framework to conduct many 
studies that have investigated the implementation of new interventions inside and 
outside the health care system. For example, it has been used to investigate the 
implementation of different types of interventions such as an alcohol screening tool, 
a chronic kidney disease management protocol, and a maternity electronic record 
system (Gask et al., 2010; Atkins et al., 2011; Blakeman et al., 2012; Bamford et al., 
2014; O'Donnell and Kaner, 2017; Scantlebury et al., 2017; May et al., 2018). In 
addition, Murray et al proposed that the use of NPT could facilitate the 
considerations regarding the implementation of an intervention at the very beginning 
of the development process (Murray et al., 2010). 
Many of the studies that adopted NPT as theoretical framework used qualitative 
methods to collect  data (May et al., 2018). Qualitative research methods have been 
increasingly embraced in the health research field, as these methods enable the 
researchers to obtain a deep understanding from the participants’ perspectives; this 
can enable  answering different types of questions - such as ‘how’ and ‘why’  - that 
are not normally answered by quantitative methods (Davison et al., 2008; Bristowe et 
al., 2015).  
In the process of the development and/or implementation of a standard surveillance 
protocol for IC patients, different health care professionals in both primary and 
secondary care may be involved. Qualitative methods could produce valuable data 
that informs the development of alternative follow-up protocol for these patients. 
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1.8. Aim and objectives of the study 
The main aim of this study is to investigate IC patients’ short and long term 
experience following their operation and to explore the implementation of current 
practices of follow up for IC patients and to understand why and how a “new” 
(alternative) model of surveillance for IC patients could be successfully developed 
and implemented. In order to fulfil its aims, the study was formed of two parts: 
 Study A: Patient national survey  
 Study B: Current practice & alternative models of surveillance for patients 
with ileal conduit urinary diversion:  A qualitative study using the 
Normalisation Process theory 
1.8.1. Study A objectives: 
 To use patients’ own reports and experiences of complications at different 
periods following surgery to quantify their frequency and determine whether 
this is affected by demographic and clinical factors, including age, gender, 
time since operation, and indication of surgery.  
 To record the nature of the follow up received by patients after surgery, 
including their access to stoma nurse.  
 To assess patients’ satisfaction with their current follow up. 
 To explore patients’ views of the optimum follow-up and to identify the factors 
(such as experience of complications or access to stoma nurse) that could be 
associated with those views.  
1.8.2. Study B objectives: 
 To describe current practice with regard to follow-up of IC patients and any 
associated problems/challenges/limitations. 
 To explore health professionals’ views regarding the need for an alternative 
model of surveillance, its best setting and the appropriate investigations. 
 To identify barriers and facilitators to implementing alternative models. 
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1.9. Thesis outline 
 
Following this Introduction chapter (literature review and aim of the study), chapter 2 
will describe the methodology of both study A & B in details. On chapter 3, the 
results from study A (Patient national survey) will be presented. This will describe 
patients’ demographics, their experience post-surgery, their satisfaction with follow 
up and their preference of surveillance settings. The results of the statistical analysis 
examining the association between patient characteristics and their reporting of 
complications, their satisfaction and their preferences for follow up will be presented 
in details. 
Chapter 4 contains the results of thematic analysis of the interviews with health 
professionals and the outcome of mapping the resulting themes under the NPT 
constructs.  
Chapter 5 presents the key findings and the strengths and limitations of each of the 
studies. A comparison of the findings with literature will be described followed by the 
implications of the study results and potential areas for future research. 
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Chapter 2. Materials and Methods 
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2.1. Study A: Patient national survey 
 
The aim of this phase of the study was to investigate IC patients’ short and long term 
experience following their operation and identify their preferences for follow up. 
2.1.1. The role of the Urostomy Association 
The survey took place in the UK through the Urostomy Association (UA) which is a 
UK registered national charity representing the interests of people with a urinary 
diversion. The survey was developed by AA and RSP (MD supervisor) following 
discussions with UA members at one of their annual meetings. The discussions that 
took place with the patients at the UA meeting were about the need for getting the 
voice of urostomy patients heard regarding their condition and their follow-up. These 
discussions revealed the variations in the follow-up received by patients and the 
possible lack of awareness at primary care of patients’ care needs that arise 
because of urostomy associated complications. Subsequent literature review 
(chapter 1) showed the absence of patient reported outcomes after IC apart from 
measurement of HRQoL. This drove the development of the questionnaire, the 
purpose of which was to measure IC-related complications as experienced by 
patients and explore their experiences of, and preferences for, follow up. The UA 
carries out regular surveys of its members and the survey for the current study was 
adopted by the UA as their annual survey for the year 2012. 
2.1.2. Designing the patient questionnaire 
The questionnaire explored four main areas. These were: patients’ experience of 
complications following IC; the follow up they have received; their satisfaction of 
care; and their views of the optimum surveillance. The review of literature (chapter 1) 
reporting the complications of IC operations informed the questionnaire 
development. The main complications identified in the literature were: urinary tract 
infections (UTI), parastomal hernia, urolithiasis, appliances issues, bowel, renal and 
skin complications. These were used to develop a list of complications that patients 
were asked about throughout the questionnaire. The differences in reports of the 
frequency of complications in literature resulted in the development of a separate 
question asking the patients to rank the complications they had experienced 
according to frequency. In addition, the increasing evidence of successful models of 
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a community based pathways developed for cancer patients follow up encouraged 
us to explore this setting of follow up by asking the patients about their view of 
primary care follow up (Howell et al., 2012). 
It was considered that a self-administered questionnaire would be preferable to an 
interviewer-administered one for the following reasons. Firstly, it would allow patients 
to express themselves freely, reducing the possibility of bias. Secondly, it would 
minimise the burden on the student of data collection, allowing the possibility of 
increasing the sample size within the same amount of resources (Bowling, 2005) 
The first draft of the questionnaire was pre-tested among 14 patients who were 
members of the UA and all were ≥ 5 yrs. after IC surgery. These members were 
selected and approached by the secretary of the association and agreed to help with 
the pre-testing of the questionnaire. The aim of the pre-testing was to check for the 
clarity of questions, face validity and to reveal any complications that were not 
addressed in literature but experienced by this population of patients.  The 
demographics of the 14 patients are shown at table 2.1. The patients received the 
first draft personally from the UA secretary in an envelope containing a covering 
letter and information sheet in addition to the questionnaire.   A free text box was 
provided at the end of the questionnaire inviting participants to give their opinion of 
the questionnaire and to suggest modifications or additions. 
Patient characteristics  N 
Gender 
Male 
Female 
 
4 
10 
Age at surgery 
<60 
≥60 
 
2 
12 
Indication for surgery 
Benign 
Cancer 
 
8 
6 
Time since surgery(yrs.) 
5-10 
>10 
  
2 
12 
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Table 2.1. Demographics of the pre-test sample. 
The pre-testing results were used to refine the content and to produce the final 
version of the patient survey. The following changes were made: 
1. Adding a phrase after question 11 to ask the patient to skip questions 12 and 13 if 
their answer was ‘No’ to Q11. 
2. Adding a question about the easiness of access to stoma nurse. 
3. Adding a question asking those patients who indicated that transfer of (follow-up) 
care to their local doctor was inappropriate, why they felt this. 
4. Revising the wording of the question where patients were asked to rank the 
complications according to the frequency. A key was added to the question to 
explain what each number represent in term of frequency. For example 0 represents 
never, 1 represents rarely etc.  
The final questionnaire was formed of 5 main sections and was named ‘Ileal conduit 
experience questionnaire’ (ICE-Q) (Appendix 1). The first section included 
demographic questions, the indication and the date of surgery. Section 2 explored 
the patient experience of complications during three periods following surgery: up to 
2 years, 2-5 years and after 5 years. The third section asked about experience of 
post-hospital discharge if applicable, patient satisfaction with care and access to 
stoma nurse (SN). The fourth section of the ICE-Q explored the care needs of 
patients with a urostomy, their view of community follow up by local doctor and their 
opinions of the optimum follow up schedule for the first 2 years and afterwards. The 
final section asked the patients to rate the IC-related problems they suffered from 
according to their frequency. The questionnaire was over 9 pages and had 21 
questions in total. 
The questionnaires were dispatched between May and July 2012 to 2000 members 
selected randomly by UA from their membership database. Each member received a 
covering letter, information sheet (Appendix 2) and a freepost return envelope with 
the questionnaire. It was emphasised that participation was entirely voluntary and 
that the questionnaire responses would be analysed and presented anonymously. 
Filling the questionnaire and returning it was considered to be consent for 
participation. 
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The completed questionnaires were returned to the UA national office and all were 
delivered to the RSP office at the Freeman hospital. The completed questionnaires 
were stored in secure NHS offices of, firstly, RSP and then, AA.  
2.1.3. Data entry, checking and clearing 
Of the 2000 patients invited to participate, 1190 (59.5%) returned the questionnaire. 
AA set up an Excel spread sheet where the responses were manually transferred 
from the questionnaire into Excel spread sheet by two individuals (AA, JO). AA 
entered the data from 442 questionnaires and JO from 650. Returned questionnaires 
from 98 patients were excluded due to incomplete answers; questionnaires with 
incomplete answers to any of the questions at the first section (demographics, date 
and time of surgery) or second section (report of complications) were considered 
incomplete.  The data was all then re-checked for accuracy by AA. For each of the 
1092 included questionnaires, the answer to a randomly selected question on the 
hard copy was compared to the equivalent response on the dataset spreadsheet. All 
data entry errors found in this way were corrected.  
2.1.4. Data analysis 
The data was coded to facilitate analysis. The data was in the form of 21 variables 
initially corresponding to the number of questions. Another 24 new variables were 
created for analysis. Two variables were created where patients were categorised 
into three age groups (according to their age at the operation) (<60, 60-74, ≥75) and 
three categories according to time in years since operation (<5, 5-10, >10). For each 
of the seven complications, two new categorical variables were created, one’ Ever 
reported’ (Yes/No) and another ‘Ever reported as frequent’ (Yes/No). In addition, two 
new categorical variables were created for ‘Ever reported a complication’ (Yes/No) 
and ‘Ever reported a frequent complication’ (Yes/No). Another 2 continuous variables 
were created to represent the number of   ‘Ever reported’ and ‘Ever reported as 
frequent’ complications; these took values in the range 0-7.  A categorical variable 
was created to identify patients who reported ≥ 3 complications (Yes/No). Another 
categorical variable was created to show those who preferred lifelong follow up 
(Yes/No). For simplicity, the access to stoma nurse variable was converted to a 
binary variable (Easy / Very easy or Difficult / Very difficult). Another categorical 
variable was created to identify whether respondents had answered a question that 
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asked them to give a reason if they think GP follow up is inappropriate; Answering 
this question was considered implicitly to represent ‘Lack of preference of community 
follow up’. 
The coded data was exported to Stata®14 software in which statistical analysis was 
conducted. All the variables and values were labelled in Stata. Chi square tests were 
used to identify associations between reporting complications, reporting being 
discharged from secondary care follow up, dissatisfaction with follow up, lifelong 
preference of follow up,  lack of preference of  community follow up and each of the 
patient characteristics (age group, years since surgery, indication for surgery, 
discharge from secondary care and access to stoma nurse). One-way anova was 
used to compare the mean number of reported complications (Ever reported and 
Ever reported as frequent) across different categories of patients characteristics 
variables. When there were unequal variances in the compared groups, the Kruskall-
Wallis test was used instead of anova to compare the medians and distributions. 
Multivariable logistic regression models were developed to identify associations 
between reporting complications and respondents’ characteristics (age group, years 
since surgery, indication of surgery, discharge from secondary care and access to 
stoma nurse). This was done separately for each type of complication (Ever reported 
and Ever reported as frequent), for reporting any complication (Ever reported a 
complication and Ever reported a frequent complication) and for reporting ≥ 3 
complications. Similarly three models were developed to identify associations 
between each of dissatisfaction with follow up, lifelong preference of follow up, lack 
of preference of community follow up and the patient characteristics. These 3 models 
were re-run adding 2 more variables (Ever reported a complication and Ever 
reported a frequent complication) to identify further possible associations with 
reporting complications. A multivariable logistic regression models was developed to 
identify association between reporting discharge from secondary care and 
respondents’ characteristics (age group, years since surgery and indication of 
surgery). Another multivariable logistic regression model was run to identify the 
association between referral back to secondary care after discharge and patients’ 
characteristics (age group, years since surgery, indication of surgery and access to 
stoma nurse) initially, with this repeated adding 2 more variables (existence of a 
regular GP follow up and reporting ≥ 1 frequent complication). 
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Goodness of fit was checked for each model using the Hosmer & Lemeshow test 
(Hosmer Jr et al., 2013)and fit was adequate in each instance.  
Throughout a two-sided p value <0.05 was considered statistically significant.  
 
  
37 
 
2.2. Study B: Current practice & alternative models of surveillance for 
patients with ileal conduit urinary diversion:  A qualitative study using 
the Normalisation Process Theory 
 
The aim of this part of the study was to explore the implementation of current 
practices of follow up for IC patients and to understand why and how a “new” 
(alternative) model of surveillance for IC patients could be successfully developed 
and implemented. 
2.2.1. Study design and setting 
This was a multicentre qualitative study, with a semi-structured interview design. The 
study took place at three Trusts in different regions in England: North, Yorkshire and 
the Midlands. The centres were selected on the basis of the following criteria: 
different geographic areas, large catchment population, and being a regional centre 
for the treatment of bladder cancer ± urology reconstructive surgery. From previous 
working experience at two of the three centers, AA was aware of the differences in 
the approach to follow up in the two sites and it was considered that this variation 
would be valuable to explore diversity of experiences and views. The follow up 
schedule for the third centre emerged during the interviews. The study followed a 
research protocol that was modified to reach its final shape by the fourth version 
(Appendix 3) before obtaining ethical approval (07/09/2017). The study was 
sponsored by Heart of England NHS Foundation Trust (Appendix 4&5). 
2.2.2. Study population 
A purposive sample of 20 potential participants were identified through a designated 
PI at each of the 3 participating centres. The aim was to recruit health professionals 
from different disciplines who were actively involved in IC patients’ surveillance and 
care: i.e. surgeons, specialist nurses and stoma nurses. They were invited to 
participate by AA via their work email address; a participant information sheet 
(Appendix 6) was attached to the email. A reminder email was sent to the non-
responders after 2 weeks. The date and time of the interview was agreed via email 
with the health professionals who agreed to participate.  
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2.2.3. Ethical approval 
After consulting the R&D department at HEFT and review of HRA guidelines, it was 
determined that ethical approval was not required initially as the study started at a 
single site and Newcastle University ethical approval was considered sufficient at 
this stage (Appendix 7). After deciding to extent the study to cover multiple sites, an 
application for ethical approval through IRAS was started and the study was then 
approved by Health Research Authority on the 07/09/2017 (IRAS ID: 194469 as a 
multicenter study (Appendix8). The research team (MD student and supervisors) 
signed a confidentiality agreement as required by Newcastle University which stated 
that the student will ‘ treat all information received through the University Project as 
confidential, entering into a confidentiality agreement on request from the University, 
and only disclose such results as are agreed with the Project Supervisor on the 
University Project’. 
;http://www.ncl.ac.uk/res/assets/documents/PGRPolicyv10111114FINALClean.pdf 
2.2.4. Data collection 
Face-to face semi structured interviews were conducted by AA with the participants 
at their place of work. The interviews were conducted during the period between 
31/01/2017 until 6/02/2018. All interviews were conducted in English. The 
participant’s job title, and years and areas of experience were among the data 
collected. 
The interviewer obtained written informed consent from all the participants (Appendix 
9). The consent confirmed that participants understand that their participation is 
voluntary and that they were willing to let the project researcher include anonymous 
quotations from them in the write up of the study. Participants had adequate chance 
to ask questions, and these were answered to the participant’s satisfaction prior to 
giving written informed consent. Participants were also assured that their views and 
opinions will not be revealed to the senior colleague who nominated them as a 
potential participant, nor anyone outside of the research team.  Furthermore, they 
were told that no interviewees would be identified in the thesis or any publications 
arising from the study.  
The interviews were guided by a topic guide and audio-recorded (after obtaining 
verbal consent for this). The development of the topic guide was influenced by the 
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literature reporting on IC long term complications, the NPT constructs and review of 
guidelines (chapter 1). The guide was refined following review and discussions 
between AA, LS (MD supervisor) and TF (one of the authors of the NPT). The guide 
was divided into three major areas: area 1 explored participants’ views of the 
purpose of long-term follow-up following IC; area 2 discussed participants’ current 
practice in following up IC patients; and area 3 explored the views of the participants 
of the best follow up strategy and the potential barriers and facilitators to 
implementation of this (Appendix 10). The first few interview transcripts were 
reviewed and discussed with LS, and comments about areas of probing and new 
ideas emerging were incorporated into the subsequent interviews. In addition, the 
topic guide was used flexibly and allowed to evolve as the interviews progress; if 
new issues were raised by interviewees these were added to the guide for 
subsequent interviews, so that sufficient depth was reached. The number of 
interviews was planned to be decided by reaching saturation of themes (Francis et 
al., 2010; Baker et al., 2012). Saturation of themes from the interviews was reached 
after 14 interviews; a further 3 interviews were conducted as the participants had 
already agreed to participate and this enabled checks for saturation. No new themes 
emerged from the additional three interviews. 
2.2.5. Data management  
Each participant was allocated a personal identity code to protect their identity. 
Interviews were transcribed verbatim and anonymized, prior to analysis. The 
transcription was carried by a medical secretary at the Urology department at Heart 
of England NHS Trust (Verdelle Stewart) and the transcript was compared to the 
audio record by AA to check for accuracy.  
2.2.6. Data analysis 
The data analysis took place in two stages, (1) Thematic analysis; followed by (2) 
Mapping the emergent themes onto the four constructs of the NPT (i.e an application 
of the Framework approach)(Ritchie et al., 2013). AA conducted the initial analysis of 
the first few interviews using a thematic analysis approach (Spencer and Ritchie, 
2002). First, familiarity was obtained by reading and then re-reading the transcripts. 
Secondly, a thematic framework was developed by generating initial codes using line 
by line inductive analysis. Similar codes were collated under potential themes. The 
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themes were reviewed to check they worked in relation to the dataset. Similar 
themes (sub-themes) were grouped under seven main themes. Thirdly, the thematic 
framework was applied to the rest of the transcripts. At the second stage, the sub-
themes then were mapped onto Normalization Process Theory four main constructs 
of the theory; ie the constructs formed the analysis framework. These were further 
categorised into facilitating factors and barriers to implementation.  
The initial coding framework and its analysis using the NPT four constructs was 
discussed with LS and reviewed by TF. After completing the coding for the whole 
dataset, the final framework of analysis was established guided by discussions with 
LS and TF. 
Recruitment and analysis were simultaneous, so that issues that emerged from 
preliminary analysis of early interviews informed later interviews.  The three clinical 
groups were analysed together and the results are presented for all three combined; 
in the event that a view was expressed by individuals in only one group (e.g. stoma 
nurses), or not expressed by individuals in a specific group, this has been made 
clear in the text. 
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Chapter 3. Study A: Results of patient national survey 
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3.1. Introduction: 
This part of the study aimed to investigate IC patients’ short and long term 
experience following their operation. Using this survey, patients were asked to report 
on complications they believed were IC related and the follow up care they had 
received and to express their views on the optimum follow up (chapter 2). The 
following are the responses received from the 1092 eligible questionnaires. The 
results are organised into four sections: 
 Respondents’ demographics & characteristics 
 Patient reported complications 
 Discharge and satisfaction with follow up 
 Patients’ preference for follow up 
 
3.2. Respondents’ demographics & follow up characteristics  
The mean (SD) age of respondents when they had their surgery was 71.2 
(SD=10.39) years, with 88.9% of patients aged 60 year or older. Males comprised 
58.2% of the respondents. The mean (SD) time since operation was 10.1 (9.36) 
years. The indication for surgery was cancer for the majority (78%) of respondents. 
38% of the respondents reported they had been discharged from secondary care 
follow up. Only 16.5% reported that they had difficulty in accessing a stoma nurse 
(Table 3.1.). 
Female respondents represented 41.8% of the whole sample, however they were 
the majority in certain subgroups. They were 73.6 %( n= 89) of the respondents 
below the age of 60, and 83.9 %( n=203) of the group who had ileal conduit surgery 
for a benign indication. Male respondents who had surgery for benign indication 
were the smallest subgroup of the respondents (3.6%, n= 39), and males who had 
surgery for a cancerous indication were the largest (54.7%, n=597).  
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Mean age (range), years  71.2 (24-97)  SD 10.39 
Age N (%) 
<60 
60-74 
≥ 75 
 
121 (11.1) 
528 (48.3) 
443 (40.6) 
 
Gender N (%) 
Male 
Female 
 
 636 (58.2) 
 456 (41.8) 
 
Mean time since surgery (range), years  10.1 (1-68) SD 9.36 
Time (in years) since surgery, N (%) 
<5 
5-10 
>10  
 
307 (28.1)      
401 (36.7)       
384 (35.2)   
 
Indication for surgery, N (%) 
Benign 
Cancer  
 
245 (22.4) 
847 (77.6) 
 
Discharged* N (%) 
Yes 
No 
 
415 (38) 
677 (62) 
 
Access to stoma nurse, N (%) 
Easy / Very easy  
Difficult / Very difficult  
 
822 (83.5) 
163 (16.5) 
 
*Discharged from follow up at secondary care 
Table 3.1. Respondents’ demographics and characteristics. 
 
Category Male Female 
Age N (%) 
<60 
60-74 
≥ 75 
 
32 (26.5) 
306 (57.9) 
298 (67.3) 
 
89 (73.5) 
222 (42.1) 
145 (32.7) 
Time (in years) since surgery, N (%) 
<5 
5-10 
>10 
 
198 (64.5) 
235 (58.6) 
203 (52.9) 
 
109 (35.5) 
166 (41.4) 
181 (47.1) 
Indication for surgery, N (%) 
Benign 
Cancer  
 
39 (16.2) 
597 (70.3) 
 
203 (83.8) 
253 (29.7) 
 
Table 3.2. Gender distribution by age, time since surgery and indication for surgery. 
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3.3. Patient-reported complications 
3.3.1. Reported complications at different post-operative periods 
Patients were asked to report on complications they had experienced during different 
periods following their surgery. During the first 2 years after the procedure, UTI was 
the most commonly reported complication (reported by 38.1% of respondents), 
followed by appliances issues (30.7%) and parastomal hernia (27.3%). Between 2 
and 5 years post-surgery, UTIs remained the most common complication (38.1%) 
followed by parastomal hernia (32.4%) and skin related complications (22.0%). After 
5 years from IC operation, patients still reported UTIs, hernia and skin most often 
(38.8%, 36.0% and 20.6%, respectively). UTI (48.2%), parastomal hernia (39.3%) 
and appliance complications (36.3%) were the most ‘Ever reported’ complications. 
12.1% (132) of the respondents reported no complications at any time. (Table 3.3 & 
Figure 3.1) 
Time 
since 
surgery*  
 
UTI 
N (%) 
Appliances 
 N (%) 
Hernia 
N (%) 
Skin 
N (%) 
Bowel 
N (%) 
Kidney 
N (%) 
Stones 
N (%) 
Narrow 
Stoma 
N (%) 
<2 years  416 
(38.1) 
335 
(30.7) 
298 
(27.3) 
283 
(25.9) 
207 
(18.9) 
 124 
(11.4) 
28 
(2.5) 
34 
(3.1) 
2-5 years 355 
(38.1) 
180 
(19.3) 
302 
(32.4) 
205 
(22.0) 
165 
(17.7) 
115 
(12.3) 
27 
(2.9) 
27 
(2.9) 
>5 years 276 
(38.8) 
109 
(15.3) 
256 
(36.0) 
146 
(20.5) 
118 
(16.6) 
103 
(14.5) 
33 
(4.6) 
28 
(3.9) 
Any time 
(n=1092) 
527       
(48.2)      
400       
(36.6)       
430       
(39.3)     
368       
(33.7)       
258  
(23.6 )      
188       
(17.2) 
57        
(5.2)      
59        
(5.4)      
* The analysis of complications in <2 years from the procedure included all 1092 respondents; that for 
2-5 years included 931 respondents; and that for >5 years included 711 respondents. 
Table 3.3.Patient reported complications overall and by time since procedure. 
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Figure 3.1. Percentage of patients reporting complications by time since procedure 
and type of complication. 
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3.3.2. Ever reported a complication  
In total 87.9% of respondents reported one or more complication(s) at any time since 
the procedure. More than half (52.7%) of the respondents reported one (26.0%) or 
two (26.7 %) complications. 18.4% reported three, 11.0% reported 4, 4.1% reported 
5 and 1.4 reported 6 complications. Only 3 patients (0.3%) reported all 7 listed 
complications (Table 3.4). 
Number of 
reported 
complications 
No. of respondents Percentage of all 
respondents 
Percentage of 
respondents who 
reported  
≥1complication(s)* 
0 132 12.1 - 
1 284 26.0 29.6 
2 292 26.7 30.4 
3 201 18.4 20.9 
4 120 11 12.5 
5 45 4.1 4.6 
6 15 1.4 1.6 
7 3 0.3 0.3 
* Total number of respondents who reported ≥1 complication was 960. 
Table 3.4. Number and percentage of complications reported at any time since 
procedure. 
 
The frequency of ever reporting a complication was significantly higher amongst 
female than male respondents (90.8% vs 85.9%, p=0.014); respondents who had 
surgery five years or more ago compared to more recently (90.8% & 89.3% vs 
82.4%, p=0.002); those who had an ileal conduit for a benign cause rather than 
cancer (93.0% vs 86.5% p=0.006); and those who found difficulty accessing stoma 
nurses compared to those who found  access easy (94.5% vs 87.9%, p=0.015) 
(Table 3.5). Frequency did not differ by age or whether the respondent had been 
discharged from hospital follow-up. 
When all variables were fitted simultaneously in a logistic regression model, only 
having surgery 5-10 ago (OR=1.93, 95%CI 1.15-3.24, p=0.012) and difficulty 
accessing a stoma nurse (OR=2.15, 95%CI 1.06-4.38, p=0.034) remained 
significantly associated with ever reporting a complication following ileal conduit 
surgery (Table 3.6).   
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Category Ever reported a 
complication(n) 
Total (N) Ever reported a 
complication (%) 
 P 
Gender 
Male 
Female  
 
546  
414 
 
636 
456 
 
85.9 
90.8 
 
0.014 
Age  
<60 
60-74 
≥ 75 
 
110 
464 
386 
 
121 
528 
443 
 
90.9 
87.9 
87.1 
 
0.528 
Time since surgery 
<5 
5-10 
>10 
 
253 
364 
343 
 
307 
401 
385 
 
82.4 
90.8 
89.3 
 
 
0.002 
Indication for surgery   
Benign 
Cancer  
 
225 
735 
 
242 
850 
 
93.0 
86.5 
 
0.006 
Discharged  
Yes 
No 
                                                          
369 
591 
415 
677 
88.9 
87.3 
 
0.426 
Access to stoma nurse 
Easy / Very easy 
Difficult / Very difficult 
 
723 
154 
 
822 
163 
 
88.0 
94.5 
 
0.015 
 
Table 3.5. Frequency of ‘Ever reported a complication’ among different patients 
groups, numbers (n), percentages (%) and p values. 
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 Odds Ratio    95% CI P      
Gender    
Male 1 - - 
Female 1.22 0.77- 1.97 0.392 
    
Age    
≥ 75 1 - - 
60-74 0.95 0.61-1.49 0.824 
<60 1.12 0.50-2.52 0.775 
    
Indication for surgery    
Cancer  1 - - 
Benign  1.80 0.90-3.60 0.096 
    
Time since surgery    
<5  1 - - 
5-10 1.93 1.15-3.24 0.012 
>10 1.47 0.85-2.55 0.169 
    
Discharged     
No 1 - - 
Yes 0.92 0.58-1.49 0.763 
    
Difficult access to stoma nurse    
No 1 - - 
Yes  2.15 1.06-4.38 0.035 
 
Table 3.6. Multivariable logistic regression identifying patient characteristics 
significantly associated with ‘Ever reporting a complication’, odds ratios (OR), 95% 
confidence intervals (CI) and p values. 
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3.3.3. Reporting three or more complications 
35.2 % of respondents reported ≥3 complications. This was significantly higher 
amongst the following categories of respondents: females (43.9%), <60 years old 
(54.6%), time since surgery 5-10 yrs. (35.9 %), time since surgery >10 yrs. (41.9%), 
benign indication for surgery (52.5%) (p<0.001) and difficulty accessing a stoma 
nurse (47.9%, p=0.002) (Table 3.7). 
Using multivariable logistic regression, there was a significant positive association 
between benign indication for surgery (OR=1.65,95% CI 1.14-2.41, p=0.008), age 
<60 years (OR=1.99, 95%CI 1.25-3.21,p=0.004), 5 years or more post-surgery 
(OR=1.95, 95% CI 1.36-2.80, p<0.001), difficult access to stoma nurse (OR 1.55, 
95% CI 1.10-2.22p= 0.015) and reporting at least 3 reported complications. Patients 
who had been discharged were significantly less likely to report 3 or more 
complications. (OR=0.67, 95% CI 0.50-0.91, p=0.011) (Table3.8). 
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Category Reporting ≥3 
complications (n) 
Total 
(N) 
Reporting ≥3 
complications (%) 
P   
Gender 
Male 
Female  
 
184 
200 
 
636 
456 
 
28.9 
43.9 
 
<0.001 
Age  
≥ 75 
60-74 
<60 
 
136 
182 
66 
 
443 
528 
121 
 
30.7 
34.5 
54.6 
 
<0.001 
Time since surgery 
<5 
5-10 
>10 
 
79 
144 
161 
 
307 
401 
385 
 
25.7 
35.9 
41.9 
 
<0.001 
Indication for surgery   
Benign 
Cancer  
 
127 
257 
 
242 
850 
 
52.5 
35.2 
 
<0.001 
Discharged  
Yes 
No 
 
138 
246 
 
415 
677 
 
33.3 
36.3 
 
0.300 
Access to Stoma nurse 
Easy / Very easy 
Difficult / Very difficult 
 
288 
78 
 
822 
163 
 
35.0 
47.9 
 
0.002 
 
Table 3.7. Frequency of reporting three or more complications at different patients 
groups, numbers (n), percentages (%) and p values. 
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 Odds Ratio    95 % CI P     
Gender    
Male 1 - - 
Female 1.24 0.918-1.70 0.157 
    
Age     
≥ 75 1 - - 
60-74 1.09 0.81-1.48 0.555 
<60 1.99 1.25-3.21 0.004 
    
Indication for surgery    
Cancer 1 - - 
Benign  1.65 1.14-2.41 0.008 
    
Time since  surgery    
< 5 1 - - 
5-10 1.95 1.36-2.80 <0.001 
>10 2.45 1.67-3.62 <0.001 
    
Discharged    
No 1 - - 
Yes 0.67 0.50-0.91 0.011 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 1.55 1.10-2.22 0.015 
 
Table 3.8. Multivariable logistic regression identifying patient characteristics 
significantly associated with reporting three or more complications, odds ratios (OR), 
95 % confidence intervals (CI) and p values. 
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3.3.4. Number of ‘Ever reported’ Complications:  
The mean number (SD) of reported complications was 2.10 (1.42) while the median 
was 2 (5%-95% range: 0-5).The mean number of ever reported complications was 
higher amongst respondents younger than 60 years (2.66, P <0.001), those who had 
their surgery 5-10 years ago (2.11, p<0.001) and more than 10 years (2.34, p<0.001) 
and respondents who found it difficult to access a stoma nurse (2.66, p<0.001) 
(Table 3.9). Within the gender and indication for surgery categories, the median 
number of ever reported complications was higher amongst female respondents (2, 
0-5) and those who had surgery for benign indication (3, 0-6) (p<0.001), but did not 
differ according to whether the individual had been discharged from hospital follow-
up (Table 3.10). 
Category Mean (SD) P  
Age  
<60 
60-74 
≥ 75 
 
2.66 (1.53) 
2.07 (1.44)   
1.95 (1.32) 
 
<0.001 
Time since surgery   
<5 
5-10 
>10 
 
1.75 (1.31) 
2.11 (1.34) 
2.34 (1.53) 
 
<0.001 
Access to stoma nurse 
Easy / Very easy 
Difficult / Very difficult 
 
2.06 (1.38)   
2.66 (1.54) 
 
<0.001 
 
Table 3.9. Mean number of reported complications by age, time since surgery and 
access to stoma nurse, with p values from one-way anova. 
 
Category Median (5%-95% range) P  
Gender 
Male 
Female  
 
2 (0-4) 
2 (0-5) 
 
<0.001 
Indication for surgery   
Benign 
Cancer  
 
3 (0-6) 
2 (0-4) 
 
<0.001 
Discharged 
Yes 
No 
 
2 (0-4) 
2 (0-5) 
 
0.915 
 
Table 3.10. Median (5%-95%) number of reported complications by gender, 
indication for surgery and discharge from secondary care, with p values from 
Kruskall-Wallis test. 
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3.3.5. Patient reported frequency of complications  
Ever reported a frequent complication and associated characteristics  
493 (45.2%) of respondents reported at least one frequent complication. The 
frequency was significantly higher amongst females (53.7%), those aged less than 
60 years (65.3%), those being long after surgery (5-10yrs.; 48.6%, > 10yrs.; 51.3%), 
those who had a benign indication for surgery (59.92%) (p<0.001) and those who 
found difficulty accessing a stoma nurse (57.1%) (p=0.004) (Table 3.11). 
In multivariable analysis, age <60 yrs. (OR=2.52, 95% CI 1.56-4.08, p<0.001) & 60- 
74 yrs. (OR=1.36, 95% CI 1.02-1.81, p=0.034), time since IC operation more than 5 
years ( OR=2.33, 95% CI 1.65-3.28, p<0.001) and difficult access to a stoma nurse 
(OR=1.44, 95%CI 1.01-2.05, p=0.043) were all significantly associated with reporting 
at least one frequent complication(Table 3.12).  
Hernia (21.3%), UTI (17.6%), bowel (11.8%) and appliances problems (11.2%) were 
the complications most commonly reported as frequent (Table 3.13). 
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Category Ever reported 
a frequent 
complication(n) 
Total 
(N) 
Ever reported a 
frequent complication 
(%) 
P  
Gender 
Male 
Female  
 
248 
245 
 
636 
456 
 
39.0 
53.7 
 
<0.001 
Age  
≥ 75 
60-74 
<60 
 
173 
241 
79 
 
443 
528 
121 
 
39.1 
45.6 
65.3 
 
<0.001 
Time since surgery 
<5 
5-10 
>10 
 
101 
195 
197 
 
307 
401 
385 
 
32.9 
48.6 
51.3 
 
<0.001 
Indication for surgery   
Benign 
Cancer  
  
145 
348 
 
242 
850 
 
59.9 
40.9 
 
<0.001 
Discharged 
Yes 
No 
 
193 
300 
 
415 
677 
 
46.5 
44.3 
 
0.480 
Access to stoma nurse 
Easy / Very easy 
Difficult / Very difficult 
 
368 
93 
 
822 
163 
 
44.8 
57.1 
 
0.004 
 
Table 3.11. Frequency of ‘Ever reported a frequent complication’ by patient groups, 
numbers (n), percentages (%) and p values. 
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 Odds Ratio    95 % CI P      
Gender    
Male 1 - - 
Female 1.33 0.99-1.79 0.058 
    
Age     
≥ 75 1 - - 
60-74 1.35 1.02-1.81 0.039 
<60 2.52 1.56-4.08 <0.001 
    
Indication for surgery    
Cancer 1 - - 
Benign  1.26 0.87-1.83 0.222 
    
Time since surgery    
< 5 1 - - 
5-10 2.32 1.65-3.28 <0.001 
>10 2.41 1.66-3.5 <0.001 
    
Discharged    
No 1 - - 
yes 0.88 0.66-1.18 0.400 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 1.44 1.01-2.05 0.043 
 
Table 3.12. Multivariable logistic regression identifying patient characteristics 
significantly associated with ‘Ever reported a frequent complication’, odds ratio (OR), 
95% confidence intervals (CI) and p values. 
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 Reported frequency 
Type of 
complication 
Frequently N(%) Sometimes N(%) Rarely 
N(%) 
Never N(%) 
Bowel 129 (11.8)        128 (11.7) 90 (8.2) 745 (68.2) 
Kidney 88 (8.2) 75 (6.9) 80 (7.3) 849 (77.8) 
UTI 192 (17.6) 229 (21.0) 187 (17.1) 484 (44.3) 
Stones 14 (1.3) 14 (1.3) 28 (2. 6) 1036 (94.9) 
Hernia 233 (21.3) 95 (8.7) 85 (7. 8) 679 (62.2) 
Stoma stenosis  19 (1.7) 20 (1.8) 30 (2.8) 1023 (93.7) 
Appliances 122 (11.2) 292 (26.7) 209 (19.1) 469 (43.0) 
 
Table 3.13. Patient reported frequency of experiencing different types of 
complications. 
Of those who reported at least one frequent complications, 57.8 % and 26.8% 
reported one and two frequent complications respectively (Table 3.14). On average 
patients reported a mean (SD) of 0.72(0.99) frequent complications; the median (5%-
95% range) was 0(0-3). The median number of reported frequent complications was 
significantly higher (1(0-3), <0.001) amongst female respondents, those who were 
younger (< 60 yrs.) and those who had surgery more than >10 years ago. Similarly, it 
was significantly higher for respondents who had surgery for benign cause (1(0-3), 
p<0.001), and those who found difficulty accessing a stoma nurse (1(0-3), p=0.003) 
(Table 3.15). 
No. of frequent 
complications 
Frequency Percentage of 
all 
Percentage of those reporting ≥ 1 
frequent complication* 
0 599 54.9 - 
1 285 26.1 57.8 
2 132 12.1 26.8 
3 65 5.9 13.2 
4 6 0.5 1.2 
5 2 0.2 0.4 
6 2 0.2 0.4 
7 1 0.1 0.2 
*The total number of patients reporting ≥ 1 frequent complication was 493 
Table 3.14. Number (%) of frequent complications reported, among all respondents 
and among those who reported at least one frequent complication. 
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Category Median (5%-95%) P  
Gender 
Male 
Female  
 
0 (0-2) 
1(0-3) 
 
<0.001 
Age  
<60 
60-74 
≥ 75 
 
1 (0-3) 
0 (0-3) 
0 (0-2) 
 
<0.001 
Indication for surgery   
Benign 
Cancer  
 
1 (0-3) 
0 (0-2) 
 
<0.001 
Time since surgery   
<5 
5-10 
>10 
 
0 (0-2) 
0 (0-3) 
1 (0-3) 
 
<0.001 
Discharged 
Yes 
No 
 
0 (0-2) 
0 (0-3) 
 
0.929 
Access to stoma nurse 
Easy / Very easy 
Difficult / Very difficult 
 
0 (0-3) 
1 (0-3) 
 
0.003 
All patients 0 (0-3)  
 
Table 3.15. Median number (5%-95% range) of frequent complications reported at 
different patients groups with p values from Kruskall-Wallis test. 
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3.3.6 Characteristics associated with reporting different types of complications 
Using multivariable logistic regression, the patients and clinical  characteristics 
significantly associated with ‘Ever reported’ and ‘Ever reported as frequent’ for each 
individual complication were as follows.  Ever reporting bowel problems was 
associated with female gender (OR=1.51, 95% CI 1.80-2.11, p=0.016) and difficulty 
accessing a stoma nurse (OR= 1.62, 95% CI 1.11-2.36, p=0.012) (Table 3.16).  
Reporting frequent bowel problems was significantly associated with female gender 
(OR=1.73, 95% CI 1.09-2.74, p=0.02), benign indication for surgery (OR=1.83, 95% 
CI 1.11-3.02, p=0.018), age less than 60 years old (OR=2.32, 95% CI 1.23-4.38, 
p=0.01) discharged status (OR= 0.56, 95% CI 0.36-0.89, p=0.013). Report frequent 
bowel complications was not affected by access to stoma nurse (Table 3.17). 
Ever reporting kidney problems was significantly associated with benign indication 
for surgery (OR= 2.13, 95% CI 1.36-3.36, p=0.001), more than 10 years after 
surgery (OR=2.37, 95% CI 1.47-3.85, p<0.001) and less across discharged patients 
(OR= 0.65, 95% CI 0.45-0.95, 0.024) (Table 3.18). Reporting frequent kidney 
complications was significantly associated with benign indication for surgery (OR= 
2.02, 95% CI1.11-3.67, p=0.022), more than 10 years after surgery (OR=2.97, 95% 
CI 1.45-6.09, p=0.003) and difficult access to stoma nurse (OR= 1.83, 95% CI 1.07-
3.1, p=0.029) (Table 3.19). 
Ever reporting UTI was associated with benign indication for surgery (OR=1.88, 95% 
CI 1.29-2.74, p=0.001), 5-10 yrs. after surgery (OR= 1.64, 95% CI 1.17-2.30, 
p=0.004) and >10 yrs. after surgery (OR=2.80, 95% CI 1.93-4.07, p=<0.001) (Table 
3.20). Reporting frequent UTI was significantly associated with benign indication for 
surgery (OR=2.04, 95% CI 1.31-3.16, p=0.001), age 60-74 yrs.(OR=1.55, 95% CI 
1.05-2.30, p=0.029) & <60years (OR= 2.07, 95% CI1.17-3.66, p=0.012), 5-10 yrs. 
after  surgery  (OR=3.53, 95% CI 2.03- 6.14,p< 0.001), and  more than 10years after 
surgery (OR=5.01, 95% CI 2.85-8.81,p< 0.001) (Table 3.21). 
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 Odds Ratio    95%CI P  
Gender    
Male 1 - - 
Female  1.51 1.08-2.11 0.016 
    
Age     
≥ 75 1 - - 
60-74 1.19 0.85-1.68 0.295 
<60 1.58 0.96-2.62 0.073 
    
Indication for surgery    
Cancer 1 - - 
Benign  1.19 0.8-1.79 0.385 
    
Time since surgery    
< 5 1 - - 
5-10 1.03 0.71-1.53 0.847 
>10 1.08 0.72-1.64 0.709 
    
Discharged    
No 1 - - 
Yes 0.79 0.57-1.11 0.173 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 1.61 1.11-2.36 0.012 
 
Table 3.16. Multivariable logistic regression identifying patient characteristics 
significantly associated with ever reporting bowel complication, odds ratios (OR), 
95% confidence intervals (CI) and p values. 
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 Odds Ratio    95 %CI  P  
Gender    
Male 1 - - 
Female 1.73 1.09-2.74 0.020 
    
Age    
≥ 75 1 - - 
60-74 1.56 0.96-2.53 0.074 
<60 2.32 1.23-4.38 0.010 
     
Indication for surgery    
Cancer 1 - - 
Benign  1.83 1.11-3.02 0.018 
    
Time since surgery    
< 5 1 - - 
5-10 1.43 0.84-2.41 0.184 
>10 1.42 0.81-2.48 0.217 
    
Discharged    
No 1 - - 
Yes 0.56 0.36-0.89 0.013 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 1.54 0.95-2.5 0.083 
 
Table 3.17. Multivariable logistic regression identifying patient characteristics 
significantly associated with reporting bowel complication as frequent, odds ratios 
(OR), 95% confidence intervals (CI) and p values. 
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 Odds Ratio    95 %CI  P  
Gender    
Male 1 - - 
Female 0.88 0.59-1.31 0.520 
    
Age     
≥ 75 1 - - 
60-74 1.11 0.76-1.63 0.590 
<60 1.25 0.7-2.23 0.455 
    
Indication for surgery    
Cancer 1 - - 
Benign  2.13 1.36-3.36 0.001 
     
Time since surgery    
< 5 1 - - 
5-10 1.48 0.92-2.38 0.107 
>10 2.37 1.47-3.85 <0.001 
    
Discharged    
No 1 - - 
Yes 0.65 0.45-0.95 0.024 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 1.39 0.91-2.12 0.131 
 
Table 3.18. Multivariable logistic regression identifying patient characteristics 
significantly associated with ever reporting kidney complication, odds ratios (OR), 
95% confidence intervals (CI) and p values. 
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 Odds Ratio    95 %CI P  
Gender    
Male 1 - - 
Female 1.41 0.8-2.46 0.235 
    
Age     
≥ 75 1 - - 
60-74 1.32 0.75-2.33 0.331 
<60 1.45 0.66-3.19 0.356 
    
Indication for surgery    
Cancer 1 - - 
Benign  2.02 1.11-3.67 0.022 
    
Time since surgery    
< 5 1 - - 
5-10 1.61 0.77-3.36 0.210 
>10 2.97 1.45-6.09 0.003 
    
Discharged    
No 1 - - 
Yes 0.77 0.46-1.28 0.315 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 1.83 1.07-3.15 0.029 
 
Table 3.19. Multivariable logistic regression identifying patient characteristics 
significantly associated with reporting kidney complication as frequent, odds ratios 
(OR), 95% confidence intervals (CI) and p values. 
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 Odds Ratio    95 %CI  P  
Gender    
Male 1 - - 
Female 1.00 0.74-1.35 0.989 
    
Age     
≥ 75 1 - - 
60-74 1.33 0.99-1.77 0.056 
<60 2.31 1.42-3.74 0.001 
    
Indication for surgery    
Cancer 1 - - 
Benign  1.88 1.29-2.74 0.001 
    
Time since surgery    
< 5 1 - - 
5-10 1.64 1.17-2.3 0.004 
>10 2.80 1.93-4.07 <0.001 
    
Discharged    
No 1 - - 
Yes 0.85 0.64-1.14 0.288 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 1.28 0.9-1.83 0.172 
 
Table 3.20. Multivariable logistic regression identifying patient characteristics 
significantly associated with ever reporting UTI complication, odds ratios (OR), 95% 
confidence intervals (CI) and p values.  
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 Odds Ratio    95 %CI  P  
Gender    
Male 1 - - 
Female 1.19 
0.8-1.77 
0.385 
  
 
 
Age   
 
 
≥ 75 1 
- 
- 
60-74 1.55 
1.05-2.3 
0.029 
<60 2.07 
1.17-3.66 
0.012 
  
 
 
Indication for surgery  
 
 
Cancer 1 
- 
- 
Benign  2.04 
1.31-3.16 
0.001 
  
 
 
Time since surgery  
 
 
< 5 1 
- 
- 
5-10 3.53 
2.03-6.14 
<0.001 
>10 5.01 
2.85-8.81 
<0.001 
  
 
 
Discharged  
 
 
No 1 
- 
- 
Yes 0.91 
0.63-1.3 
0.604 
  
 
 
Difficult access to stoma nurse  
 
 
No 1 
- 
- 
Yes 1.08 
0.7-1.68 
0.716 
 
Table 3.21. Multivariable logistic regression identifying patient characteristics 
significantly associated with reporting UTI complication as frequent, odds ratios 
(OR), 95% confidence intervals (CI) and p values. 
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Ever reporting stone problems was associated with time from surgery 5-10 yrs. and 
>10 years (OR=2.93, 95% CI1.14-7.57, p=0.026, OR=4.43, 95% CI1.71-11.45, 
p=0.002) (Table 3.22). Reporting frequent stone problems was associated 
significantly with age category 60-74 years old (OR=4.95, 95% CI1.03 -23.8, 
p=0.047) (Table 3.23). 
Ever reporting hernia problems was less associated with younger age (<60 years: 
OR=0.41, 95% CI 0.25-0.68, p<0.001; 60-74 years: OR= 0.65, 95% CI 0.49-0.86, 
p=0.003) and discharge from secondary care (OR=0.70, 95%CI 0.53-0.94, p=0.019). 
It was associated with time since surgery (5-10 yrs.: OR=2.00, 95% CI 1.41-2.83, p< 
0.001>10 years: OR= 2.32, 95% CI 1.59-3.37, p< 0.001) (Table 3.24). Reporting 
frequent hernia complications was associated with female gender (OR=1.50, 95% CI 
1.06-2.12, p=0.021), time since operation categories of 5-10 years (OR=2.13, 95% 
CI 1.38-3.29, p=0.001) and >10 years (OR=2.68, 95%CI 1.69-4.25, p<0.001). It was 
negatively associated with discharged status (OR=0.70, 95% CI 0.50-0.99, p=0.043) 
(Table 3.25).  
Ever reporting stoma stenosis was significantly associated with benign indication for 
surgery (OR=3.10, 95% CI 1.44-6.64, p=0.004) and age <60 yrs. (OR= 3.59, 95% CI 
1.46 -8.80, p=0.005) (Table 3.26). Reporting frequent stenosis was associated with 
age<60 yrs. (OR=4.94, 95% CI 1.02-23.87, p=0.047) (Table 3.27). 
Ever reporting appliances problems was associated with age < 60 years (OR=1.67, 
95%CI 1.05-2.65, p=0.031) and difficulty accessing stoma nurse (OR=2.13, 95% CI 
1.50-3.01, p<0.001) (Table 3.28). No association was identified between reporting 
appliances complications frequently and patients ‘characteristics (Table 3.29). 
None of the characteristics were significantly associated with reporting skin 
problems- ever or frequent (Tables 3.30 & 3.31). 
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 Odds Ratio    95 %CI P  
Gender    
Male 1 - - 
Female 1.01 
0.52-1.97 
0.967 
  
 
 
Age   
 
 
≥ 75 1 
- 
- 
60-74 0.73 
0.38-1.42 
0.360 
<60 1.74 
0.75-4.02 
0.197 
  
 
 
Indication for surgery  
 
 
Cancer 1 
- 
- 
Benign  1.99 
0.96-4.11 
0.063 
  
 
 
Time since surgery  
 
 
< 5 1 
- 
- 
5-10 2.93 
1.14-7.57 
0.026 
>10 4.43 
1.71-11.45 
0.002 
  
 
 
Discharged  
 
 
No 1 
- 
- 
Yes 0.56 
0.31-1.03 
0.062 
  
 
 
Difficult access to stoma nurse  
 
 
No 1 
- 
- 
Yes 1.80 
0.94-3.41 
0.074 
 
Table 3.22. Multivariable logistic regression identifying patient characteristics 
significantly associated with ever reporting stone complications, odds ratios (OR), 
95% confidence intervals (CI) and p values. 
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 Odds Ratio    95 %CI P  
Gender    
Male 1 - - 
Female 1.61 0.47-5.46 0.447 
    
Age     
≥ 75 1 - - 
60-74 4.95 1.03-23.87 0.047 
<60 5.00 0.62-40.49 0.131 
    
Indication for surgery    
Cancer 1 - - 
Benign  0.44 0.1-2.01 0.288 
    
Time since surgery    
< 5 1 - - 
5-10 5.72 0.66-49.63 0.113 
>10 6.89 0.74-64.28 0.090 
    
Discharged    
No 1 - - 
Yes 1.15 0.36-3.64 0.813 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 1.18 0.31-4.46 0.811 
 
Table 3.23. Multivariable logistic regression identifying patient characteristics 
significantly associated with reporting stone complications as frequent, odds ratios 
(OR) 95% confidence intervals (CI) and p values. 
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 Odds Ratio    95 %CI  P  
Gender    
Male 1 - - 
Female 1.18 0.88-1.6 0.273 
    
Age     
≥ 75 1 - - 
60-74 0.65 0.49-0.86 0.003 
<60 0.41 0.25-0.68 <0.001 
    
Indication for surgery    
Cancer 1 - - 
Benign  0.95 0.65-1.39 0.807 
    
Time since surgery    
< 5 1 - - 
5-10 2.00 1.41-2.83 <0.001 
>10 2.32 1.59-3.37 <0.001 
    
Discharged    
No 1 - - 
Yes 0.70 0.53-0.94 0.019 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 1.12 0.78-1.59 0.545 
 
Table 3.24. Multivariable logistic regression identifying patient characteristics 
significantly associated with ever reporting hernia complications, odds ratios (OR) 
95% confidence intervals (CI) and p values. 
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 Odds Ratio    95 %CI P  
Gender    
Male 1 - - 
Female 1.50 1.06-2.12 0.021 
    
Age     
≥ 75 1 - - 
60-74 0.82 0.59-1.15 0.252 
<60 0.56 0.31-1.01 0.055 
    
Indication for surgery    
Cancer 1 - - 
Benign  0.77 0.5-1.2 0.257 
    
Time since surgery    
< 5 1 - - 
5-10 2.13 1.38-3.29 0.001 
>10 2.68 1.69-4.25 <0.001 
    
Discharged    
No 1 - - 
Yes 0.70 0.5-0.99 0.043 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 1.07 0.71-1.61 0.763 
 
Table 3.25. Multivariable logistic regression identifying patient characteristics 
associated with reporting hernia complications as frequent, odds ratios (OR) 95% 
confidence intervals and p values. 
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 Odds Ratio    95 %CI P  
Gender    
Male 1 - - 
Female 1.20 0.57-2.5 0.632 
    
Age    
≥ 75 1 - - 
60-74 1.07 0.49-2.37 0.861 
<60 3.59 1.46-8.8 0.005 
    
Indication for surgery    
Cancer 1 - - 
Benign  3.10 1.44-6.64 0.004 
    
Time since surgery    
< 5 1 - - 
5-10 0.75 0.32-1.78 0.519 
>10 1.99 0.91-4.31 0.083 
    
Discharged    
No 1 - - 
Yes 0.37 0.19-0.75 0.006 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 1.23 0.59-2.57 0.573 
 
Table 3.26. Multivariable logistic regression identifying patient characteristics 
significantly associated with ever reporting stoma stenosis, odds ratios (OR) 95% 
confidence intervals (CI) and p values. 
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 Odds Ratio    95 %CI P  
Gender    
Male 1 - - 
Female 2.02 0.6-6.75 0.255 
    
Age    
≥ 75 1 - - 
60-74 1.79 0.44-7.25 0.414 
<60 4.94 1.02-23.87 0.047 
    
Indication for surgery    
Cancer 1 - - 
Benign  1.16 0.34-3.9 0.811 
    
Time since surgery    
< 5 1 - - 
5-10 0.92 0.22-3.86 0.905 
>10 2.02 0.53-7.72 0.304 
    
Discharged    
No 1 - - 
Yes 0.69 0.23-2.03 0.497 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 2.41 0.85-6.85 0.099 
 
Table 3.27 Multivariable logistic regression identifying patient characteristics 
significantly associated with reporting stoma stenosis as frequent, odds ratios (OR) 
95% confidence intervals (CI) and p values. 
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 Odds Ratio    95 %CI P  
Gender    
Male 1 - - 
Female 0.99 0.73-1.34 0.947 
    
Age     
≥ 75 1 - - 
60-74 1.26 0.93-1.69 0.131 
<60 1.67 1.05-2.65 0.031 
    
Indication for surgery    
Cancer 1 - - 
Benign  1.29 0.88-1.87 0.188 
    
Time since surgery    
< 5 1 - - 
5-10 1.26 0.89-1.76 0.188 
>10 0.82 0.57-1.19 0.302 
    
Discharged    
No 1 - - 
Yes 0.98 0.73-1.31 0.877 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 2.13 1.5-3.01 <0.001 
 
Table 3.28. Multivariable logistic regression identifying patient characteristics 
significantly associated with ever reporting appliances complications, odds ratios 
(OR) 95% confidence intervals (CI) and p values. 
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 Odds Ratio    95 %CI P  
Gender    
Male 1 - - 
Female 0.99 0.73-1.34 0.947 
    
Age    
≥ 75 1 - - 
60-74 1.26 0.93-1.69 0.131 
<60 1.67 1.05-2.65 0.031 
    
Indication for surgery    
Cancer 1 - - 
Benign  1.29 0.88-1.87 0.188 
    
Time since surgery    
< 5 1 - - 
5-10 1.26 0.89-1.76 0.188 
>10 0.82 0.57-1.19 0.302 
    
Discharged    
No 1 - - 
Yes 0.98 0.73-1.31 0.877 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 2.13 1.5-3.01 <0.001 
 
Table 3.29. Multivariable logistic regression identifying patient characteristics 
significantly associated with reporting appliances complications as frequent, odds 
ratios (OR) 95% confidence intervals (CI) and p values. 
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 Odds Ratio    95 %CI P  
Gender    
Male 1 - - 
Female 1.24 0.92-1.68 0.159 
    
Age     
≥ 75 1 - - 
60-74 1.06 0.79-1.42 0.711 
<60 1.11 0.7-1.77 0.665 
    
Indication for surgery    
Cancer 1 - - 
Benign  1.30 0.9-1.89 0.165 
    
Time since surgery    
< 5 1 - - 
5-10 1.20 0.85-1.69 0.302 
>10 0.92 0.63-1.34 0.663 
    
Discharged    
No 1 - - 
Yes 1.09 0.81-1.46 0.557 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 1.20 0.84-1.7 0.322 
 
Table 3.30. Multivariable logistic regression identifying patient characteristics 
significantly associated with ever reporting skin complications, odds ratios (OR) 95% 
confidence intervals (CI) and p values. 
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 Odds Ratio    95 %CI P  
Gender    
Male 1 - - 
Female 1.72 0.55-5.32 0.348 
    
Age     
≥ 75 1 - - 
60-74 2.54 0.74-8.7 0.138 
<60 2.49 0.4-15.54 0.330 
    
Indication for surgery    
Cancer 1 - - 
Benign  0.39 0.09-1.68 0.208 
    
Time since surgery    
< 5 1 - - 
5-10 4.45 0.51-38.73 0.177 
>10 4.55 0.49-42.13 0.183 
    
Discharged    
No 1 - - 
Yes 2.63 0.83-8.28 0.099 
    
Difficult access to stoma 
nurse 
   
No 1 - - 
Yes 1.91 0.62-5.85 0.258 
 
Table 3.31. Multivariable logistic regression identifying patient characteristics 
significantly associated with reporting Skin complications as frequent, odds ratios 
(OR) 95% confidence intervals (CI) and p values. 
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3.4. Discharge and satisfaction with follow-up 
3.4.1. Discharge from hospital follow-up 
Of the respondents, 415 (38.0%) reported that they had been discharged from 
hospital follow up. The frequency of reporting discharge was significantly higher 
across those aged ≥ 75yrs (45.6%, p<0.001), who were longer since operation (5-10 
yrs. 39.7% & >10 yrs.56.8%, p<0.001) and had a benign indication for surgery 
(44.2%, p=0.024) (Table 3.32). In multivariable logistic regression, reporting 
discharge from secondary care was significantly associated with longer time since 
surgery y (p<0.001), but was negatively associated with age 60-74 (p=0.002) with no 
effect from gender or indication for surgery (Table 3.33). 
Category Discharged 
(N) 
Total (N) Discharged (%) P 
Gender 
Male 
Female  
 
241 
174 
 
636 
456 
 
37.9 
38.2 
 
0.929 
Age  
<60 
60-74 
≥ 75 
 
44 
165 
206 
 
121 
528 
443 
 
36.4 
31.3  
45.6 
 
<0.001 
Time since surgery   
<5 
5-10 
>10 
 
38 
159 
218 
 
307 
401 
385 
 
12.4  
39.7 
56.8 
 
<0.001 
Indication for surgery   
Benign 
Cancer  
 
107 
308 
 
242 
850 
 
44.2  
36.2 
 
0.024 
 
Table 3.32. Discharge from secondary care by different patient characteristics, 
numbers (n), percentages (%) and p values of Chi-square test. 
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 Odds Ratio    95% CI P      
Gender    
Male 1 - - 
Female 0.83 0.61-1.13 0.238 
    
Age    
≥ 75 1 - - 
60-74 0.63 0.47-0.84 0.002 
<60 0.84 0.52-1.36 0.467 
    
Indication for surgery    
Cancer  1 - - 
Benign  1.22 0.84-1.77 0.288 
    
Time since surgery    
<5  1 - - 
5-10 4.40 2.96-6.56 <0.001 
>10 8.56 5.70-12.86 <0.001 
 
Table 3.33. Multivariable logistic regression identifying patient characteristics 
significantly associated with reporting discharge from secondary care, odds ratios, 
95% Confidence intervals (CI) and p values. 
 
Of discharged patients, 138 (33.2%) reported they had been seen regularly by their 
GP to follow-up their stoma. One-third of discharged patients (32.3%; n=134) said 
they had been referred back to hospital following their discharge. 120 of these 
respondents gave a cause for referral back to secondary care.  Parastomal hernia 
(35%) was the most common cause for re-referral followed by UTIs (15.8 %) then 
skin problems (15%) (Table 3.34 & Figure 3.2). 
Referral back to hospital was significantly associated only with reporting a frequent 
complication (OR=4.33, 95% CI 1.48-12.70, p=0.008), and not with any other 
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characteristics including stoma nurse access or the presence of regular GP follow-up 
(Table 3.35). 
Reasons for re-referral Frequency Percentage 
Hernia 42 35.00 
UTI 19 15.83 
Skin 18 15.00 
Stoma 15 12.50 
Bowel 8 6.67 
Renal 5 4.17 
Cancer recurrence 4 3.33 
Haematuria 3 2.50 
Other reasons 6 5.00 
Total  120 100% 
 
Table 3.34. Reasons for referral back to secondary care. 
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Figure 3.2. Reasons for referral back to secondary care. 
 
 
 
 
 
 
 
 
Hernia UTI Skin
Stoma Bowel Renal
Cancer recurrence Haematuria others
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 Odds 
Ratio    
95 %CI P  
Gender    
Male 1 - - 
Female 1.09 0.64-1.85 0.744 
Age     
≥ 75 1 - - 
60-74 1.00 0.61-1.65 0.997 
<60 1.04 0.47-2.3 0.923 
Indication for surgery    
Cancer 1 - - 
Benign  1.44 0.79-2.62 0.231 
Time since surgery    
< 5 1 - - 
5-10 0.96 0.41-2.25 0.919 
>10 1.37 0.6-3.13 0.455 
Difficult access to stoma nurse    
No 1 - - 
Yes 1.32 0.78-2.23 0.304 
GP follow up    
No 1 - - 
Yes 0.96 0.59-1.55 0.870 
Report ≥1 frequent complication    
No 1 - - 
Yes 4.33 1.48-12.70 0.008 
 
Table 3.35. Multivariable logistic regression identifying patient characteristics 
significantly associated with reporting referral back to secondary care after 
discharge, odds ratios, 95% Confidence intervals (CI) and p values. 
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3.4.2. Patient satisfaction 
Only 171 respondents (15.7 %) were dissatisfied with their follow-up. The frequency 
of dissatisfaction was significantly higher amongst patients who had surgery for 
benign indication, those who had been discharged and those who found difficulty 
accessing a stoma nurse (p<0.001) (Table 3.36). 
Running a multivariable logistic regression including patient characteristics, benign 
indication for surgery (OR=2.86, 95% CI 1.71-4.7, p<0.001), discharge from 
secondary care (OR=2.23, 95% CI 1.48-3.37, p<0.001) and difficult access to stoma 
nurse (OR=7.92, 95%CI 5.27-11.89, p<0.001) all remained positively associated with 
reporting dissatisfaction with follow up (Table 3.37). Risk of reporting dissatisfaction 
was significantly lower in two groups: 5-10 years since operation (OR=0.59, 95% CI 
0.36- 0.98, p= 0.041) and >10 years from operation (OR=0.47, 95% CI 0.28-0.80, 
p=0.006). After re-running the model adding two additional independent variables 
(Ever reported a complication and Ever reporting a frequent complication), reporting 
a frequent complication was also significantly associated with reporting 
dissatisfaction (OR=1.73, 95% CI 1.16-2.58, p=0.007) (Table3.38). 
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Category Dissatisfied 
with Follow up  
(n) 
Total (N) Percentage P value 
Gender 
Male 
Female  
 
94 
77 
 
636 
456 
 
14.8 
16.9 
 
0.345 
Age  
≥ 75 
60-74 
<60 
 
68 
74 
29 
 
443 
528 
121 
 
15.4 
14.0 
24.0 
 
0.024 
Time since  surgery 
<5 
5-10 
>10 
 
47 
59 
65 
 
307 
401 
385 
 
15.3 
14.7 
16.9 
 
0.681 
Indication for surgery   
Benign 
Cancer  
 
65 
110 
 
242 
850 
 
25.2 
12.9 
 
<0.001 
Discharged 
Yes 
No 
 
93 
78 
 
415 
677 
 
22.4 
11.5 
 
<0.001 
Access to stoma nurse 
Easy / Very easy 
Difficult / Very difficult 
 
84 
76 
 
822 
163 
 
10.2 
46.6 
 
P<0.001 
 
Table 3.36. Dissatisfaction with follow up by patients’ characteristics, numbers (n), 
percentages (%) and p values from chi-square test. 
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 Odds Ratio    95% CI P  
Gender    
Male 1 - - 
Female 0.64 0.4-1 0.051 
    
Age     
≥ 75 1 - - 
60-74 0.70 0.45-1.08 0.110 
<60 1.20 0.64-2.24 0.555 
    
Indication for surgery    
Cancer 1 - - 
Benign  2.85 1.7-4.77 <0.001 
    
Time since surgery    
< 5 1 - - 
5-10 0.59 0.35-0.97 0.041 
>10 0.47 0.27-0.8 0.006 
    
Discharged    
No 1 - - 
Yes 2.23 1.48-3.37 <0.001 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 7.91 5.27-11.88 <0.001 
 
Table 3.37. Multivariable logistic regression identifying patient characteristics 
significantly associated with reporting dissatisfaction with follow up, odds ratios (OR), 
95% Confidence intervals (CI) and p values. 
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 Odds Ratio    95 %CI P  
Gender    
Male 1 - - 
Female 0.60 0.38-0.96 0.033 
Age      
≥ 75 1 - - 
60-74 0.67 0.43-1.03 0.074 
<60 1.04 0.55-1.97 0.891 
Indication for surgery    
Cancer 1 - - 
Benign  2.81 1.68-4.72 <0.001 
Time since surgery    
< 5 1 - - 
5-10 0.52 0.31-0.87 0.013 
>10 0.41 0.24-0.71 0.002 
Discharged    
No 1 - - 
Yes 2.29 1.51-3.47 <0.001 
Difficult access to stoma nurse    
No 1 - - 
Yes 7.62 5.06-11.48 <0.001 
Report ≥1  complication    
No 1 - - 
Yes 1.52 0.70-3.31 0.288 
Report ≥1 frequent 
complication 
   
No 1 - - 
Yes 1.73 1.16-2.58 0.007 
 
Table 3.38. Multivariable logistic regression identifying patient characteristics 
significantly associated with reporting dissatisfaction with follow up, adding 2 more 
variables (Ever reported a complication and Ever reported a frequent complication),  
odds ratios(OR), 95% Confidence intervals (CI) and p values. 
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Of the 921 patients who were satisfied with care, 645 provided further information 
about the reason for this. Among these respondents, the most commonly endorsed 
reason for satisfaction was the follow up they had received and the investigations 
they had during it: 33.0% (213 patients) reported this. The care received from the 
stoma nurse (181 patients, 28.06%) was the second most common reason for 
satisfaction, followed by the care provided by the surgeon (109, 16.9%) (Table 3.39). 
Reason of satisfaction Number Percentage  
Follow up 213 33.0 
Stoma nurse 181 28.1 
Surgeon 109 16.9 
Team 52 8.1 
Communication 23 3.6 
Access to care 37 5.7 
GP 5 0.8 
Total  645 100 
*645 respondents gave answer to this question. 
Table 3.39. Reasons for satisfaction with follow up reported by patients. 
 
Of the 171 patients who were not satisfied, 128 provided further information on the 
reasons for this.  Inadequate follow up (64, 50%) was the most commonly endorsed 
reason for dissatisfaction, followed by care of the stoma nurse (33, 25.78%), then 
complications (14, 10.1%) and communication (13, 10.1%). (Figure 3.3).  
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Figure 3.3. Reasons of dissatisfaction reported by patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inadequate FU Stoma nurse
Complications Communication
Delay of after treatment care Admin
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3.5. Patients’ preferences for follow up   
3.5.1. First two years following surgery 
When asked about the first 2 years following IC, the most commonly chosen 
schedule for  surgeon review was 6 monthly (551; 52.4%); this was followed by 3 
monthly (311; 29.6%). For stoma nurse review, patients chose 3 monthly (395; 
40.0%), not routinely (257; 26.0%) then 6 monthly (245; 24.8%) (Table3.40). 
 Surgeon review* Stoma nurse review** 
Chosen frequency Number Percentage Number Percentage 
3 monthly 311 29.6 395 40.0 
6 monthly 551 52.4 245 24.8 
12 monthly 133 12.7 70 7.1 
3m/ 6m 10 0.1 6 0.6 
6m/12m 1 0.1 0 0 
3m/12m 1 0.1 2 0.2 
Monthly 0 0 13 1.3 
Not routinely 44 4.0 257 26.0 
Total answered 1051 100 988 100 
*41 (3.8%) respondents gave no answer to this question 
**104(9.5%) respondents gave no answer to this question 
Table 3.40. Patients’ preferences for surgeon and stoma nurse follow up schedule 
during the first 2 years post-surgery. 
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3.5.2 Length of follow up in secondary care after 2 years 
When patients were asked of their views on the length of follow up in secondary care 
after the first 2 years, 40.6% (n=425) chose lifelong follow-up as their preferred 
option. 18.6% of respondents chose review when problems develop, while only 4.5 
%( n=47) opted for no more follow up after 2 years. The remainder opted for variable 
periods of follow up (Table 3.41). 
Being 5-10 years postoperative (OR= 1.87, 95% CI 1.31-2.65, p=0.001) or>10 years 
postoperative (OR= 2.17, 95% CI 1.47-3.22 p<0.001) were significantly associated 
with choosing lifelong follow up in multivariable analysis. Patients who had been 
discharged from secondary care were less likely to choose lifelong follow up 
schedule (OR= 0.15, 95% CI 0.11-0.21, p<0.001) (Table 3.42). None of the other 
variables (age, gender, indication for surgery and access to stoma nurse) were 
significantly associated with preferring lifelong follow-up, although being female was 
borderline statistically significantly (OR=1.37, 95%CI 1-1.88, p=0.053). 
Similar results were obtained on repeating the analysis adding ‘Ever reported a 
complication’ and ‘Ever reported a frequent complication’ as two additional 
independent variables (Table 3.43). 
Patient choices of length 
of secondary care  
Number Percentage 
Lifelong 425 40.6 
When problems develop 195 18.6 
5 yrs. 141 13.6 
1-4 yrs. 146 13.9 
6-10 yrs. 87 8.3 
No more 47 4.5 
11-20 yrs. 6 0.6 
Total 1047  
*45 (4.1%) respondents gave no answer to this question 
Table 3.41.  Patients’ preferences for length of secondary care follow up after first 2 
years.    
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 Odds Ratio    95% CI P  
Gender    
Male 1 - - 
Female 1.37 1-1.88 0.053 
    
Age     
≥ 75 1 - - 
60-74 1.29 0.95-1.76 0.105 
<60 1.11 0.67-1.83 0.681 
    
Indication for surgery    
Cancer 1 - - 
Benign  1.35 0.9-2.02 0.141 
    
Time since surgery    
< 5 1 - - 
5-10 1.87 1.31-2.65 0.001 
>10 2.17 1.47-3.22 <0.001 
    
Discharged    
No 1 - - 
Yes 0.15 0.11-0.21 <0.001 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 1.40 0.96-2.05 0.081 
 
Table 3.42. Multivariable logistic regression identifying patient characteristics 
significantly associated with lifelong preference of follow up, odds ratios (OR), 95% 
Confidence intervals (CI) and p values. 
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 Odds 
ratio 
95% CI  P 
Gender    
Male 1 - - 
Female 1.37 1-1.88 0.052 
Age      
≥ 75 1 - - 
60-74 1.30 0.95-1.77 0.102 
<60 1.12 0.68-1.85 0.668 
Indication for surgery    
Cancer 1 - - 
Benign  1.34 0.9-2.01 0.150 
Time since surgery    
< 5 1 - - 
5-10 1.86 1.3-2.66 0.001 
>10 2.18 1.46-3.25 <0.001 
Discharged    
No 1 - - 
Yes 0.15 0.11-0.21 <0.001 
Difficult access to stoma nurse    
No 1 - - 
Yes 1.39 0.95-2.04 0.089 
Report ≥1  complication    
No 1 - - 
Yes 1.23 0.77-1.97 0.380 
Report ≥1 frequent complication    
No 1 - - 
Yes 0.95 0.70-1.28 0.723 
Table 3.43. Multi variable logistic regression identifying patient characteristics 
significantly associated with lifelong preference of follow up, adding 2 more variables 
(Ever reported a complication and Ever reported a frequent complication), odds 
ratios (OR), 95% Confidence intervals (CI) and p values. 
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3.5.3. Patients’ preferences for follow up 2-5 years after surgery 
When asked about the postoperative period of between 2 and 5 years , the most 
commonly chosen schedules for  surgeon review were 12 monthly (61.3%)  followed 
by 6 monthly (23.8%). For stoma nurse review, patients selected ‘Not routinely’ 
(44.1%) and 12 monthly (29.8%) as the most preferred regimens (Table 3.44). 
 Surgeon review* Stoma nurse review** 
 Number Percentage Number Percentage 
Monthly  0 0 3 0.4 
3 monthly 17 1.8 48 5.6 
6 monthly 222 23.8 170 19.9 
12 monthly 571 61.4 255 29.8 
6m/12m 2 0.2 0 0 
2 yrs. 4 0.4 1 0.1 
2-5 yrs. 1 0.1 1 0.1 
Not routinely 115 12.3 377 44.1 
Total answered 932 100 855 100 
*160 (14.7%) respondents gave no answer to this question. 
**237(21.7%) respondents gave no answer to this question. 
Table 3.44. Patients’ preferences for surgeon and stoma nurse follow up schedule 
between 2 and 5 years post-surgery. 
 
3.5.4. Patients preference for follow up five years after surgery 
After 5 years, the most commonly chosen schedules for the surgeon review were 12 
monthly (58.7%), and ‘Not routinely’ (34.8%). For stoma nurse review, patients 
chose ‘Not routinely’ (59.0%), 12 monthly (32.1%) as the most preferred regimens 
(Table 3.45). 
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 Surgeon review* Stoma nurse review** 
 Number Percentage Number Percentage 
3 monthly 4 0.4 16 2.0 
6 monthly 41 4.8 53 6.6 
12 monthly 505 58.7 258 32.1 
2yrs 9 1.1 2 0.2 
5yrs 2 0.2 1 0.1 
Not routinely 300 34.8 474 59.0 
Total 861 100 804 100 
*231(21.2%) respondents gave no answer to this question. 
**288(26.4%) respondents gave no answer to this question. 
Table 3.45. Patients’ preferences for surgeon and stoma nurse follow up schedule 5 
years post-surgery. 
 
3.5.5. GP Follow up  
Every patient was asked to choose her/his preference of local doctor follow up 
schedule if she/ he felt community follow up is appropriate, 441 (40.4%) patients 
gave no answer and 37. 4 % felt that follow up with local doctor should be only ‘when 
needed’(Table 3.46). Patients were asked to give a reason if they thought GP follow 
up was inappropriate and 486 (43.5%) did so. Answering this question was assumed 
to imply patient lack of preference for community follow-up. Of these 486 patients, 
427 (87.9%) stated they did not prefer their local doctor to look after their IC because 
of lack of knowledge or experience (Table 3.47). 
The frequency of answering this question (i.e not preferring GP follow-up) was higher 
across female patients (45.6%, p=0.004) and lower among patients who had their 
surgery < 5 years ago (38.4%, p=0.032) and those who had already been 
discharged (32.3%, p<0.001) (Table 3.48). In a multivariable model, lack of 
preference of community based care was significantly associated with being longer 
since surgery (5- 10 years: OR= 1.83, 95% CI 1.30-2.57; >10 years: OR= 2.41, 95% 
CI 1.66-3.49) and negatively associated with being already discharged from 
secondary care (OR= 0.35, 95% CI 0.26-0.48) (Table 3.50). Similar results were 
obtained when running the model adding two extra variables of ‘Ever reported a 
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complication’ and ‘Ever reported a frequent complication’ (Table 3.49); neither 
complication variable was associated with lack of preference for community-based 
follow-up. 
 Number Percentage  
No answer  441 40.4 
3 monthly 20 1.8 
6 monthly 97 8.9 
12 monthly 126 11.5 
when needed 408 37.4 
Total 1092 100 
 
Table 3.46. Patients’ preferences for GP follow up schedule if appropriate. 
 
 Number Percentage 
No experience/ No knowledge 427 87.9 
Busy/ No attention 33 6.8 
No consistency 8 1.7 
Cancer can recur 3 0.6 
No facilities (i.e. scans) 6 1.2 
Prefer Stoma nurse 4 0.8 
Prefer surgeon 5 1.0 
Total answered  486 100 
*606(55.5%) respondents gave no answer to this question. 
Table 3.47. Reasons stated by patients for why they believe GP follow up is 
inappropriate. 
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Category Frequency of 
stating a 
reason (n) 
Total (N) Percentage P  
Gender 
Male 
Female  
 
260 
266 
 
636 
456 
 
40.9 
45.6 
 
0.004 
Age  
≥ 75 
60-74 
<60 
 
59 
242 
185 
 
121 
528 
443 
 
48.8 
45.8 
41.8 
 
0.270 
Time since surgery   
<5 
5-10 
>10 
 
118 
183 
185 
 
307 
401 
385 
 
38.4 
45.6 
48.2 
 
0.032 
Indication for surgery   
Benign 
Cancer  
 
117 
369 
 
242 
850 
 
48.4 
43.4 
 
 
0.173 
Discharged 
Yes 
No 
 
134 
352 
 
415 
677 
 
32.3 
52.0 
 
<0.001 
Access to stoma nurse 
Easy / Very easy 
Difficult / Very difficult 
 
371 
82 
 
 
822 
163 
 
45.1 
50.3 
 
0.226 
 
Table 3.48. Frequency of stating a reason for lack of preference of community follow 
up at different respondents groups, numbers (n), percentages (%) and p values. 
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 Odds Ratio    95% CI P  
Gender    
Male 1 - - 
Female 1.28 0.95-1.73 0.103 
    
Age    
≥ 75 1 - - 
60-74 1.18 0.88-1.57 0.276 
<60 1.29 0.81-2.06 0.281 
    
Indication for surgery    
Cancer 1 - - 
Benign  0.89 0.61-1.3 0.552 
    
Time since surgery    
< 5 1 - - 
5-10 1.83 1.3-2.57 <0.001 
>10 2.41 1.66-3.49 <0.001 
    
Discharged    
No 1 - - 
Yes 0.35 0.26-0.48 <0.001 
    
Difficult access to stoma nurse    
No 1 - - 
Yes 1.31 0.92-1.86 0.138 
 
Table 3.49. Multivariable logistic regression identifying patient characteristics 
significantly associated with lack of preference of community follow up, odds ratios 
(OR), 95% Confidence intervals (CI) and p values. 
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 Odds 
Ratio    
95 %CI  P  
Gender    
Male 1 - - 
Female 1.26 0.93-1.7 0.136 
Age     
≥ 75 1 - - 
60-74 1.16 0.86-1.55 0.328 
<60 1.23 0.76-1.97 0.398 
Indication for surgery    
Cancer 1 - - 
Benign  0.87 0.6-1.27 0.466 
Time since surgery    
< 5 1 - - 
5-10 1.72 1.22-2.42 0.002 
>10 2.27 1.56-3.31 <0.001 
Discharged    
No 1 - - 
Yes 0.35 0.26-0.48 <0.001 
Difficult access to stoma nurse    
No 1 - - 
Yes 1.26 0.88-1.8 0.204 
Report ≥1  complication    
No 1 - - 
Yes 1.36 0.87-2.11 0.175 
Report ≥1 frequent complication    
No 1 - - 
Yes 1.26 0.95-1.66 0.108 
 
Table 3.50. Multivariable logistic regression identifying patient characteristics 
significantly associated with lack of  preference of community follow up, adding 2 
more variables (Ever reported a complication and Ever reported a frequent 
complication), odds ratios (OR), 95% Confidence intervals (CI) and p values. 
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3.6. Summary of patients’ survey results  
These results represent the responses of 1092 patients who were surveyed through 
the Urostomy Association. The response rate to the questionnaire was 59.5%.  The 
respondents included males and females, of a range of ages, and times since 
surgery, and who were treated for cancer or benign indications. 
87.9% of respondents reported at least one complication since surgery, and 45.2% 
reported a frequent complication. Urinary tract infections (48.2%), parastomal hernia 
(39.3%) and appliances (36.6%) problems were the most common reported 
complications. 
Using multivariable logistic regression, certain patient characteristics were identified 
to be significantly associated with reporting complications. These were female 
gender, age < 60 years, benign indication for surgery, 5-10 yrs. & > 10 yrs. since 
surgery. 
Reporting difficulty in accessing a stoma nurse was associated with a higher risk of 
reporting complications. This variable was also strongly negatively associated with 
patient satisfaction with their postoperative care after adjusting for other factors 
(OR=7.92, 95%CI 5.27-11.89, p<0.001). 
The overwhelming majority of patients (84.3%) were satisfied with their follow up. 
Benign indications for surgery (OR=2.86, 95% CI 1.71-4.7, p<0.001), discharge from 
secondary care (OR=2.23, 95% CI 1.48-3.37, p<0.001) and difficult access to stoma 
nurse were all significantly associated with dissatisfaction.  
Of the respondents, 415 (38%) reported that they had been discharged from hospital 
follow up. One-third of the discharged patients said they had been referred back to 
hospital following their discharge. 38.9% of respondents favored lifelong hospital 
follow up. A longer time since surgery was associated with choosing lifelong hospital 
follow up. After adjusting for other factors, patients who had been discharged from 
secondary care were significantly less likely to prefer lifelong hospital follow up (OR= 
0.15, 95% CI 0.11-0.21, p<0.001). 
43.5% patients gave a reason why they felt GP follow up is inappropriate for IC 
cases; the predominant reason (87.9%) was lack of knowledge or experience. Lack 
of preference of community based care was significantly positively associated with 
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being long from surgery (OR= 1.83, 95% CI 1.30-2.57) and > 10 yrs. (OR= 2.41, 
95% CI 1.66-3.49). Those who had already been discharged from secondary care 
were significantly less likely to think GP follow-up is inappropriate (OR= 0.35, 95% CI 
0.26-0.48, p≤0.001). 
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Chapter 4. Study B results: Current practice & alternative models of 
surveillance for patients with ileal conduit urinary diversion:  A 
qualitative study using the Normalisation Process Theory 
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4.1. Introduction 
The main aim of this study was to explore the implementation of current practices of 
follow up for IC patients and to understand why and how a “new” (alternative) model 
of surveillance for IC patients could be successfully developed and implemented, 
whether in the community or secondary care. The introduction and implementation of 
an alternative model of surveillance up for ileal conduit patients would require the 
involvement of multiple stakeholders across both primary and secondary care. A 
qualitative method (semi-structured interviews with secondary care health 
professionals) guided by the Normalization Process Theory was used to conduct this 
part of the study. The theory has identified four main domains that promote or inhibit 
the kinds of co-operative work that is needed to implement service innovations in 
complex organizational contexts, the NHS for example. Those four domains are 
Coherence, Cognitive Participation, Collective Action, and Reflexive Monitoring 
(Chapter 1)(May and Finch, 2009) . 
4.2. Study sites and participants  
4.2.1. Study sites  
The interviews took place at 3 centres - designated A, B and C to protect 
participants’ identifies - in three different areas in England. The centres were at the 
North, Yorkshire and the Midlands. The centres’ characteristics are summarised in 
Table 4.1.  
Centre Region Type Approx. 
catchment 
Population 
Type of relevant 
Urology service  
A Midlands Teaching 
hospital 
800,000 Cancer 
B North  Teaching 
hospital 
1,000,000 Cancer and 
reconstruction 
C Yorkshire & 
the Humber 
District 
General  
500,000 Cancer and 
reconstruction 
 
Table 4.1. The characteristics of the centres involved in the study. 
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4.2.2 Follow up models 
As described earlier (Chapter1), the differences in the local follow up schedules 
between centre A and centre B were known before the start of the study. The follow 
up protocol at the site C emerged during the interviews. The three centres had 
different models for long-term follow up for IC patients in terms of length, settings 
and involved health professionals. Nevertheless, there was a great similarity in the 
investigations arranged on hospital visits for surveillance. 
Centre A. At this site the follow up was mainly a consultant led service. Following the 
initial few post-operative years, the patients are followed up annually at a consultant 
led clinic. There is no departmental written protocol for the length of follow-up, 
however most of the consultants tend to keep the surveillance lifelong. There was no 
Urology nurse specialist involvement in follow up due to workforce shortages, 
however there was a plan to introduce this role.  [After the end of recruitment to 
study B, AA learned that a nurse specialist had been appointed to take on the role of 
following up bladder cancer patients who had IC at a joint clinic with the consultant]. 
The stoma nurses on this site are employed by an appliances company but hold an 
honorary contract with the Trust. Their role involves solely providing stoma care 
support for patients when required. The patient accesses them via phone and an 
appointment is arranged if required.  
Centre B. At this site there is a uniform- but unwritten - local protocol for long term 
follow up. Following the initial postoperative years of consultant led follow up, patient 
surveillance is transferred to a Urology stoma nurse or a nurse specialist led clinic. A 
well-structured annual review takes place at this nurse-led clinic where patients are 
reviewed and have a set of bloods and a scan. Patients always have access to 
stoma nurses by phone, and they can be booked into a drop-in nurse-led clinic if 
required. 
Centre C. On this site there is a uniform - but again unwritten - protocol for follow up 
for 5 years after surgery. During that period patients are seen simultaneously at 2 
different clinics led by consultant and nurse specialists, respectively, for the first 2 
years. Following the initial 2 years, patients are discharged from the consultant led 
clinic and follow up continues with the specialist nurse where they are followed up for 
further three years then discharged back to community. They keep access via phone 
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to the hospital based stoma nurse clinic for stoma care support, and appointments 
are arranged if required. 
4.2.3. Participants 
Of 20 health professionals approached, 17 agreed to participate and were 
interviewed. These were 8 consultant Urological surgeons (U), 4 nurse specialists 
(NS) and 5 stoma nurses (SN). The participants’ average (range) experience in their 
current role was 13 yrs. (2.5-35). The participants’ characteristics are detailed at 
table 4.2. The average (range) interview length was 29 minutes and 46 seconds 
(12:24 -50:58). 
NO Centre Code Job title Years of experience 
in current role 
1.  X X/U/01 Consultant Urologist 27 
2.  X X/U/02 Consultant Urologist 4 
3.  X X/U/03 Consultant Urologist 17 
4.  X X/U/04 Consultant Urologist 27 
5.  X X/SN/01 Stoma nurse 14 
6.  X X/SN/02 Stoma nurse 30 
7.  Y Y/NS/01 Nurse specialist 10 
8.  Y Y/NS/02 Nurse specialist 35 
9.  Y Y/SN/03 Stoma nurse 4 
10.  Y Y/NS/04 Nurse specialist 16 
11.  Y Y/U/01 Consultant Urologist 13 
12.  Y Y/U/02 Consultant Urologist 11 
13.  Z Z/U/01 Consultant Urologist 8 
14.  Z Z/SN/01 Stoma nurse 2.5 
15.  Z Z/SN/02 Stoma nurse 9 
16.  Z Z/U/02 Consultant Urologist 4 
17.  Z Z/NS/03 Nurse specialist 3 
Table 4.2. Participants’ characteristics.  
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The three groups of health professionals were represented across all three centres 
except for centre X where no nurse specialists were involved into IC care during the 
study period. Hence, no nurse specialist could be interviewed from that site.  
4.3. Themes and Sub-themes  
Seven main themes emerged from the interviews: (1) current practice and alternative 
models; ( 2) role of surgeon & secondary care; (3) role of stoma nurse & urology 
nurse specialist; (4) community follow up; (5) General Practitioner role; (6) patients’ 
involvement and (7) resources. Tables (4.3-4.9) shows the main seven themes and 
the relevant subthemes  
Theme(1) Current practice and alternative models 
 
 
S
u
b
-T
h
e
m
e
s
 
Awareness of ileal conduit complications 
Defining complications 
Valuing of follow up 
Need for change 
No agreement on length of follow up   
Advocacy for a standard protocol 
Existing local protocols 
Defining the aims of follow up 
Accommodating benign and cancer cases 
Accommodating different types of bladder cancer follow up 
Knowledge of guidelines 
Ideas proposed for long term follow up 
 
Table 4.3. Theme 1: Current practice and alternative models.  
 
Theme(2) Role of surgeon & secondary care 
  
 
   
S
u
b
-
T
h
e
m
e
s
 
Role of surgeons at follow up 
Willingness to teach or organise 
Engagement of stakeholders 
Audit and research 
 
Table 4.4. Theme 2: Role of surgeon & secondary care.  
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Theme(3) Role of stoma nurse & Urology nurse Specialist 
  
  
 
 S
u
b
-T
h
e
m
e
s
 
Role of SN/NS at follow up 
SN/NS coordinating role 
Valuing  SN/ NS role 
Individualised care & holistic approach to care  from SN/NS  
Work relationship with non-NHS stoma nurse 
Stoma nurse access to investigations 
Lack of stoma nurses experience at non-stomal complications 
 
Table 4.5. Theme 3: Role of stoma nurse & Urology nurse Specialist. 
 
Theme (4) Community follow up 
  
S
u
b
-T
h
e
m
e
s
 Support for community based follow up 
Awareness of implications of community FU 
Similar successful models 
Communication between primary and secondary care 
] 
Table 4.6. Theme 4: Community follow up. 
 
Theme(5) General practitioner role 
   
  
  
  
S
u
b
-T
h
e
m
e
s
 Uncertainty about GP willingness to be involved 
GP role at follow up 
Lack of GP knowledge & experience 
Communication with GP 
Support of and work relationship with GP 
 
Table 4.7. Theme 5: General practitioner role.  
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Theme (6) Patients’ involvement 
  
S
u
b
-T
h
e
m
e
s
 
 
Patients’ access to secondary care 
Patients’ expectations 
Giving patients the choice 
Patient education 
Patient support groups 
 
Table 4.8. Theme 6: Patients’ involvement.  
 
Theme (7) Resources 
   
S
u
b
-T
h
e
m
e
s
 Investigations required  
Lack of SN in secondary care 
Teaching and training 
Urology workload 
 
Table 4.9. Theme 7: Resources. 
 
In the next section the sub- themes are described in relation to the four constructs of 
the NPT; the sub-themes are further classified into barriers and facilitators under 
each construct. The additional subthemes that didn’t fall under the NPT framework 
were separately discussed in a dedicated section (4.5). 
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4.4. Findings in relation to the four NPT constructs 
  
4.4.1. Coherence 
This construct represents the work of making sense of a set of practices, its aims, its 
value and how it is different from other practices. The participants showed a good 
coherence of the concept of long term surveillance for IC and of the potential need 
for introduction of an alternative model. The majority of the interviewees described 
the long term complications of IC and expressed valuing the role of surveillance. 
Stoma nurses with no urology background expressed their lack of experience of the 
non-stoma related complications. Participants considered that there was a need for 
change in surveillance in order to: reduce the risk of missing complications because 
of the (current) absence of a standardised protocol; and help to decrease the 
pressure in secondary care services. They considered that there were some 
challenges in the introduction of a shared care community pathway, including the 
need for resources and investment to make it workable. Further barriers to 
implementation of an alternative follow-up protocol were absence of a shared 
understanding of the length of follow up needed in secondary care and of how the 
surveillance scheme could be adjusted to accommodate both benign and cancer 
cases. 
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NPT construct Facilitators  Barriers 
 
 
 
Coherence  
Valuing  follow up No agreement on length of 
follow up  
Awareness of ileal conduit 
complications 
Accommodating benign and 
cancer cases 
Advocacy for a standard 
protocol 
Accommodating different types 
of bladder cancer follow up 
Knowledge of guidelines Lack of stoma nurses  
experience at non stoma 
complications 
Need for change  
Awareness of  implications of 
community FU 
 
 
Table 4.10. Facilitators and barriers to implementation of an alternative follow-up 
schedule under ‘Coherence’ construct. 
 
Facilitators  
Valuing of follow up and Awareness of ileal conduit complications  
Participants expressed that they valued the long term follow up for IC patients. This 
seemed to arise from their knowledge of the risk of long term complications that are 
associated with this surgery. Surgeons and nurse specialists showed awareness of 
the different long term complications, and they described the different adverse 
effects of the surgery i.e. renal failure, urinary tract infections, hernia etc. They 
emphasised the role of follow up in detecting these complications early. Participants 
felt that the importance of long term follow up lies in identifying minor problems 
before they exacerbate. Surgeons showed more in-depth knowledge of the 
metabolic complications such as acidosis, folic acid deficiency and the need to 
108 
 
monitor those. Most of the stoma nurses considered an additional focus of follow-up 
should be the on the social and psychological consequences of the surgery and its 
complications.  
X/U/01 
‘Follow up is very important; apart from the cancer follow up the ileal conduit has its 
own issues. Bicarbonate upset of blood cause  hyper-acidosis or low bicarbonate 
that needs to be monitored and also local issues of stomal prolapse, parastomal 
hernia, and stomal stenosis will all need addressing as well’ 
Z/SN/01 
‘Recently I had a problem with a patient who had incontinence and problems dealing 
with the stoma, leakage from the pouch which was affecting him psychologically.’ 
 
Advocacy for a standard protocol and Knowledge of guidelines 
Almost all the professionals expressed their awareness of the lack of national or 
international guidelines designed specifically for IC long term follow up, and were 
advocates of a written protocol. Several advantages of a formal arrangement of 
follow up were described by interviewees: it would minimise the risks of missing 
complications and losing patients to follow up, it can improve the communication 
between secondary and primary care; and it can provide the patient with a formal 
port of call when required .In addition, it was felt that it could provide greater 
uniformity of care and allow for auditing and research.  
X/U/03 
‘I think there should be (1) a standard transfer of care form, (2) what to look for, (3) 
point of contact by the patient. ’ 
X/U/01 
‘if we can organise their [patients] follow up then we can try our best to make sure 
we don’t lose patients to follow up  and that is why the stoma nurse clinic was set up 
many years before I started here which I think is a  good model.  A medically-led 
follow up in a consultant-led clinic with varying degrees of trainee input throws up all 
sorts of anomalous practices.’ 
 
Need for change  
The participants considered that there might be a need for change from current 
practice for two main reasons: first; the risk of non-standardised follow up that is not 
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well supported by evidence or national guidelines; and secondly the mounting 
pressure on secondary care services. According to the participants’, the absence of 
a standard model of surveillance could result in failure to identify complications, 
patients being lost in the system and inability of patients to gain access to medical 
attention when required. 
Z/SN/01 
‘…... the patient should know who to contact if they are having problems.’ 
X/U/02 
‘It [Community based follow up]) would free up spaces in your clinic to see other 
patients’   
Z/U/01 
‘At the moment I suspect it is very hit and miss that they (GPs after patients are 
discharged from secondary care) don’t know what they should be doing which is why 
patients can incur accidents  etc’ 
 
Interviewees discussed the pressure in outpatients’ clinics and on the work force in 
secondary care. The increasing numbers of follow up slots in clinics is minimising the 
space available for new patients who can wait for months for their first appointment. 
Additional stoma nurses have been appointed at one of the centres just to cope with 
workload of stoma care and maintaining the local protocol for follow up. Some 
participants expressed a belief that the increased workload in secondary care could 
stimulate the introduction of a shared care model which could work for ileal conduit 
patients as it has worked in other urology areas like prostate cancer. Furthermore, 
easily accessible and individualised care were seen as additional benefits of 
community follow up. 
Y/NS/04 
‘The negatives [of Hospital based follow up setting] are probably insufficient time with 
each patient when they attend the clinics but as we now have additional staff we are 
trying to accommodate patients who require a longer clinic time slot to deal with their 
problem on the same day.’ 
X/SN/01 
‘I do think it [community follow up] is a safe thing to do as you get to see the patient 
in their own environment.  You get to see their social setting, if they are married or if 
living on their own, if they are vulnerable, not eating or drinking, we get to see that 
side quite differently from the hospital setting.’ 
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Awareness of implications of community FU  
The majority of participants emphasised the implications of development of a 
community based follow up model and the challenges that comes with it. Most 
participants discussed the challenges and barriers of community follow up; for 
example: lack of GP experience, poor access of stoma nurses to investigations such 
as upper tract imaging and availability of space for clinics. Participants identified that 
a range of resources would be required to establish this model including training for 
GPs and community stoma nurses, financial resources and a formal communication 
route between primary and secondary care. 
Z/SN/01 
‘The GP actually asks us to review the patients because sometimes they don’t know 
how to manage them.’‘ 
X/SN/02 
‘…, the only investigation that I [community stoma nurse] can do is taking a urine 
sample ‘ 
X/U/01 
‘We [Urologists] will need willing GPs, patient co-operation and excellent 
communication between us and GP.   If GPs are not able to contact us the process 
could fail.’ 
Barriers  
No agreement on length of follow up, Accommodating benign and cancer 
cases and Accommodating different types of bladder cancer follow up. 
In terms of development of a standardised protocol, participants held very different 
opinions over the length of follow up that should be offered in secondary care before 
discharge to community if at all.  There was no common view of how long the 
patients should be reviewed in hospitals before they get discharged for a community 
follow up. Another area where there were differences in opinion was with whether 
there was a need to adjust any protocol for cancer and benign cases; this seemed 
undetermined yet by some participants or viewed differently amongst others. In 
addition, some surgeons highlighted that even surveillance of different types of 
bladder cancers can be different as they vary at their prognosis. 
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X/U/02 
‘I [a Urologist] do not know if after ten years whether we should go for discharging 
them or not; potentially from a cancer point of view we could do’ 
‘I think it would be a tailored follow up protocol according to the patient but this might 
complicates things for GPs so I don’t want to start stratifying patients ‘ 
X/SN/01 
‘The follow up plan should be exactly the same [for benign cases] because it is the 
stoma we are concentrating on;’ 
 
Lack of stoma nurses’ experience at non-stoma complications 
As might be expected for their current role, it emerged that stoma nurses’ experience 
of long term complications seemed largely focused on the stoma -related 
complications such as appliances and skin issues. The stoma nurses without a 
Urology background expressed their lack of experience and involvement with the 
monitoring of non-stoma issues. On the other hand, Urology stoma nurse specialists 
seems to have good knowledge and experience at this areas. In one of the centres, 
they described their active involvement in the implementation of local protocols, 
including requesting appropriate investigations and even interpreting the results. 
X/SN/01 
‘We [stoma nurses] don’t get involved in that [non stoma complications], we just 
focus on the stoma and the skin.  We don’t look at the kidney problems’ 
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Coherence Sub-Themes Quotes 
 
 
 
Facilitators 
Valuing of follow 
up 
X/SN/01 
‘We need to keep in contact with them [patients] 
to make sure that their minor issues do not 
become bigger problems’ 
Awareness of 
ileal conduit 
complications 
Y/NS/01 
‘I Look at the patient as a whole to see if the 
patient is coping physically,…… bloods, kidney 
function which is looked at in the outpatient 
follow up where they get scans and bloods 
taken.’  
 
Advocacy for a 
standard protocol 
X/U/01 
‘I think if you have a firm protocol  to make 
things uniform it would be very useful  for audits 
or research to see how the patient have done 
nationally because there would be a set pattern 
for follow-up, and investigations’ 
Knowledge of 
guidelines 
Y/U/01 
‘I am not aware of any follow up guidelines.’ 
 
Need for change Y/SN/03 
‘I have queried why I am still seeing people 10 
years down the line that have never had a 
problem.’ 
 
Awareness of 
implications of 
community FU 
Y/U/02 
 
‘…….; it might be difficult to set up ultrasound 
scans in the community due to lack of 
machines.’ 
 
Table 4.11. Additional examples of quotes of facilitators under ‘Coherence’ construct. 
  
 
 
 
 
113 
 
Coherence Sub-Themes Quotes 
Barriers No agreement on 
length of follow 
up 
Z/U/01 
‘Again we haven’t set it [local protocol] in stone, 
but I would say five years in total and then the 
patient is discharged.’ 
 
Accommodating 
benign and 
cancer cases 
X/U/03 
 
‘I would look at the stoma [for benign IC cases]3 
months later and if it is fine then maybe one 
more visit 6 months later and that’s it.’    
Accommodating 
different types of 
bladder cancer 
follow up 
Y/U/02 
‘Depending on the type of cancer the imaging 
would be quite intense for the first couple of 
years and then after that probably twice a year 
and then from year 5 once a year only.’ 
Lack of stoma 
nurses 
experience at non 
-stoma 
complications 
Z/SN/01 
‘We review the stoma and if there is a problem 
we deal with it, be it different pouch, leakage, 
sore skin.  If the problem is more complex, then 
it is referred to the consultant.’   
 
Table 4.12. Additional examples of quotes of barriers under ‘Coherence’ construct. 
 
4.4.2. Cognitive participation 
This construct represents the ‘relational work’ that the people do towards a set of 
practices. Successful implementation of an intervention such as IC long term 
surveillance, would require the engagement of the key professionals and their units 
and the readiness to invest time or resources into its enacting. In the absence of a 
standardised protocol or guidelines, all three units have shown proactivity towards 
establishing a follow up scheme either at the level of the local unit or individual 
surgeon. Stoma nurses described how they have invested time and underwent 
training to fulfil the requirements of their role and put extra efforts to meet patients’ 
needs. There were doubts expressed about GPs’ willingness to be involved in IC 
long term surveillance and about patients’ response to a community based model of 
follow up.    
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NPT construct Facilitators  Barriers 
 
 
 
Cognitive participation 
Existing local protocols Uncertainty about GP 
willingness to be involved 
Similar successful models Patients’ expectations 
Role of surgeons at follow 
up 
 
Support of and work 
relationship with GP 
 
Role of SN/ NS at follow 
up 
 
GP role at  follow up  
 
Table 4.13. Facilitators and barriers under ‘Cognitive participation’ construct.  
 
Facilitators   
Existing local protocols & Similar successful models 
In the absence of national or regional guidelines, two of the three units involved in 
the study have taken the initiative to develop their own follow-up protocol. While only 
one of the local protocols covered long term follow up, the description of both 
protocols by the enacting participants revealed that both of the local protocols were 
reasonably structured, organised and supported by resources such as clinics and 
investigations. With the increasing numbers of patients, one of the units had invested 
further by recruiting additional stoma nurse specialists to support the nurse led 
surveillance. 
Y/U/01 
‘..and that is [knowing the IC related complications] why  stoma nurse clinic was set 
up many years before I started here which I think is a  good model.’ 
Y/SN/03 
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‘…. Following discharge we see ileal conduit patients 3 monthly, 6 monthly and then 
annually but again in between that they also see the consultant as well.  We do ask 
the patient if they have had recent CT/bloods with the consultant to make sure these 
investigations are up to date.’ 
Participants described that all three units were actively engaged into a shared care 
pathway designed for the long term surveillance of prostate cancer patients in 
collaboration with their local Clinical Commissioning Groups (CCG), this can 
demonstrate that urology units could act similarly if an alternative community model 
of surveillance is developed. 
X/U/02 
‘We (the unit) have a protocol for stable prostate cancers.  We could have a similar 
protocol for stable bladder cancers or patients with urine diversion’  
Y/U/02 
‘   We (the unit) did a similar thing for PSA for prostate cancer and it seemed very 
successful.  We were the first people in the country to actually do such a study so it 
can be done.’  
 
Role of surgeons at follow up 
While surgeons showed good coherence of the scope and value of a follow up 
protocol, they also expressed engagement with the follow up process. When there 
was no local protocol for surveillance at one of the three units, individual consultants 
explained that each of them had initiated his own schedule. This involved regular 
visits to their clinics and a set of investigations to identify any potential complications 
related to the ileal conduit. In order to overcome the lack of communication channel 
for patients to secondary care due to shortage of stoma nurses in their unit, some 
surgeons described how they had provided patients with their secretaries’ phone 
number to facilitate the contact.  
X/U/01 
‘In the current practice we see the patient, arrange tests and arrange an appointment 
for 12 months for example.  In the meantime if there are problems the patient has to 
contact our secretaries and that is working okay’  
X/U/03 
‘The patients have my point of contact. The GPs can also contact me if they have a 
problem.  In addition the incontinence nurses also help out.’ 
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Support of and work relationship with GP 
Surgeons described how they invested time into training and collaborating with GPs 
on similar shared care pathways for prostate cancer. Most of them expressed 
willingness to play similar role for the development of a pathway for ileal conduit 
patients. 
Z/U/01 
‘…., we have a yearly GP meeting[ about the prostate cancer shared pathway] 
……… and then we will talk about any issues that have come up, we will talk about 
what they have in terms of issues and it is an educational day as part and parcel of 
shared care.’ 
X/U/01 
‘I would be more than happy to participate in a meeting with the GPs either in the 
hospital or in GP practice. …..We could have a meeting between the urology 
department staff and the local GP to teach them the requirements for stoma follow 
up. A face to face meeting would be ideal to facilitate immediate questions and 
answers rather than sending protocols by post.’   
Role of stoma nurse/ specialist nurse at follow up 
Using the existing follow up arrangements, stoma nurses & Urology nurse 
Specialists described acts of commitment and flexibility to ensure appropriate care is 
delivered. When there is a local protocol, stoma nurses described how they  adhered 
to the schedule and how they had invested in expanding their role, for example, by 
requesting the relevant tests and developing the skills to interpret the results. Stoma 
nurses explained how they worked flexibly to deliver patient care. Time and effort 
had been invested into consultation phone calls and outreach visits to make the 
service more accessible to patients and minimise the burden of travel. Stoma nurses 
without a Urology background expressed their willingness to expand their roles and 
receive the necessary training to underpin new responsibilities. 
X/SN/01 
‘If the patient requires a second follow up then I [stoma nurse] would do a second 
week[home] visit but I would do one each week for as long as it takes the patient to 
feel confident in coping with the stoma bag.’ 
X/SN/02 
‘I think that could become an extended role with some training alongside so we can 
become efficient.’ 
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GP role at follow up 
Some participants described active role for some local doctors at the current 
surveillance process. According to interviewees, some GPs already arranged annual 
reviews for IC patients, monitored renal function and referred patients back when 
specialist attention was required.  
X/U/02 
‘….,they [GPs] are very good at picking things up [complications]and sending  the 
patients to the right channel if there is any problem.’ 
 
Barriers 
Uncertainty about GP willingness to be involved  
Most of the participants expressed doubts over GPs’ willingness to engage with a 
shared care community pathway for IC patients. They spoke about a range of issues 
that they felt could make greater engagement of local doctors in IC follow-up 
challenging. These included GP workload, lack of GP expertise in this clinical area, 
GP unwillingness to take the clinical responsibility and financial arrangements.  
X/U/02 
‘I do not know how many GPs would be interested in looking after these[IC] patients 
long term.’  
‘I think overall because it [follow up review] is annual it is not very onerous for GPs to 
do that but it would add to their workload anyway.  ‘   
Z/SN/03 
‘…... when we have bloods that is in the name of the consultant they [GPs] pick up 
on this stating it is not in their name so there are certain things they won’t pick up 
on.’ 
Patients’ expectations  
Some participants expressed their concerns about possible patient lack of 
confidence in a community based follow up, and that this might affect patient 
engagement with such model. Interviewees expressed the view that patients might 
feel that GPs’ lack experience or have too heavy workload to be involved in IC follow 
up.  
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X/U/01 
‘When I mention discharge to GP care some patients are disappointed; some 
patients do not trust their GP’ 
Y/NS/04 
‘On the other hand I think there a lot of patients who feel reassured by coming back 
to secondary care for their follow up because they saw them when they were most 
vulnerable.’   
Cognitive 
participation 
Sub-
Themes 
Quotes  
 
 
 
Facilitators 
Existing 
local 
protocols 
Z/U/01 
‘they [patients] come to see me [urologist] at six 
weeks, then 3 monthly in the first year and the 
second year .. .  The reason we see them for two 
years is that they should get a CT scan at 6, 12 and 
24 months and then routine bloods in between.’ 
 
Similar 
successful 
models 
Z/U/01 
‘We have a prostate cancer and renal cancer follow 
up service out in the community that works very well  
and so for our other cancers we want to have a 
similar bladder cancer service’ 
 
Role of 
surgeons at 
follow up 
Y/U/01 
‘I would certainly have an input into it [Developing a 
new protocol]’ 
 
Role of SN/ 
NS at follow 
up 
Y/SN/03 
‘We [stoma nurses] check the results and if there 
are no changes.   If there are of concern we would 
then speak to the consultant for his input.’ 
 
 
 
 
Barriers 
Uncertainty 
about GP 
willingness 
to be 
involved 
Y/NS/04 
‘From a GP point of view, I think it would be a lot of 
extra work for them to take on and from a financial 
side it would possibly not be beneficial.’  
 
Patients’ 
expectations 
X/U/04 
 
‘…..patients would be unhappy to be discharged 
back to primary care.’ 
Table 4.14. Additional examples of quotes of facilitators and barriers under 
‘Cognitive participation’ construct. 
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4.4.3. Collective action 
This construct reflects the ability of the staff to operationalise the intervention into 
their day to day practice. It reflects how people work together to implement the 
intervention, the use of the skills available to deliver tasks and the work of allocation 
for available resources to enact certain practice.  
The participants discussed the aim of follow up in their view and explained how they 
regularly requested the investigations required to detect complications. Participants 
described how stoma nurses in particular were able to interact with patients and the 
other members of the clinical team to improve communication and enact the follow 
up. It was highlighted by participants how patients sometimes developed their own 
skills in IC self-care and founded support groups both of which were felt, by 
participants, to represent valuable assets to the implementation of the follow up 
practice. A belief that GPs lack the skills that would make them play a role at the 
implementation of a community surveillance model was expressed by most 
participants. Resources, such as lack of clinic slots and trained stoma nurses, were 
felt to represent a barrier to the existing secondary care models. 
NPT construct Facilitators  Barriers 
 
 
 
Collective action  
Defining complications Patients’ access to 
secondary care 
Defining the aims of 
follow up 
Lack of GP knowledge & 
experience 
SN/NS coordinating role Work relationship with 
non-NHS stoma nurse 
Patient education Resources  
Patient support groups Communication with GP 
 
Table 4.15. Facilitators and barriers under ‘Collective action’ construct.  
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Facilitators  
Defining complications & Defining the aims of follow up 
The complications encountered by ileal conduit patients were well defined by 
surgeons and nurse specialists. Participants’ responses reflected a clarity of their 
perception of the aim of the follow up scheme they are currently using and how they 
are using it to detect potential complications. There was a consistency amongst the 
participants about the investigations required to diagnose relevant complications, 
such as upper tract imaging and blood tests to monitor renal function, vitamin B12, 
etc. This indicates the ability of the participants to operationalise surveillance 
protocols with clear aims and usage of their tools. 
X/U/02 
‘Blood tests e.g. UE, check vitamin B12, folic acid.  For cancer patients we tend to do 
LFTs, calcium and FBC as well to look for any anaemia and urine culture.  
Regarding imaging, I would say CT scan potentially but if this is a non-cancer patient 
I would be happy also with an ultrasound of the kidneys’ 
Y/U/02 
‘We know that in the long term they can have metabolic problems; renal failure; also 
we do look at the psychological and social impact of having even a urinary diversion 
package.’ 
Stoma nurse/ Nurse Specialist coordinating role 
The role of stoma nurse was considered pivotal by many participants for the 
successful implementation of a long term surveillance protocol. In addition to their 
day to day role enacting of the follow up by requesting investigations, and clinic 
consultation, participants described how stoma nurses play an important 
coordinating role, liaising between the different parties involved in the provision of 
care. The participants’ described how stoma nurses liaise with patients, community 
stoma nurse, local doctors and surgeons to arrange simple investigations such as 
blood tests and urine cultures or more specialised imaging such as CT scans or 
loopograms. They are seen as a contact person for patients or GPs when a 
specialist advice or consultation is required because of their direct communication 
with the consultants of the unit. This interactive role in current practice was 
considered very effective and something that should be maintained in any future 
arrangements for an alternative model. 
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X/SN/01 
‘We [stoma nurses] might say [to the patient] attend your GP and get a urine sample 
checked to make sure there are no underlying infections……………. ; if we feel this [ 
a blood test] is required then we would write to the GP.’   
Z/SN/01 
‘If the problem is more complex then it is referred to the consultant.  We could do 
blood tests for renal function; if infection we can do swabs at that clinic appointment 
and we liaise with the GP for antibiotics. If they have presenting symptoms and are 
unwell I could get them reviewed in the surgical assessment unit’. 
Patient education & Patient support groups 
From their experience working with patients, participants described how they noticed 
patients acquiring skills, gaining experience and learning quickly to manage their 
condition. Participants described how patients had worked with clinicians to develop 
patient support groups which represent a platform to exchange experience and tips 
and to interact with clinicians. Participants emphasised the importance of patient 
support groups and how they are keen to link their patients to them. The patients’ 
role was seen as a valuable resource that could aid successful implementation of an 
alternative surveillance protocol. 
X/U/02 
 ‘They [patients] get actually very experienced with their stomas quickly so they can 
tell whether there is any problem or not early on and this has been my experience’ 
X/U/04 
‘They [patients] will float ideas from each other [using the patients support group] 
and surprisingly they will have a lot more resource to actually look on the internet.  I 
think the patient focus group for urostomy is good. I know that the urostomy 
association used to be very proactive and I know that when we started the process 
here.’ 
Barriers 
Patients’ access to secondary care 
In a secondary care follow up setting, the burden of travelling to hospitals was seen 
by some participants as a barrier to implementation of this model. Participants 
described that patients who are frail, live remotely, and don’t drive can struggle to 
attend their hospital appointments. Added to that, there can be issues with car 
parking availability and anxiety of coming to hospitals. Therefore, participants felt 
that attending hospital follow up can be difficult for certain group of patients. Stoma 
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nurses explained their attempts to overcome these hurdles by undertaking home 
visits, but noted that this was time consuming and costly to hospitals. A community 
based model of surveillance was felt to be a way to mitigate these problems. 
Y/U/02 
‘Discharging them [patients] would save a lot of money or time because some of 
them live a long way from the hospital.’ 
Y/NS/02 
‘……, it just takes away a lot of the anxiety surrounding attendance to the hospital 
etc. and the problems that go with that, which may seem little problems to us 
because we are fit and well, but for patients getting to a specialist centre is often a 
big ordeal and parking so if you can take away all of those layers then they can just 
focus on the thing that you are actually seeing them for.’ 
Lack of GP knowledge & experience 
Almost all of the interviewees expressed a belief that GPs currently lack the 
experience and knowledge to follow up IC patients in the community, because of 
lack of training in this area and the small number of IC cases seen by each GP 
during his/her work experience. Participants felt that GPs’ current skills are not 
sufficient to enable them to take on the clinical responsibility of community based 
follow up. Nevertheless, participants felt that GPs core skills could be built upon with 
training to enable them to be sufficiently expert to be able to enact a follow up 
protocol for IC patients. 
X/U/04 
‘…, but for the upper tract I do not think that primary care is geared to think a lot 
about the upper tract; I say this because of the NICE guidance that has been 
released for urothelial cancers last year which stipulates that an average GP is likely 
to see how many prostate cancers, how many bladder cancers, how many kidney 
cancers in his working in his working life.’ 
X/U/01 
‘Once educated I am sure the GPs could manage any complications that may arise’ 
Work relationship with non-NHS stoma nurse 
One of the three centres suffered from a shortage of stoma nurses support. In order 
to solve the problem and maintain the support patients required, the Trust have 
arranged honorary contracts for two community stoma nurses who are sponsored by 
an appliance company. It emerged during the interviews that there was a perception 
of non-NHS stoma nurse as biased towards their company products. One of the 
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appliance company stoma nurses felt that GPs are sceptical of their role if they are 
employed by a stoma appliances company. This scepticism was also clearly 
expressed by one of the hospital Nurse specialists in another unit. 
X/U/01 
‘At the moment we have not got a urology stoma nurse based in the hospital.  The 
current stoma nurse works in different institutions and provides an ambulatory 
service.’   
Y/NS/04 
‘Stoma nurses tend to be employed by companies rather than the NHS and I can 
envisaged patients being followed up by them but of course they would be biased to 
using their company’s products which might not be the best for the patient whereas 
NHS community staff would always service the patient’s best interest.’    
Resources 
It clearly emerged from the interviews that certain resources were felt to be essential 
to conduct safe and efficient surveillance. These are a standard IC follow up 
protocol, investigations, clinic capacity and skilled clinicians. As previously discussed 
apart from local protocols, the literature, national and international guidelines are 
deficient at the area of long term ileal conduit follow up (chapter1). This was 
expressed by most of participants. 
X/U/04 
‘……..particularly for ileal conduit to my knowledge there are no newer guidelines 
that I have seen.’ 
Y/NS/04 
‘In my opinion I think we follow local guidelines.  I have not come across any national 
or international guidelines.’ 
The investigations mentioned - such as blood test, urine culture and upper tract 
imaging - were described as being accessible and available in both primary and 
secondary care settings. However, community based stoma nurses expressed that 
they don’t have access to request or review the investigations. Again, many 
participants discussed how the increasing workload at Urology clinics seem to be a 
barrier against continued secondary care long term follow up. This was expressed by 
interviewees irrespective of whether they were in a centre where the current 
surveillance offered was in a consultant led or a nurse led clinics. The need for 
skilled stoma nurses was identified as a particular challenge in terms of resources.  
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X/SN/01 
‘Obviously we [community stoma nurses] would have to write to GP to request the 
forms for the bloods and ultrasound etc. and then to review the results and let us 
know if there is an issue.’ 
‘If we are in a GP clinic then obviously we would have access for results but if I am 
working out in the community on my own, I would have to go to that GP practice to 
get the results’ 
X/U/01 
‘………to see these patients in the community to take the burden off secondary care. 
In urology we are inundated with referrals’ 
Communication with GP 
The difficulty of communicating with local doctor was raised as a barrier by many 
participants. The process of gaining access to GPs and waiting for responses was 
described as being long and not easy. This barrier was described particularly by 
stoma nurses and nurse specialists.  
X/SN/02 
‘I [community stoma nurse]do generally have to go through the GP [ to arrange an 
investigation] and that can take quite a long time to contact them  if they are not 
working that day etc; it can take up to a week to get an answer from a GP.’ 
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Collective 
action 
Sub-Themes Quotes  
 
 
Facilitators 
Defining 
complications 
Y/NS/ 02 
‘Sometimes I have problems with the stoma 
itself and perhaps clients’ difficulties, skin 
problems etc.’   
‘Our patients can often go onto develop 
stones, have obstruction at later times, 
sometimes deterioration in renal function.’ 
 
Defining the aims 
of follow up 
Y/NS/04 
 ‘To make sure the conduit is functioning well; 
check their kidney function is not 
compromised; check they have the correct 
products.’ 
 
Investigations 
required 
X/U/01 
‘Tests would include conduit urine for 
microbiology, serum bicarbonate, renal 
function and to check for upper tracts with 
ultrasound or CT scan at least twice a year.’ 
 
SN / NS 
coordinating role 
X/U/03 
‘The stoma nurse provides a contact for the 
patient and she would contact our department 
should the need arise.’   
 
Patient education Y/U/02 
‘Most patients are competent to look after their 
stoma and do very well.’    
 
Patient support 
groups 
Y/NS/01 
‘They could be provided with contact numbers 
of relevant associations so that they don’t feel 
they are out there on their own coping with 
something on their own.’ 
 
 
Table 4.16. Additional examples of quotes of facilitators under ‘Collective action’ 
construct. 
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Collective 
action 
Sub-Themes Quotes  
Barriers Patients’ access to 
secondary care 
X/SN/01 
‘…, if the patient is elderly with poor 
mobility then I would do a home visit so 
there is flexibility.’ 
 
Lack of GP knowledge 
& experience 
Y/U/01 
 
‘Discharging directly back to GPs in the 
current climate is impractical.’     
 
Work relationship with 
non-NHS stoma nurse 
X/SN/01 
‘GPs tend to be very sceptical about 
the[appliances] company, they don’t 
particularly want company nurses to be 
involved with the patients; they think we 
are there to make ways to get more 
business for the company.’    
 
Resources  Y/U/01 
‘The only thing that is imperfect about it 
[the secondary care follow up] is the 
capacity for the stoma nurse follow up 
clinic because of the numbers of 
patients.’ 
 
 Communication with 
GP 
Z/SN/03 
‘Access in the hospital is easier because 
we can email the consultant’s secretary 
for quicker response.  In the GP practice 
this process might take a bit longer.’ 
 
Table 4.17. Additional examples of quotes of barriers under ‘Collective action’ 
construct. 
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4.4.4. Reflexive monitoring 
The work of appraisal of a practice or intervention is of paramount importance to 
successful implementation. This work starts by collecting data followed by an 
evaluation of the outcomes which usually leads to certain measures that might lead 
to reconfiguration of the service.  
According to interviewees, reflexive monitoring was clearly deficient across the three 
centres. Apart from a few audits which were either done long time ago or were not 
mainly  focused on assessing the effectiveness of IC follow up , most of the 
participants reported not being involved in, or aware of,  any form of evaluation of  
current practice. One of the participants explained how he relied on an informal ‘chat’ 
with the patients to get their feedback on their care. No facilitators emerged under 
this construct.  
X/U/02 
‘Q. Do you use any method to evaluate your follow scheme for those patients? 
A. Not particularly although in the next 4 to 5 months we will be auditing my 
cystectomies and part of it is ileal conduit to look at various things’ 
Y/U/02 
‘I know X [name of the surgeon] picked out this years ago and he even looked at 
doing renograms in these patients but this was about 20 years ago’ 
 
Reflexive monitoring 
 
Quotes 
Barriers X/U/03 
‘Whenever the patients come to clinic we have a 
good chat and they often come to my office rather 
than the clinic to have a long chat about their 
care.’ 
  
Y/NS/04 
‘I think a few years ago there was an informal 
study by our Matron where she was  trying to 
avoid patients having duplicated appointments 
with the doctors and the nurses but I don’t think 
very much happened with that maybe due to being 
too time consuming at that time.’ 
 
Table 4.18. Additional examples of quotes of barriers under ‘Reflexive monitoring’ 
construct. 
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4.5. Additional themes  
Several additional themes emerged during the analysis process that could not be 
mapped under the NPT four constructs. 
Ideas proposed for long term follow up & Support for community based follow 
up 
Many participants suggested models of follow up different to the ones they are 
currently following. The majority of these ideas favoured community based 
surveillance models. Some participants were able to give a comprehensive 
description of what the model of care might involve. One of the ideas that was 
repeatedly suggested was the development of a shared care community based 
surveillance model where the different parties contribute. Under this model, local 
doctors could provide resources such as the clinic room, taking bloods and, perhaps, 
ultrasound scans. The Urology department would provide a trained stoma nurse who 
is well connected to the urology surgical team at the hospital and who would run 
structured clinics in the GP practice. .The hospital doctors would offer training 
sessions to patients to improve awareness of their condition and enhance their skills 
of self-care. Participants felt that this model could have many benefits. It would 
provide an accessible service to patients by a well-trained clinician who has strong 
connection to specialist care, and at the same time relieve the pressure on 
secondary care. Because this theme reflects hypothetical ideas rather than action, it 
was not mapped under the NPT (which is a theory of actions). 
X/SN/02 
‘I think we [stoma nurses] could run structured clinics in GP practices for these 
patients; this would also facilitate quicker access to GPs for example requests for 
bloods/radiology.  This would make life easier as any investigations could be dealt 
with quickly.’   
Giving patients the choice 
Another interesting theme that emerged was to provide community-based and 
hospital-based models for surveillance simultaneously and to allow the patient to 
choose between them.  Some participants felt that this would satisfy certain groups 
of patients, for example, those who only get reassured by hospital visits and those 
who struggle to travel to hospitals. 
 
129 
 
Z/SN/03 
‘…I think it is patients choice because some like to attend the hospital as they feel 
they get things done better or they can get to us quicker than being seen by the GP.’ 
 
Engagement of stakeholders 
Participants repeatedly expressed their views that, for the development of a standard 
surveillance scheme, all stakeholders (including GPs, patients, nurses and 
surgeons) should be involved. Again, this was hypothetical but reflects participants’ 
beliefs in the importance of involving all those concerned. 
X/U/01 
‘…but it would be worthwhile consulting with the patients, GP and stoma nurses in 
order to create a strict protocol that we can adhere to which would be useful.’ 
 
Valuing SN role 
Many surgeons expressed their appreciation of the role the stoma nurses play. They 
described the effort and the flexibility shown by SN to help patients. They valued 
stoma nurses’ co-ordination role  between primary and secondary care and role as a 
contact person for patients to facilitate delivery of care. This expression of 
appreciation to another team member didn’t entirely fall under any constructs of the 
theory, although it reflects good work relationships. 
X/U/02 
‘.., we have a very accessible stoma nurse who sees these patients regularly.’ 
X/U/03 
‘I found that the stoma nurse is provides a vital service post cystectectomy in 
assisting the patient to cope with the stoma bag.’ 
 
 
 
 
 
 
 
130 
 
4.6. Summary of results 
 
17 professionals from 3 different centres were interviewed over the period of one 
year. The participants represented 3 different groups of health care professionals 
involved into IC patients care; surgeons, stoma nurses and specialist nurses. 
Following the analysis of data guided by NPT, facilitators and barriers were identified 
under the four main constructs of the theory. 
On the facilitators’ side, participants described good understanding of the scope, 
value and aim of an IC follow up protocol. They expressed their views of the need for 
change in current practice due to lack of guidelines and the service workload. 
Participants considered the implications associated with embedding a new model of 
surveillance that is based in the community. Participants described the engagement 
of stakeholders in the current process of follow up. Surgeons described putting effort 
into developing local protocols; nurses explained how they invested into their 
training; and participants highlighted how patients established support group to 
facilitate their own teaching. The stoma nurses were regarded to play an eminent 
role in making the follow up workable by coordinating between all stakeholders and 
putting extra effort to make the service accessible to patients. 
Several barriers were found on all four areas of the theory. There was a lack of 
agreement over the length of the follow up and the need to adjust follow-up care to 
different patients groups. Based on their working experience, participants raised 
concerns regarding GPs’ willingness to be part of an IC follow-up protocol. Most of 
our sample considered that GPs lack the experience and knowledge that would 
enable them to provide postoperative care at the community. Resources - such as 
trained stoma nurses, clinic times, - were seen as a barrier against successful 
implementation of any surveillance model whether in primary or secondary care. 
Audits were lacking according to the interviewees, making the appraisal work 
deficient at the process of embedding a surveillance protocol. 
One of the themes that emerged strongly but didn’t fall under any NPT construct was 
the idea of development of a shared care community-based surveillance model 
where all the different parties involved contribute to the surveillance. 
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Chapter 5. Discussion 
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5.1. Key Findings of study A: Patient national survey 
 
1. Frequency of reporting complications 
In this study the vast majority (87.9%) of the 1092 respondents reported at least one 
complication since surgery; almost half of them (45.2%) reported a frequent 
complication; and about a third (35.2 %) reported three or more complications.  
2. Commonly reported complications 
Urinary tract infections (48.2%), parastomal hernia (39.3%) and appliances (36.6%) 
problems are the most common reported complications, both ‘Ever’ and ‘Frequent’. 
When comparing patients’ answers about the first 2 years post-surgery to those 
about five years after surgery, the frequency of reporting UTIs remains stable but 
there is a notable decrease for reporting appliances problems and an increase of 
parastomal hernia. Hernia (21.3%), UTI (17.6%), bowel (11.8%) and appliances 
complications (11.2%) were the most commonly reported as occurring frequently. 
Parastomal hernia (35.0%) was the most common cause for re-referral back to 
secondary care followed by UTIs (15.8 %) and skin problems (15.0%). 
3. Patient characteristics and reporting complications: 
Using multivariable logistic regression analysis, certain patient characteristics were 
significantly associated with reporting complications. These were age <60yrs, benign 
indication for surgery, female gender and 5-10yrs. or >10yrs. after surgery.  
Being younger than 60yrs was significantly associated with reporting ≥3 
complications, ‘Ever reported a frequent complication’ and higher numbers of ‘Ever 
reported’ and ‘Ever reported as frequent’ complications. It was also significantly 
associated with reporting stoma stenosis, appliances problems, frequent UTIs and 
bowel problems.  
Benign indication for surgery was significantly associated with reporting ≥3 
complications, higher number of ‘Ever reported as frequent’ complications, kidney, 
UTIs, stoma stenosis and frequent UTIs, bowel and kidney complications. 
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Female gender was significantly associated with higher number of both ‘Ever 
reported’, ‘Ever reported as frequent’ complications, and with bowel complications 
and frequent bowel and hernia complications. 
Being more than 10 years after surgery was significantly associated with reporting ≥3 
complications, ’Ever reported a frequent complication’, higher number of ‘Ever 
reported’ &’ Ever reported as frequent’ complications, and with kidney, UTI, stone 
and hernia complications. 
 4. Access to stoma nurse and frequency of reporting complications 
Less than 15% of our respondents reported that access to stoma nurse was difficult 
or very difficult. This was significantly associated with ‘Ever reported a complication’, 
≥3 complications, ‘Ever reported a frequent complication’ and higher numbers of 
‘Ever reported’ and ‘Ever reported as frequent’ complications. It was also associated 
with reporting bowel, kidney and appliances related problems.  
5. Patients’ satisfaction and preferences for follow up 
Most of the respondents (84%) were satisfied with their follow up. The adequacy of 
the follow up scheme, and stoma nurse care were the main reasons stated by 
patients to explain their satisfaction. Inadequate follow up, stoma nurse care and 
complications were the main reasons for dissatisfaction. In multivariable analysis, 
benign indication for surgery, difficult access to stoma nurse, discharge from 
secondary care and reporting a frequent complication were all significantly 
associated with dissatisfaction.  
39% of respondents favoured lifelong hospital follow up. Interestingly, this option was 
significantly less popular amongst patients who had already been discharged but 
was favored by those who had their surgery for 5 years or longer ago. 44% of 
respondents reported they would not prefer follow up with their local doctor and 88% 
of these attributed this to GP lack of knowledge and experience. 
5.2. Strength and limitations of study A 
Current literature lacks PROM series where IC patients report on the long term 
different physical complications of this surgery. In the absence of a standard protocol 
for long term follow up for IC patients, the data obtained from more than one 
thousand respondents to this survey could be of great value to inform the 
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development of a standardized alternative follow up scheme. The additional value of 
these results is that most of the respondents (785, 71.9%) had their operation for five 
years or more and more than a third (384, 35.2%) had it for more than a decade ago. 
Literature on long-term consequences is especially limited. 
The response rate to the survey was 60%. This is reasonably comparable to national 
patient surveys such as National Cancer Patient Experience Surveys for the years 
2015 and 2016 (NHS-England, 2017). For this survey, the overall response rate over 
the 2 years was about 66% out of more than116, 000 cancer patients on each 
survey. Patients were asked to evaluate the care they received after being 
diagnosed with cancer by answering a questionnaire of 59 questions (NHS-England, 
2017).  
One of the limitation of the survey is the potential for selection bias. Those invited to 
take part were all members of the Urostomy Association. This group of patients 
might be generally more involved in their self-care and possibly receiving extra 
support from the association in the form of advice and tips regarding the 
management of their condition. They could have also joined the UA because they 
had experienced complications. This could possibly impact on the frequency of 
experiencing complications, satisfaction with follow-up and preferences for follow-up 
found in the survey. In addition, and like any survey, it is possible that survey 
respondents and non-respondents differ in ways that impact on the reporting of the 
outcomes of interest.  
The characteristics of the survey respondents were broadly comparable to those of 
patients included in   the BAUS national cystectomy audit covering the 2 years of 
2014 and 2015 ,except for gender distribution (Jefferies et al., 2018). The median 
age of the survey group was 72 yrs. compared to 69 yrs. for the national audit. The 
indication for surgery was cancerous for 78% of the respondents compared to 86% 
on the audit. The distribution of gender (Male: Female) was 58%:42% in this study 
compared to 74%:26% on the cystectomy audit. This comparison need to be 
interpreted with care, given that not all (86%) of the patients in the audit had IC as a 
method of UD and, for 14% of patients in the audit, information on IC indication was 
either not clear or missing. Moreover, benign cases can have IC surgery without 
cystectomy so will not be included in the audit.  
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Another limitation of this part of the study was that it relies on patients’ recall of 
previous events which can affect the accuracy of reporting. Moreover, it is possible 
that some of the complications attributed by the patients to the surgery are not 
actually a consequence of the surgery. In addition, the pre-test sample might not 
have been representative as the majority had their surgery more than 10 yrs. ago 
and the group who had surgery <5 yrs. ago was not represented. Had a more 
representative group been included, the feedback on the questionnaire may have 
differed. However, since relatively few changes needed to be made to the survey 
following pre-testing, it seems unlikely that this will have had a major impact on the 
study.  
The development of the questionnaire as a patient reported outcome measure  
followed several, but not all, of  the steps described in literature (Coyne et al., 2006). 
The need for the questionnaire was established based on the lack of similar 
measures for IC complications in literature. The purpose of questionnaire, and the 
initial draft, took into account the views expressed by patients through a group 
discussion at their support group. Face/ content validity was assessed by pretesting 
the questionnaire amongst patients and refining the questionnaire accordingly. 
Choosing a self-administered mode allowed for involvement of a larger number of 
patients reaching more than one thousand and possibly minimized the bias that 
could had been created with interviewer-administered survey. Reproducibility to 
check that the measure will produce similar results if repeated was not tested. 
Criterion validity could not be tested as there was no gold standard measure to 
compare to. This was also the case for responsiveness, as the questionnaire was 
not designed to produce a final score. Nor was it designed to contain subscales 
meaning reliability was not assessed. 
5.3. Key findings of study B: Current practice & alternative models of 
surveillance for patients with ileal conduit urinary diversion:  A qualitative 
study using the Normalisation Process theory 
By conducting interviews at three hospitals in different areas in England, it was 
evident that current IC follow-up care differs. Three different models were seen 
across the three units: 
  Long term consultant led model 
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 Long term nurse led model. 
 Short term combined consultant and nurse led model  
 
Variation was also seen in the resources availability to each unit; while one was able 
to recruit additional nurse specialists to cover stoma care, another was struggling to 
have stoma nurses at all and had to rely on company sponsored community stoma 
nurses. 
The key findings from the qualitative study were as follows: 
1. Coherence (make sense): Participants expressed clear understanding of the 
rationale for long term surveillance for IC patients. Their awareness of the 
long term complications of IC reported in literature and the need to identify 
these problems throughout regular investigations made them value follow up. 
Most participants expressed the view that there was a need for change from 
current practice to a standardised evidence based protocol in order to 
alleviate the risk of missing complications and to a more shared community 
based follow up to decrease the pressure of secondary care. Participants 
highlighted the implications of the development of a new model of surveillance 
that is more community based. They discussed the challenges that could face 
the implementation of such model such as lack of skills, access to resources, 
GPs’ workload and patients’ concerns. On the other hand, they described the 
benefit of such approach as freeing more spaces at hospital clinics and taking 
away the burden of travel from patients. Views varied about the length of 
follow up required at secondary care (i.e. whether 5yrs, 10 yrs. or lifelong). 
Another area where opinions differed was whether tailoring of any new follow 
up protocol was required according to the indication for IC surgery and 
different types of bladder cancer. 
2. Cognitive participation (engagement): Participants described the engagement 
of themselves and their units with the current IC surveillance process and with 
any attempts to formalise it. Two of the three units and individual surgeons in 
the third one described development of their own protocols. Stoma /specialist 
nurses discussed how they engaged with local protocols and some of them 
described how they invested time and training to make it work. Nurses 
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developed their skills to enable themselves to interpret investigations such as 
ultrasound reports and request further advice when required. Some 
participants raised concerns regarding the readiness and willingness of GPs 
to be involved in follow up and patients’ possible frustrations if care is 
transferred from secondary to primary care. 
3. Collective action (implementation): Participants were able to define the aims 
of their units’ local protocol and how they enact them day to day. 
Investigations required were requested on a regular basis as planned. Stoma 
nurses played a pivotal coordinating role between patients, GPs, consultants 
and even on call team when patients were acutely ill. According to 
participants, patients developed their personal skills at stoma self-care and 
worked to establish support groups to help each other. Resources were 
considered a barrier to the secondary care model with the lack of sufficient 
stoma nurses and clinic spaces. Participants constantly expressed their belief 
that GPs lack the skills to provide the care for stoma patients, and this was 
seen as a hurdle for implementation of a shared care community based 
pathway. Difficulties in communicating with local doctors was seen as another 
barrier to a community-based model of surveillance. 
4. Reflexive monitoring (evaluation): The work of appraisal of the current 
practice for surveillance was deficient across all three centres and there are 
no formal audits that was conducted recently to assess the used protocols 
and reflect on the outcomes. A few participants thought that the 
standardisation of surveillance would create a good opportunity for audit and 
research, especially for the comparison of surgical outcomes between units. 
5.4. Strengths and limitations of study B 
This appears to be the first qualitative study to explore the area of Urology practice 
dealing with the long-term follow up for ileal conduit patients. The use of qualitative 
methods allowed knowledge and understanding to be obtained from the participants’ 
perspectives. This could help to understand ‘Why’ and ‘How’ an alternative model of 
surveillance could be implemented; these types of questions cannot usually be 
answered by conventional quantitative methods. The NPT provided a generalised 
framework that was beneficial for the analysis of the implementation process and 
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allowed for exploration of different areas that can influence the implementation of the 
current practice and the development of a new follow-up model. 
One of the potential limitations of the study is the limited number of centres involved. 
However, the 3 units had three different models of IC surveillance, resulting in a 
diversity of participant experiences and views. Another potential limitation of the 
study is that it was restricted to England; if the results were to be used to inform the 
development of national (i.e. UK) or international guidelines then more areas and 
countries may need to be included to ensure representativeness of themes and 
issues. 
The study recruited different types of health professionals involved into the follow up 
care of IC (Lincoln and Guba, 1985)patients. This was a strength, as the results 
represented multidisciplinary perspectives. Nurse specialists were not represented at 
one of the three centres simply because there were none employed. Interestingly, 
after the end of the study, this unit started introducing the nurse specialist role at 
post cystectomy follow up clinics. 17 out of 20 invited health professionals agreed 
and participated in the study; however, there is always a possible limitations that 
different themes could emerge from the health professionals who declined to take 
part. A further a limitation of the study was that it did not, for reasons of time, recruit 
GPs, whose views and opinions would be crucial in the implementation of any 
community-based follow up.   
The use of NPT framework to guide the analysis could have restricted the 
emergence of different themes outside the framework of the theory. That is why an 
initial thematic analysis was conducted before mapping emerging themes onto the 
theory constructs. The themes that didn’t fall under the NPT framework were 
separately discussed in a dedicated section on the results chapter (chapter 4). In 
terms of quality assurance, several actions were taken (Lincoln and Guba, 1985). In 
terms of credibility, the topic guide was designed to stimulate the participants to 
express their views about their current practice and to propose alternative models of 
surveillance. The interviewees were given the opportunity to comment on any area of 
discussions and to add any further comments toward the end of the interviews on 
anything they felt they wanted to raise (Appendix 10). The topic guide was revised 
several times before the start of the interviews following discussions between AA 
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and LS and once the interviews started, any new themes were raised by 
interviewees were added to the guide for subsequent interviews. During the analysis 
process participants’ comments were compared; for example participants’ views of 
the length of follow up at secondary care were compared and the comparison 
revealed significant variation at their opinions. One of the limitations was the single 
coding of the transcripts by AA. However LS and TF reviewed the transcripts of the 
initial three interviews and the initial coding framework and their comments guided 
subsequent analysis. In terms of transferability, the recruitment of the participating 
sample, the participants, and their centres’ characteristics were clearly described in 
the methodology and results sections (Chapters 2 & 4).  
5.5. Comparison with literature  
In terms of reporting long term IC complications, the largest series in the literature 
have relied on hospital records and indicate that 45%-66% of patients will develop at 
least one complication (Madersbacher et al., 2003; Shimko et al., 2011; Gilbert et al., 
2013). The findings here indicate that 88% of patients reported at least one 
complication. This could demonstrate the value of patient-reported outcomes to 
record patient experiences that could be missed by relying only on hospital records. 
It is possible that some patients reported complications which were less serious than 
those recorded in hospital records. However it might be argued that these “less 
serious” complications are also important to patients and any alternative model of 
surveillance should be aware of these in order to ensure that it meets patients’ 
needs. 
There is a growing evidence of the cumulative nature of IC related complications and 
how they can develop decades after surgery (Shimko et al., 2011).This agrees with 
the finding here of a significant association between reporting complications and 
being >10yrs post-surgery. It could possibly also explain the higher frequency of 
complications reported by the survey respondents than seen in other studies 
(Hautmann et al., 2011) as more than the third of them had their IC surgery more 
than a decade ago.  
In the current study urinary tract infections (48.2%), parastomal hernia (39.3%) and 
appliances (36.6%) were the most commonly reported complications. This does not 
correspond with the literature reports where renal and bowel complications are 
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amongst the top three, although previous reports on infections were of similar 
frequency to the survey results (Madersbacher et al., 2003; Shimko et al., 2011; 
Gilbert et al., 2013). Clearly, bowel and renal side effects could be of greater concern 
from the clinical perspective, but the survey findings may suggest that they possibly 
not the most bothersome from the perspective of the patient. 
This study has highlighted the association of reporting complications with certain 
groups such as younger age (<60) and benign indications for surgery. Interestingly, 
Wood et al reported that stoma complications are significantly higher in females with 
intractable urinary incontinence who received IC (Wood et al., 2004). The mean age 
of the patients on Wood’s series was 48 years old. This could draw attention towards 
the quality of life that patients experience after such a major surgery for the 
treatment of intractable benign bladder conditions  and raise questions about 
whether a different counselling approach is required for this group.   
In the current study, there was a significant association between difficult access to a 
stoma nurse and reporting complications and satisfaction with follow-up. This 
concept is supported by several studies which highlighted the role of specialist 
nursing care; some even showed  more  favourable patient satisfaction rating   for 
nurse led follow up for cancer patients when compared to the traditional physician 
led model (Lewis et al., 2009a; Leahy et al., 2013). In addition, there have been no 
proven advantage in terms of recurrence detection rate in both models (Howell et al., 
2012).  
About 60% of the respondents in the current study did not prefer lifelong hospital 
follow-up. This could indicate a level of acceptability of different follow-up models 
based at the community. Nevertheless, GP lack of experience and knowledge was a 
concern to most of the group (88%) who did not favour local doctor surveillance. 
These findings broadly agree with those of a qualitative study that explored cancer 
patients’ views of follow-up; while patients appreciated having their care locally, they 
emphasised the need for further training to GPs to fulfil this role (Hall et al., 2011). 
To our knowledge, the qualitative part of this study represents the first report in 
literature to explore, using NPT, the facilitators and challenges that face the 
implementation of IC follow up schedule, both in terms of current practices and at 
any potential alternative models. Most of the themes that emerged could be mapped 
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onto the four constructs of the theory: coherence; cognitive participation; collective 
action and reflexive monitoring (May and Finch, 2009; Murray et al., 2010). The 
participants’ coherence of the value of follow-up  was driven by their understanding 
of the complications, and their knowledge did match mostly what has been reported 
in literature about IC related complications (Hautmann et al., 2011). The findings 
revealed a lack of experience among community stoma nurses when it comes to 
metabolic complications; this type of complications is evident in literature reports 
(Roth and Koch, 2018). The participants were aware of the lack of guidelines 
designed specifically to IC follow up and the review of the current urology guidelines 
(Chapter 1) confirm this (The National Institute for Health and Care Excellence 2015; 
Alfred Witjes et al., 2017; Chang et al., 2017).  
A review of qualitative studies exploring patients’ and health professionals’ views 
about cancer follow-up found that the participants felt that secondary care 
appointments were limited in terms of dedicated time and that psychological support 
need by patients was not provided due to the pressure on the service (Lewis et al., 
2009b). In addition, there is a growing tendency towards the development of a 
community based shared care pathway at different medical specialities (Davies and 
Batehup, 2011). A similar theme emerged from analysis in the current study where 
participants highlighted the pressure on the secondary care service and how a 
community based care could help to solve this problem. In addition in the current 
study participants raised concerns about local doctors’ knowledge and experience 
and the lack of skills to follow up IC patients, which agrees with the results from a 
qualitative study that explored cancer patients views (Hall et al., 2011).  
The Urology specialist nurses participating in the current  study described  how they 
were able to engage successfully with the local protocols, in keeping with current 
evidence that supports the possibility of providing a  successful nurse led follow up 
(Howell et al., 2012; Leahy et al., 2013). Moreover, the interviewees believed that 
patients are very keen on acquiring skills and that their education could facilitate their 
care. Similarly, several studies in the literature, in cancer patients and those with 
other conditions, have shown a growing support  for patient empowerment and 
supporting patients to self-manage their condition and even self-refer to specialist 
care (Davies and Batehup, 2011; de Silva, 2011; Foster and Fenlon, 2011). 
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5.6. Implications of the study for future research and future follow-up     
This study has highlighted the high occurrence of complications following IC surgery. 
It has emphasised the need to take into consideration the less risky but perhaps 
more bothering side effects of this operation such as parastomal hernia, appliance 
issues and infections. The current study did not assess side-effect bother directly 
and future research might usefully investigate bother and impact on life associated 
with each complication.  
The results also draw attention toward the higher frequency of dissatisfaction within 
follow-up and reporting of complications among certain groups, such as females and 
those who has surgery for benign conditions. This might also drive future research, 
for example focussed on options for the surgical management of young females with 
benign bladder symptoms not responding to medical treatment.  
In terms of follow-up, the findings broadly support the idea of the development of a 
community based shared care pathway. There was a reasonable acceptance from 
patients (60%) and health professionals for a greater role for primary care in follow-
up. To add to the data generated in this study, it would be valuable to conduct future 
qualitative research projects to explore the views of the primary care health 
professionals and patients on shared-care community-based follow-up. 
The results obtained from both the patient survey and the health professional 
interviews demonstrated the pivotal role of stoma nurses in the care of this group of 
patients and how they plays a coordinating role between all parties involved in 
patient care. This should be considered in the future in any development of 
alternative models of surveillance in order to ensure that the valuable role of stoma 
nurses is maintained. 
The ultimate goal of this project was to inform the need for and development of an 
alternative follow-up schedule for IC patients. In terms of moving this forwards,  the 
results of this study could stimulate health experts to work with patient 
representatives to co-design a standard long term follow up schedule that meets the 
patients’ needs and is equally capable of early identification of serious medical 
complications of this surgery. This would be in keeping with the national cancer 
strategy for England 2015 -2020 which emphasizes the value of patient involvement 
and  feedback to help to improve the care provided for cancer patients across the 
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country (NHS-England, 2015). As suggested by participants in the qualitative 
interviews, follow-up could be conducted in the community by a stoma / Urology 
specialist nurse who is appropriately trained and possesses strong links with the 
secondary care. However, while the survey findings suggests that patients value 
stoma nurse access in current follow up, it would be essential to ensure that they 
would find nurse-led follow up in the community acceptable. This new follow up 
protocol might also include a supported self-management programme to empower 
patients to participate more actively in their care.  How best to deliver such a 
programme, and what it might contain, could be the focus for future research. 
5.7. Conclusion 
The high and cumulative incidence of IC related complications suggest the 
development of a standardised, evidence based long term surveillance protocol. A 
shared care community based nurse led scheme could be a suitable model that can 
be successfully implement after further evaluation. 
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Appendix 1. Patient ‘Ileal conduit experience questionnaire’ (ICE-Q). 
 
 
 
Section 1: About yourself 
1. Your gender                          Male               Female  
2. Your age                                 .......... years 
 
3. In which year did you have your ileal conduit urinary diversion operation? …………. 
 
4. Why did you have to have an ileal conduit urinary diversion? 
 Bladder cancer 
 Urinary incontinence 
 Bladder Pain 
 Urgency and frequent urination 
 Other please state ........... 
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Section 2 
A. The first 2 years after the operation 
5. In the first 2 years after the operation, approximately how frequently were you seen? 
                                                          By your surgeon                            By your stoma nurse? 
Every 3 months                                                                                                                       
Every 6 months                                                                                                                       
Every 12 months                                                                                                                  
Not routinely          
Other, please state                          .........                                            ......... 
 
6.Did you develop any of the following problems during the first 2 years after your operation? (You 
may choose more than one answer) 
 Bowel problems 
 kidney problems 
 water infection 
 Kidney stones 
 hernia or bulging around the stoma 
 narrowing of the stoma 
 Problems with the skin around the stoma 
 Problems with getting the stoma appliance to stick to the skin  
 Any other problems. Please state ………………………………………………………………………… 
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B. The period between 2 and 5 years after the operation 
7. Thinking about the period between 2 and 5 years after your operation, approximately 
how frequently were you seen? 
                                                          By your surgeon                            By your stoma nurse? 
Every 3 months                                                                                                                       
Every 6 months                                                                                                                       
Every 12 months                                                                                                                  
Not routinely          
Other, please state                          .........                                            ......... 
 
 
8. Did you develop or continue to suffer from any of the following problems during the 
period between 2 and 5 years after your operation? (You may choose more than one 
answer) 
 Bowel problems 
 kidney problems 
 water infection 
 Kidney stones 
 hernia or bulging around the stoma 
 narrowing of the stoma 
 Problems with the skin around the stoma 
 Problems with getting the stoma appliance to stick to the skin  
Any other problems. Please state ………………………………………………………………………… 
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C. More than 5 years after the operation 
9. Thinking about the period starting from 5 years after your operation, approximately how 
frequently were you seen? 
                                                          By your surgeon                            By your stoma nurse? 
Every 3 months                                                                                                                       
Every 6 months                                                                                                                       
Every 12 months                                                                                                                  
Not routinely          
Other, please state                          .........                                            ......... 
 
 
10. Did you develop or continue to suffer from any of the following problems during the 
period starting from 5 years after your operation? (You may choose more than one answer) 
 Bowel problems 
 kidney problems 
 water infection 
 Kidney stones 
 hernia or bulging around the stoma 
 narrowing of the stoma 
 Problems with the skin around the stoma 
 Problems with getting the stoma appliance to stick to the skin  
Any other problems. Please state ………………………………………………………………………… 
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Section 3: Discharge arrangements from hospital care 
11. Have you been discharged from routine regular hospital care? 
 Yes,  
a. After how many years of follow up following your operation were you discharged from 
regular hospital care?........years 
 No 
If you answered No, please go to Question 14. 
12. If you have been discharged, have you had to go back to the hospital for problem (s) related to your 
stoma/operation? 
 Yes 
a. What was the problem (s)? ................................................................ 
 No 
  
13. If you have been discharged, have you been seen by the local doctor (GP) regularly to check on your 
stoma or your kidney function? 
 Yes  
a. Approximately how frequently? every.............months 
 no 
 14. Looking back, have you been satisfied with the follow up you had since your operation? 
 Yes 
 No 
If no what would like to have been done differently (if anything)? 
……………………………………………………………………………………………………………………………………………………………............. 
If yes what aspects of your care were particularly helpful to you? 
………………………………………………………………………………………………………………………………………………. 
15.  Overall how easy have you found it to get help from a stoma therapist or nurse when you required it? 
 Very easy 
 Quite easy 
 Quite difficult 
 Very difficult 
150 
 
Section 4: Your opinion 
Based on your own personal experience what do you think is the best way to follow up 
people who have had an ileal conduit diversion (Urostomy) operation? Please give your 
opinion by answering the following questions. 
15. How often should people be seen in the first 2 years after urostomy? 
                                                    By the surgeon                        By the stoma nurse? 
Every 3 months                                                                                                                       
Every 6 months                                                                                                                       
Every 12 months                                                                                                   
Not routinely         
Other, please state                       .........                                           ......... 
16. After the first 2 years following the operation, for how many more years do you think 
people with a Urostomy should be seen regularly at the hospital before the care is 
transferred to their local doctor (GP)? 
 No further follow up needed 
 For .......... years (please state) 
 People should only be reviewed when they develop problems with the Urostomy 
 People should continue to be seen regularly at the hospital for the rest of their life 
17. If you feel people should be seen regularly after the first 2 years, approximately how 
often should they be seen? 
a. From between 2 and 5 years after the operation 
                                                         By the surgeon          By the stoma nurse? 
Every 3 months                                                                                                                       
Every 6 months                                                                                                                       
Every 12 months                                                                                             
Not routinely         
Other, please state                        .........                                            ......... 
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b. From 5 years after the operation 
                                                          By the surgeon       By the stoma nurse? 
Every 3 months                                                                                                                       
Every 6 months                                                                                                                       
Every 12 months                                                                                                   
Not routinely            
Other, please state                          .........                                           ......... 
 
18. If you feel that transfer of peoples’ care concerning their Urostomy to their local doctor 
(GP) is appropriate, approximately how frequently do you think people should be seen by 
their GP? 
 Every 3 months 
 Every 6 months 
 Every 12 months 
 When needed 
 other, please state ………………………………………………………………………………………. 
19. If you feel that transfer of peoples’ care concerning their Urostomy to their local doctor 
(GP) is not appropriate, please explain your reasons here 
....................................................................................................................................................
.................................................................................................................................................... 
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Section 5: Complications related to your ileal conduit operation (Urostomy) 
19. Please give a score to each of the following problems according to how often you have 
experienced them since your operation. 
Please use the following scoring system to tell us how often you experienced any of these 
problems.  Please write the appropriate number in the box. 
Score  Frequency 
0  Never 
1  Rarely 
2  Sometimes 
3  Frequently 
 Bowel problems 
 Kidney problems 
 Urine infection 
 Urinary stones 
 Hernia/bulging around stoma 
 Narrowing of the stoma (stenosis) 
 Problems with appliance 
 Other, please state …………………………………………………………………………………………… 
The End! 
Thank you for taking the time completing the questionnaire. We will collect all the results 
anonymously and publish the findings. The NHS can then use the results to plan the best care for 
people with Urostomy. 
If you would like to be contacted regarding any follow up questions please give a contact detail 
such as telephone number, email address or postal address below. 
Your Contact (only complete if you wish): ………………….……………………………………………………………….. 
Robert Pickard and Ather Abdelbaky 
Department of Urology, Freeman Hospital, Newcastle upon Tyne, NE7 7DN. 
0191 213 7139,Robert.pickard@nuth.nhs.uk 
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Appendix 2. Participant information sheet (Study A) 
 
 
 
 
 
 
 
 
Care for people with urinary diversion: patient questionnaire 
 
 
 
 
 
  
Dear Madam/Sir,  
Thank you for taking the time to answer this questionnaire. This survey aims to 
record the care people currently get after having an ileal conduit urinary diversion 
operation (Urostomy) and find out the opinions of people with urostomy regarding 
the follow up arrangements they feel would be best in the future. It has been 
organised by Professor Robert Pickard and Dr Ather Abdelbaky from the 
Department of Urology, Freeman Hospital, Newcastle upon Tyne in collaboration 
with the Urostomy Association. Your participation is entirely voluntary and you do 
not have to include any details that may identify you. Please use the enclosed 
freepost envelopes to return the completed questionnaire.  
 
Please tick the box that corresponds to the appropriate answer or write your 
answer in the box or next to each question. 
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Appendix 3. Research protocol (Study B) 
 
“Implementation of a long term follow up schedule for 
patients with ileal conduit urinary diversion:  A qualitative 
study using the Normalisation Process theory”  
 
Chief investigator:  
 
Mr Ather Abdelbaky 
Consultant Urologist & MD student 
Heart of England NHS Foundation Trust 
Birmingham B9 5SS 
Email: ather.abdelbaky@heartofengland.nhs.uk 
Phone: 0121 424 1138 
 
Principal investigators at other sites: 
 
Chris Harding                                             Ased Ali 
Consultant Urologist     Consultant Urologist 
Freeman Hospital      The Mid Yorkshire Hospitals NHS 
Trust 
Newcastle upon Tyne     Wakefield 
NE77DN       WF14DG 
Email:chris.harding@nuth.nhs.uk    Email:ased_ali@hotmail.com 
Phone: 0191 233 6161 ext 37597                       Phone:01924 541000 
 
MD Supervisor: 
 
Prof Linda Sharp 
Professor of Cancer Epidemiology 
Institute of Health & Society  
Newcastle University  
Newcastle upon Tyne  
NE2 4AX   
Email: linda.sharp@ncl.ac.uk 
Phone: 0191 208 6275 
 
Institution(s) responsible for the running of the study 
 
Heart of England NHS Trust 
Newcastle University 
Newcastle upon Tyne NHS Trust 
The Mid Yorkshire Hospitals NHS Trust 
 
Sponsor of the study 
 
Heart of England NHS Foundation Trust 
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Abstract 
 
Ileal conduit (IC) is the most frequent urinary diversion procedure performed 
following radical cystectomy and for patients with intractable lower urinary tract 
symptoms, particularly incontinence (1). Several reviews have highlighted the high 
rates of long term complications but the best schedule of surveillance care remains 
undecided (2-13). In the absence of guidelines, there has been a great variation at 
the long term follow-up practice amongst different units. 
The aim of this study is to understand how and why a “new” (alternative) model of 
surveillance for IC patients can be successfully implemented. The study will use an 
implementation theory known as the Normalization Process Theory (NPT).  The NPT 
specifies four constructs relating to collective action in a new service implementation: 
Coherence, Cognitive Participation, Collective Action, and Reflexive Monitoring (14). 
The study will use a qualitative methodology of semi-structured interviews with 
approximately 20 healthcare professionals who are involved in the care for IC 
patients at 3 different areas in England. The interview will aim to describe current 
practice of follow-up for these patients and what influences this; the participant’s 
views of the ideal follow up schedule; the barriers and facilitators to ideal follow-up; 
and what needs to be in place for successful implementation. Interviews will be 
audio-recorded, transcribed, and anonymized. An inductive thematic analysis will be 
conducted, and findings interpreted with respect to the domains of the NPT. 
Abbreviations   
 
Abbreviation Definition 
IC Ileal conduit 
NPT Normalisation process theory 
HEFT Heart of England NHS Foundation Trust 
UTI Urinary tract infection 
NHS National health system 
GP General practitioner 
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Background  
 
Ileal conduit (IC) is the most frequent urinary diversion procedure performed 
following radical cystectomy and for patient with intractable lower urinary tract 
symptoms particularly incontinence or bladder pain. Several reviews have 
highlighted the high rates of long term complications following this surgery but the 
best schedule of surveillance care remains undecided. Among the national and 
international health and urology associations there is no clear guidelines for the 
length, setting or modality of long term care for IC patients.(15, 16).With the current 
pressure on the NHS, a community based follow up might need to be explored as an 
option. 
The data relating to long-term complications is summarized in table 1. Incidence of 
complications in most series is at least 66% and in subgroup of patients who had IC 
for >15 years it could reach to 94%. Long term follow up has been recommended, 
however the length and the settings have not been specified. 
Table1. Series with more than 50 patients and at least 4 years of follow up (2-4, 11-13)
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Madersbacher 2003 131 98 27 24 23  24 9  
Wood DN 2004 93 63.4    16.5 9.2   
Samuel  2005 178 48 29       
Shimko  2010 1057 75.6 20.0 20.0 16.5 13.9 2.1 15.3 12.8 
Jin 2011 50 120 36       
Gilbert 2013 544 60 4.0  45.4 7.35 6.25 4.6 31.3 
 
This high rate of long term complications justifies the need for the development of a 
more standardized long term follow up schedule. The schedule could facilitate the 
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prevention, early detection and treatment for such complications.   At the moment, IC 
patients return to secondary care for follow-up.  Consistent with moves in other areas 
of the health service (and in cancer follow-up), there may be possibilities to involve 
primary care more in the follow-up of these patients.  The potential role of primary 
care – and barriers and facilitators to their involvement - has not previously been 
examined. 
The aim of this study is to understand how and why a “new” (alternative) model of 
surveillance for IC patients can be successfully implemented, whether in the 
community or secondary care. 
The implementation of interventions is increasingly being studied using theory-led 
research designs. This study will be guided by the Normalization Process Theory. 
This theory regards implementation as a social process which requires collective 
actions of participants. The theory has identified four main domains that promote or 
inhibit the kinds of co-operative work that is needed to implement service innovations 
in complex organizational contexts, the NHS for example.  
Objectives  
 
 To describe current practice with regard to follow-up of IC patients and any 
associated problems/challenges/limitations. 
 To explore health professionals’ views regarding “ideal” long-term follow-up, 
including the best setting and the appropriate investigations. 
 To identify barriers and facilitators to implementing  long term follow up 
schedule for IC patients 
Study Methodology  
 
 Study design  
 This is a qualitative research study, with a semi-structured interview 
design. 
 The study will attempt to recruit approximately 20 health professionals. 
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 The participants will be interviewed at their place of work or another 
location convenient for them. 
  The chief investigator has received training in conducting qualitative 
interviews for research. 
 
 Study  intervention   
 The CI will conduct a face to face semi structured interview with the 
participants; this is likely to last 30- 60 minutes. 
  The interview will be will be guided by a topic guide and audio 
recorded. 
  The guide will be divided into 3 major areas: Area (1) will explore 
participants’ views of the purpose of long-term follow-up. Area (2) will 
discuss participants’ current practice in following up IC patients. Area 
(3) will explore the views of the participants of the best follow up 
scheme and the potential barriers and facilitators to implementation of 
this. 
 The topic guide will be used flexibly and allowed to evolve as the 
interviews progress; if new issues are raised by interviewees these will 
be added to the guide for subsequent interviews, so that sufficient 
depth is reached. 
 
 
Study population 
 
 Source of participants 
Potential participants will be identified through the clinical lead of bladder 
cancer at the 3 participating sites.  They will be approached initially by the CI 
via work email or phone call. Those potentially interested in being interviewed 
will be sent a study information sheet, which they will have time to review 
before deciding to take part. 
 Inclusion criteria 
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Healthcare professionals who are involved in the follow up of ileal conduit 
patients. This will include urological surgeons, urology nurse specialists, and 
renal specialists. 
 Exclusion criteria 
Healthcare professionals who have no experience or knowledge of follow up 
of ileal conduit patients. 
Study procedure  
 A study information leaflet will be sent by email prior to the interview to 
participants explaining the aim and the methods of the project. Once the 
participant expresses his/her interest by email or phone call, a hard copy of 
the PIS will be sent to him/her. Participants will be given 24 hours to consider 
the information once the PIS is sent.The chief investigator will then obtain a 
written informed consent from the participant. The consent will confirm that 
participants understand that their participation is voluntary and that they are 
willing to let the project researcher include anonymous quotations from them 
in the write up of the study. Participants will also have had adequate chance 
to ask questions, which will have been answered to the participant’s 
satisfaction prior to giving written informed consent. 
Participants will be assured of confidentiality; whether or not they take part in 
the study and, if they do, their views and opinions will not be revealed to the 
senior colleague who nominated them, nor anyone outside of the research 
team.  Furthermore, no interviewees will be identified in the CI’s thesis or any 
publications arising from the study.   
 
 Data collection  
 Each participant will be allocated a personal identity code which will 
ensure their anonymity on the study. 
 Interviews will be audio-recorded, transcribed, and anonymized, prior to 
analysis. 
 The transcription will be carried by a medical secretary at the Urology 
department at Heart of England NHS Trust (Verdelle Stewart).  
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 Transcripts will be coded.  A thematic analysis will be used to identify 
emerging themes. These will be interpreted with respect to the NPT 
domains. 
 The participant job title, years and area of experience will be among the 
data. 
 
 Study timelines:  
 Expected duration of the study 6 months (interviews: 3 months; coding, 
analysis and write-up: 3 months). 
 Start time: 1/04/2016. 
 
 
 Risk:  
 No potential risks to the participants have been identified. 
 If the participant felt distressed during the interview, the interview will 
be stopped and only restart after confirming that the participant is 
happy to continue. 
Benefit 
 
 The only direct benefit to participants is knowing that contributing to this study might 
eventually help improve follow-up of their future patients.  
Data Management  
 
 Interviews will be audio-recorded and will be copied anonymised to the CI’s 
password protected laptop. Once transcribed and checked, the recordings will 
be moved onto a blank encrypted CD and archived.  
 
 As part of the data management, each participant will be allocated a personal 
identity code for the study. Using this code a separate database will be saved 
removing all personal identifying data creating a pseudonymised data set. The 
interviews collected data will be anonymised when the results are written up. 
The research team (MD student and supervisors) have signed a 
confidentiality agreement as per Newcastle University 
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http://www.ncl.ac.uk/res/assets/documents/PGRPolicyv10111114FINALClean
.pdf. 
Statistical Analysis 
 
 Data will be imported into the qualitative data analysis software NVivo. An 
abductive analysis will be conducted. This will be done by coding data 
inductively using a thematic analysis and examined for relevance to 
implementation. To relate the data to Normalization Process Theory, codes 
will be transposed onto the four main constructs of the theory. 
 Recruitment and analysis will be simultaneous, so that issues that emerge 
from preliminary analysis of early interviews can inform later interviews).   
 Ather Abdelbaky will carry out the analysis under the supervision of Professor 
Sharp, who is experienced in the conduct of qualitative research. 
Interpretation of the findings with respect of the NPT will be discussed with Dr 
Tracey Finch, of Newcastle University; Dr Finch was one of the developers of 
the NPT.  
Quality assurance, monitoring & safety 
  
The methodology was agreed with both of the educational supervisors, Prof. Robert 
Pickard and Prof. Linda Sharp of Newcastle University. Further internal Newcastle 
University review of the MD project was carried out by Dr Catherine Haighton 
Lecturer in Public Health Research of Institute of Cellular Medicine, and by Mr 
Tahseen Hasan Lecturer of Urology and consultant urological surgeon. 
Ethical Issues 
 
The study has been approved by Newcastle university ethics committee. Ref: 
3550/2016. The study did not require REC review as it is a qualitative study 
recruiting only health professionals. 
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Finance and resource use 
The study is self-funded as part of the MD thesis of the CI; this will cover as well any 
travel expenses if required. 
Dissemination of Results and Publication policy 
The data collected will be used for conference abstracts and a scientific paper. The 
CI will be using data to write up part of his MD thesis. 
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Appendices of study B protocol 
 
A. Topic guide 
Introduction 
Purpose of interview. Confidentiality. 
Can you tell me a bit about yourself – how long you’ve been in practice, etc  
1-Participant’s perspective of follow-up and long term complications  
How important is it to provide follow up for patients with ileal conduit? Why? 
What do you want to achieve?  [What is a good outcome of follow-up for you/the 
patient?] 
Ideally, how long -Should follow-up last for? Why? [Is/should length of follow-up be 
different for different patients?]   
What kind of complications have you seen? How serious? 
2-Partcipant’s current practice 
What is your current practice of follow up for IC patients? 
How do you decide what follow-up a particular patient will get?   
Are you using any national or international guidelines? 
When? (Frequency) 
What Investigations? (Scans, blood test, others) 
Who? (Professionals involved) 
What is the role of stoma nurse in your current practice? 
Where? (Setting) 
How long? (Length) How do you decided when to stop follow-up (if ever)] 
Do you ever discharge patient to primary care? At what point? 
+/-what arrangement do you use on discharge ensure that GP are comfortable with 
taking that care over from secondary care? (Feedback, meetings, letters) 
What is good/ bad about current follow-up practice? [What works well/ what doesn’t work 
well? 
Do you do any evaluation of whether current follow-up “works” ? How can it get better?  
3- Do you feel a need to change follow up schedule 
What are the options? 
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Discuss each - Where; Who; How; Setting  
Do you think these would be better or worse than current follow-up? Why? 
Would anything need to be in place to allow changes to follow-up? (e.g. safety net to 
ensure discharged patients don’t fall through crack in service; training of health 
professionals; rapid route back into hospital clinic; more patient education] 
Would there be a need to evaluate any “new” follow-up strategy?    
4-Discharge to primary care 
How safe it is to discharge patient to community? Why? Which patients could be 
discharged? 
What benefits (if any) the secondary care would get from transferring the care to primary 
care?  [Would there be any benefits for primary care?] 
How much skills/ knowledge do GPs have to look after those patients? How can it be 
improved? What role can you personally play? 
Which complications you think the GP will need to deal with frequently? (UTIs, hernia) 
What could be missed with community-based follow-up? How to avoid this? (Renal 
function) 
What investigations? How frequent? Do GP have sufficient resources in the community 
to undertake follow-up? 
What role could stoma nurses play? 
How can patient education help? 
What would be the indications to refer patient back to hospital? 
What might make community follow up difficult? (e.g. Communications with specialists, 
guidelines, GP knowledge, access to SN, patients preference. Etc) 
What would help/been need to make community FU work well? (e.g. Communications 
with specialists, guidelines, GP knowledge, access to SN, patients preference. Etc) 
5. Close 
Is there anything else you would like to discuss, or tell me, about follow-up of these 
patients, either now or in the future? 
Thank you for your help. 
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Appendix 4. Letter of sponsorship for single site (Study B) 
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Appendix 5. Letter of sponsorship for multiple sites (Study B) 
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Appendix 6. Participant information sheet (Study B) 
Heart of England NHS Trust 
Urology Department 
Participant information leaflet 
Study Title: Implementation of a long term follow up schedule for 
patients with ileal conduit urinary diversion:  A qualitative study using 
the Normalisation Process theory 
 
Investigator:  Ather Abdelbaky 
Consultant Urological surgeon Heart of England NHS Trust & MD Student Newcastle University 
 Introduction: 
Dear colleague you are invited to participate in this research study about the best schedule for 
follow up of ileal conduit patients. Ileal conduit (IC) is the most frequent urinary diversion procedure 
performed following radical cystectomy and for patient with intractable lower urinary tract 
symptoms particularly incontinence. Several reviews have highlighted the high rates of long term 
complications but the best schedule of surveillance care remains undecided. In the absence of 
guidelines, there has been a great variation at follow up practice amongst different units. 
What is the aim of this study? 
The purpose of this research is to understand how and why a “new” (alternative) model of 
surveillance for IC patients can be successfully implemented. The study will use an implementation 
theory known as the Normalization Process Theory (NPT). This is a theory that studies the collective 
action in a new service implementation.  
What is the Normalization Process Theory? 
This is a social science theory that specifies four constructs relating to collective action in a 
new service implementation: Coherence, Cognitive Participation, Collective Action, 
and Reflexive Monitoring. The theory has identified four main domains that promote or inhibit 
the kinds of co-operative work that is needed to implement service innovations in complex 
organizational contexts, the NHS for example. You can read more about the theory at this 
link www.normalizationprocess.org. 
The theory has been used to understand the dynamics of implementing, and integrating 
some new healthcare technology or complex intervention at different medical specialities. 
The results have been published at many peer reviewed journal. 
http://www.normalizationprocess.org/bibliography/. 
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What happens if I agree to participate? 
You will be interviewed by the researcher for 30-60 minutes. 
Do I have to participate? 
Your participation is voluntary. We will describe the study further and based on that you can decide 
to join or not. If you agree to participate you will be asked to sign a consent form to say that you 
have agreed to take part. You can withdraw your consent at any time without giving a reason. 
Is there any disadvantages/risks of taking part of the study? 
No risks identified; the participant will only provide the time needed for the interview which is about 
30-40 minutes. You can be interviewed at your work place or any convenient place for you. 
What are the possible benefits of taking part of the study? 
The main benefit to participants is knowing that contributing to this study might eventually help 
improve follow-up of your current or future patients.  
Expenses and payments  
No expenses or payments are made to participants. 
Is my participation confidential? 
Your participation is totally confidential; whether or not you take part in the study and, if you do, 
your views and opinions will not be revealed to the colleague who nominated you.  No interviewees 
will be identified in the CI’s thesis or any publications arising from the study.   
Who is organizing and funding the study? 
The study is part of the MD thesis of the CI and it is sponsored by the Heart of England NHS Trust. 
The MD is self-funded by the researcher who is a consultant employed by the trust at the Urology 
department. 
How is the data collected and managed? 
Each participant will be allocated a personal identity code.Interviews will be audio-recorded, 
transcribed, and anonymized, prior to analysis.   As soon as possible after the interview they will be 
copied to the CI’s laptop which is password protected, and wiped from the audio-recording device. 
Once transcribed and checked, the recordings will be moved onto a blank encrypted CD and 
archived. 
 Using the personal identity code of each participant a separate database will be saved removing all 
personal identifying data creating a pseudonymised data set. The interviews collected data will be 
anonymised when the results are written up. The research team (MD student and supervisors) have 
signed a confidentiality agreement as per Newcastle University 
http://www.ncl.ac.uk/res/assets/documents/PGRPolicyv10111114FINALClean.pdf 
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Has the study design been reviewed? 
The methodology was agreed with both of the educational supervisors, Prof. Robert Pickard and 
Prof. Linda Sharp of Newcastle University. Further internal Newcastle University review of the MD 
project was carried out by Dr Catherine Haighton Lecturer in Public Health Research of Institute of 
Cellular Medicine, and by Mr Tahseen Hasan Lecturer of Urology and consultant urological surgeon. 
The protocol has been reviewed as well by the research and development department at Heart of 
England NHS Trust 
What will happen to the data and results at the end of the study? 
Data will be retained for minimum of 1 year till the MD thesis submitted .At the end of this period 
any paper documentation will be destroyed using confidential shredding service and any electronic 
data will be deleted form personal computer, trust or university server. 
What if I need more information or want to participate? 
If you want to know more or want to join the study, please contact  
Ather Abdelbaky 
Consultant Urological surgeon Heart of England NHS Trust & MD Student Newcastle University 
ather.abdelbaky@heartofengland.nhs.uk / Tel: 0121 424 1138 
What if I have a complaint? 
If you have any complaint regarding the study or your involvement, please contact: 
Prof. Linda Sharp 
Institute of Health & Society 
Newcastle University    
Baddiley Clark Building 
Richardson Road 
Newcastle upon Tyne NE2 4AX   
Telephone: +44 (0)191 208 6275 
email: linda.sharp@ncl.ac.uk  
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Appendix 7. University ethics form (Study B) 
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Appendix 8. Letter of HRA ethical approval (Study B)
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Appendix 9. Participant consent form (Study B) 
Heart of England NHS Trust 
Urology Department 
IRAS ID: 194469 
Centre Number: 
Participant Identification Number for this trial: 
CONSENT FORM 
Title of Project: Implementation of a long term follow up schedule for patients with ileal conduit 
urinary diversion:  A qualitative study using the Normalisation Process theory 
Name of Researcher: Ather Abdelbaky 
          Please initial box  
1. I confirm that I have read the information sheet dated 10/08/17 (version 4.2.) for the 
above study. I have had the opportunity to consider the information, ask questions and have 
had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason. 
 
3. I understand that my participation is fully confidential. 
4. I understand that the interviews collected data will be anonymised when the results are written 
up. 
 
5. I agree to the use of anonymised direct quotations from my interview in publications. 
 
6. I agree to take part in the above study 
 
 
            
Name of Participant  Date    Signature 
 
            
Name of Person  Date    Signature 
taking consent 
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Appendix 10. Interviews topic guide (Study B) 
 
“Implementation of a long term follow up schedule for 
patients with ileal conduit urinary diversion:  A qualitative 
study using the Normalisation Process theory”  
 
Topic guide 
Introduction 
Purpose of interview. Confidentiality. 
Can you tell me a bit about yourself – how long you’ve been in practice, etc  
1-Participant’s perspective of follow-up and long term complications  
How important is it to provide follow up for patients with ileal conduit? Why? 
What do you want to achieve?  [What is a good outcome of follow-up for you/the 
patient?] 
Ideally, how long -Should follow-up last for? Why? [Is/should length of follow-up be 
different for different patients?]   
What kind of complications have you seen? How serious? 
2-Partcipant’s current practice 
What is your current practice of follow up for IC patients? 
How do you decide what follow-up a particular patient will get?   
Are you using any national or international guidelines? 
When? (Frequency) 
What Investigations? (Scans, blood test, others) 
Who? (Professionals involved) 
What is the role of stoma nurse in your current practice? 
Where? (Setting) 
How long? (Length) How do you decided when to stop follow-up (if ever)] 
Do you ever discharge patient to primary care? At what point? 
+/-what arrangement do you use on discharge ensure that GP are comfortable with 
taking that care over from secondary care? (Feedback, meetings, letters) 
182 
 
What is good/ bad about current follow-up practice? [What works well/ what doesn’t work 
well? 
Do you do any evaluation of whether current follow-up “works” ? How can it get better?  
3- Do you feel a need to change follow up schedule 
What are the options? 
Discuss each - Where; Who; How; Setting  
Do you think these would be better or worse than current follow-up? Why? 
Would anything need to be in place to allow changes to follow-up? (e.g. safety net to 
ensure discharged patients don’t fall through crack in service; training of health 
professionals; rapid route back into hospital clinic; more patient education] 
Would there be a need to evaluate any “new” follow-up strategy?    
4-Discharge to primary care 
How safe it is to discharge patient to community? Why? Which patients could be 
discharged? 
What benefits (if any) the secondary care would get from transferring the care to primary 
care?  [Would there be any benefits for primary care?] 
How much skills/ knowledge do GPs have to look after those patients? How can it be 
improved? What role can you personally play? 
Which complications you think the GP will need to deal with frequently? (UTIs, hernia) 
What could be missed with community-based follow-up? How to avoid this? (Renal 
function) 
What investigations? How frequent? Do GP have sufficient resources in the community 
to undertake follow-up? 
What role could stoma nurses play? 
How can patient education help? 
What would be the indications to refer patient back to hospital? 
What might make community follow up difficult? (e.g. Communications with specialists, 
guidelines, GP knowledge, access to SN, patients preference. Etc) 
What would help/been need to make community FU work well? (e.g. Communications 
with specialists, guidelines, GP knowledge, access to SN, patients preference. Etc) 
 
5. Close 
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Is there anything else you would like to discuss, or tell me, about follow-up of these 
patients, either now or in the future? 
Thank you for your help. 
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